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Abstract 
The roam objectives of this PhD project were to relate anal~ te solubility in 
supercritical carbon dioxide via molecular structure and also to investigate the factors 
that influence the solubility and extraction of analytes in a supercritical fluid 
extraction (SFE) when using carbon dioxide as the solvent. 
The polarity of an analyte was selected as the key parameter to developing a means of 
estimating steroid solubility in supercritical carbon dioxide. Polarity can be estimated 
by the hydrophobicity term, log P (based on partition coefficients), and also of the 
solubility parameter, 0,. The use of partition coefficient in conjunction with a 
calculated solubility parameter was demonstrated as a reasonable means of estimating 
steroid solubility in supercritical carbon dioxide. Experimental determination of the 
solubility of several steroid compounds with a range in polarities in supercritical 
carbon dioxide was carried out in order to correlate solute polarity to the solute 
solubility. A chromatographic method was also investigated based on capacity factor 
measurements for the prediction of steroid solubility in supercritical carbon dioxide. 
The application of supercritical fluid extraction (SFE) \\<ith carbon dioxide and 
modified carbon dioxide for the extraction of four antifungals from an animal feed 
matrix has been investigated. The SFE experiments were designed to optimize 
e:\.1:raction conditions for the extraction of the antifungals from the animal feed to 
allow for the evaluation of the most significant variables influencing extraction. A 
method was also developed for the analysis of the SFE animal feed extracts by 
packed-column supercritical fluid chromatography. The modification of the mobile 
phase with polar modifier was necessary to elute the antifungals. The procedure 
provided an alternative separation selectivity to the existing reversed phase high 
performance liquid chromatography techniques v.ith much shorter analysis time. 
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Chapter 1.0 Introduction and Background to Supercritical Carbon Dioxide 
1.1. Development of Supercritical Fluids 
Historically, Hannah and Hogarth 1 first reported the unique solvent properties of 
supercritical ethanol. They discovered that the concentration of cobalt chloride in 
supercritical ethanol was higher than the value predicted by vapour pressure 
calculations. These properties remained unnoticed, except for a few references in the 
geological literature,2-4 until Booth and Bidwell's review in 1948.5 Zhuze and co-
workers6 reported a process for determining lanolin from wool grease in 1958, but the 
real starting point for the use of supercritical fluids as an extraction media was 
demonstrated by Zosel7 at the Max Planck Institute for Coral Research. Since that 
time, supercritical fluid e)"TIaction has found widespread use in numerous areas in 
chemical engineering. The use of supercritical fluids as chromatographic mobile 
phases was first demostrated by KJesper et al.8 These scientists used supercritical 
chlorofluoromethanes as mobile phases for the separation of nickel porphyrin isomers, 
KJesper et al. continued to develop SFC with packed columns by applying the 
technique to polystyrene oligomer separations.9 These developments were followed by 
Sie et al. 10-15 who investigated the use of carbon dioxide, isopropanol, n-pentane and 
other materials as mobile phases with packed columns while applying the technique to 
the analysis of polycyclic aromatic hydrocarbons, antioxidants, dyes and epoxy resins, 
Giddings et al. 16- I7 demonstrated the migration of carotenoids, sugars, nucleosides, 
amino acids, polypeptides, various pol:ymers and other solutes using what \\"a5 
described as "high pressure gas chromatography" with carbon dioxide or ammonia as 
the mobile phase. The work of Giddings in the late 1960's, which showed various 
potential application areas, caused supercritical fluids' future to appear promising. In 
1981, a further important development was demonstrated when fused silica capillary 
column SFC was introduced by Novotny and Lee. 18 Nowadays supercritical fluids 
are e»"1:ensively used in extraction and chromatography. 
1.2 Supercritical Fluids 
All substances can exist as solids, liquids or gases. A substance becomes 
supercritical fluid when it is maintained at temperatures and pressures above the 
critical point, Cp; this is illustrated in the form of a phase diagram (Figure 1.1). 19 
Pressure 
Liquid 
Pc t ••• -------.. -------.---------.----~------------------ __________________________________ •. ____ ~,.-------.---_. _____ _ 
Solid 
Gas 
Temperature T c 
Figure 1.1 Phase diagram for a single substance. 19 
The critical point is defined by a critical temperature, T c' and a critical pressure, Pc' 
above which the substance is neither a gas nor a liquid, but has properties of both. At 
temperatures and pressures above the critical point the substance does not condense or 
evaporate to form a liquid or a gas, but is a fluid with properties changing 
continuously from gas-like to liquid-like as the pressure increases. Equilibrium 
conditions between gas and liquid are represented by a solid black curve in Figure 1.1. 
Below the T c and Pc gas and liquid states co-exist whenever the pressure and 
temperature conditions are such that they are in equilibrium. At the critical point (Cp) 
2 
the densities between the two phases become identical and the distinction bet\\'een gas 
and liquid no longer exists, and the substance becomes a supercritical fluid. 
The physical and chemical properties of supercritical fluids, such as solvating power. 
diffusion and viscosity are all a function of density. At constant temperature, the 
density and hence the solvent strength increases as the pressure increases. The greater 
the density then the greater the solvating power of the supercritical fluid. The density 
changes at a maximwn rate near the critical point. In addition the solubility depends 
on density and increases with pressure. Small pressure d.ifIerences have a marked 
effect on density close to the critical point. While raising pressure increases the 
density, raising temperature decreases the density. Figure 1.2 shows the density 
isotherm for carbon dioxide at several temperatures. 19 
0.93 
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Figure 1.2 Phase diagram for carbon dioxide at several temperatures. 19 
In the region allocated just above the critical pressure. relatively small changes in 
pressure result in a fairly large changes in density. For example, at 35°C an increase 
~ 
.' 
in pressure of only 20 bar from 80 to 100 bar will result in a density increase from 
0.451 g ml- 1 to 0.725 g ml-1. However, a further increase of 100 bar results in a 
much smaller density increase, and carbon dioxide at 35°C and 200 bar has a density 
of 0.872 g ml-1. However the rate of increase in density is less for higher temperature 
isotherms. This is because the density of a supercritical fluid is function of both 
pressure and temperature. 
Table 1.1 Physical Property values for gases, supercritical fluids and liquids. 20 
Density Viscosity Self-diffusion 
(103 kg m-3) (mPa. s) Coefficient 
(104 m2s-1) 
Gas (0.6-2) x 103 (1-3) x 102 0.1-0.4 
30°C,1 atm 
Supercritical fluid 
NearTc Pc 0.2-0.5 (1-3) x 10-2 0.7 x 100-3 
Near T r., 4P c 0.4-0.9 (3-9) x 10-2 0.2 x 10-3 
Liquid 0.6-1.6 0.2-0.3 (0.2-2) x 10-5 
30°C,I atm 
Table 1.1 shows some approximate values of important properties: density, viscosity, 
and diffusion coefficients. The diffusivity of a supercritical fluid is somewhere 
between that of a gas and a liquid, the viscosity is similar to that of a gas while the 
density is close to that of a liquid. 
The high diffusi\'ity of a supercritical fluid allows it to penetrate porous materials, 
while the liquid-like densities enable supercritical fluids to dissolve anal)tes from a 
solid matrix. The density of a supercritica1 fluid is easily controlled by pressure and 
temperature enabling the solvation characteristics of a supercritical fluid to be tailored 
for particular applications. In additio~ their low viscosity provides favourable flow 
characteristics aiding mass transfer of analytes from the extraction cell to the 
collection system. 
Table 1.2: Critical parameters of selected substances useful as supercritical fluids. 20 
Fluid T" (Oe) PI' (Atm) Density (21ml) 
Carbon Dioxide 31.1 72.9 0.47 
Nitrous Oxide 36.5 71.7 0.45 
Ammonia 132.5 112.5 0.24 
n-Pentane 196.6 33.3 0.23 
n-Butane 152.0 37.5 0.23 
n-Propane 96.8 42.0 0.22 
Sulphur Hexafluoride 45.5 37.1 0.74 
Xenon 16.6 58.4 1.10 
Methanol 240.5 78.9 0.27 
Water 374 227 0.0.34 
The two parameters which are important when considering the selection of 
supercritical fluid are the critical temperature and pressure. Ideal supercritical fluids 
should possesses low T c and Pc allowing them to be used with commercially available 
pumps and ovens. Their usefulness is determined by their critical parameters. 
solvating properties, toxicity and availability. Carbon dioxide is unique amongst the 
list of supercritical fluids shO\vn in table 1.2 for effective supercritical fluid extraction 
or chromatography. Its low critical temperature allows extractions to be carried out at 
low temperatures, thereby permitting extractions to be performed on thermally labile 
compounds. Modest compression of carbon dioxide produces a profound change in its 
5 
fluid density as shown on figure 1.2 due to the high non-ideality exhibited by this 
- --
fluid. It is also non-flammable, non-toxic and easy to dispose of, properties which 
facilitate its use in a laboratory environment. 
1.3 Fundamental Properties of Supercritical Fluids Relevant to Extraction and 
Chromatography 
1.3.1 Introduction 
The principal factor that governs the properties of a solvent can be explained in terms 
of intennolecular forces. The power of such forces strongly depends on the distance 
between molecules. In a liquid solvent, the density of the liquid is constant; the 
molecular distances change so little that only a little change in solvent properties 
results. In the case of a supercritical fluid, the kinetic energies of molecules are high 
due to a higher temperature than the critical temperature. The molecular distances and 
hence the density can be controlled mechanically by controlling the pressure from a 
gas-like value to a liquid-like value \\ithout condensation to liquid. This uruque 
behaviour enables the properties of a supercritical fluid to be controlled. 21 
1. 3. 2 Supercritical Fluids as Solvents 
A supercritical fluid must have solvating power if it is to be used as an extraction 
solvent or a chromatographic mobile phase. The solvating power of a supercritical 
fluid is enhanced when it is compressed; the density of the fluid approaches that of a 
liquid. Figure 1.3 demonstrates the behaviour of molecules in gas, liquid and 
supercritical states in terms of the intermolecular potential and the average molecular 
cnergy.21 
6 
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Figure 1.3 The behaviour of molecules in gas, liquid and supercritical states in terms 
of the intermolecular potential and the average molecular energy. 21 
An energetically lower state is preferred at low temperatures. In the liquid state at low 
temperatures, each molecule feels the attractive intermolecular potential. Most 
molecules are then trapped in the potential well. The depth of the potential well is 
usually larger than the average kinetic energy per molecule, moving around only in a 
small region surrounded by adjacent molecules. On the contrary, in the gaseous state, 
most molecules at high temperatures can move freely over the attractive "potential 
well" due to the large average kinetic energy resulting in expanding the free volume of 
the system.21 
In the supercritical fluid state near the critical temperature, some molecules can move 
freely and some are trapped to form weak clusters. This is due to the kinetic energies 
of each molecule fluctuating around the average value. Clusters are formed when the 
molecular kinetic energy is smaller than the attractive energy between adjacent 
8 
molecules. These clusters ruso rapidly change in size and constitution due to molecular 
collisions. When a solute molecule is introduced into the supercritical fluid and the 
solute-solvent attractive interaction is larger than the solvent-soh'ent interaction, the 
solute molecule is surrounded by the solvent molecules to form a cluster. This is due 
to the attractive potential energy surrounding the solute molecule being larger than the 
average kinetic energy of the solvent (supercritical) molecules. The formation of 
clusters around a solute molecule is considered a major cause of enhanced solubility in 
supercritical fluids. 
1.4 General Solubility Theory 
When two charges q and -q are separated by a distance ~ they constitute an electric 
dipole moment, ~. A polar molecule is a molecule with a permanent electric dipole 
moment that arises from the partial charges on atoms linked by polar bonds. Non-
polar molecules may acquire a dipole moment in an electric field on account of the 
distortion the field causes in their electronic distributions and nulear positions. 
Similarly, polar molecules may have their existing dipole moments modified by the 
applied field. 19 
Dipole moments can reveal important information through their role in intermolecular 
forces and in their contribution to the ability of a substance to act as a solvent for 
ionic solids. When a polar solvent such as water dissolves an ionic solute it plays two 
roles: Firstly, strong attractive electrostatic forces (to opposite charged ions) reduce 
the free energy of the system, and secondly there is a reduction in the coulombic 
interactions between the ions in the solution. When a molecule with no ~~ent 
9 
dipole moment is surrounded by a polar solvent the attractive forces do not exist and 
the molecule is said to be insoluble. In other \vords the attraction of water to itself is 
much grater than to non polar molecules and as a result water squeezes out the non 
polar molecules. 
1. 4.1 Intermolecular Forces 
The electrostatic interactions between molecules can often be described in terms of the 
van der Waal forces of attraction. These attractive forces can be sub-divided into: 
1. The London, or "dispersion" force between non-polar atoms and molecules as well 
as polar molecules. 19 These forces are the weakest of all chemical forces of 
attraction. In the dispersion interaction, an instantaneous dipole on one molecule 
induces a dipole on the other molecule, and the two dipoles then interact to lower 
energy. They are dependent on temperature and increase with the molecular volume as 
well as the number of electrons. Dispersion forces are responsible for the 
condensation of the nonpolar substances into liquids and solids as well as for the 
solubility of nonpolar substances into nonpolar liquids. 
2. Dipole/dipole interactions: The Keeson or "?rientation" force, which exists between 
any pair of polar molecules each possessing permanent dipoles. 19 These interactions 
are responsible in part for the association of polar liquids and also explain the 
condensation of polar substances from the gaseous state to liquids and solids at low 
temperatures. 
3. Dipole/induced-dipole interactions: The Debye, or "induction forces" which exist 
between a molecule \\ith a dipole moment and any other molecule by \1rtue of the 
dipole induced in the second molecule by the permanent dipole. 19 The strength of the 
10 
interaction depends on the dipole moment of the polar molecule and the polarizability 
of the second molecule. 
The total attractive interaction energy between molecules is therefore the sum of all 
three contributions discussed above. It should be noted here that because carbon 
dioxide is a symmetrical molecule it does not possess a permanent dipole moment. It 
does however have a permanent quadrupole i.e. 1\vo dipole moments back-to-back. 
This makes an important contribution to the intermolecular forces, but operates over a 
shorter range than dipole-dipole interactions. 
1.4.2 Repulsive Forces and Total Interactions 
When molecules are squeezed together, the nuclear and electronic repulsions and the 
rising electronic kinetic energy begin to dominate the attractive forces. 
Repulsion 
Potential Distance ofSeparatlon (r) 
Energy 0 
Attractive 
Energy 
Figure 14 is the Lennard Jones expression plot of repulsive and attractive terms. 19 
The sum curve (dashed line) has it's minimum at ro' which is equivalent to the nearest 
two molecules can approach \\ithout being repelled from one another. 
1 1 
As well as van der Waal forces of attraction there are Coulombic forces of attraction 
which exists between ions. These forces are proportional to the charges on the ions, 
and inversely proportional to the distance between them. Coulombic forces are 
omnidirectional and can operate over a longer range than other intermolecular forces. 
1.4.3 Solubility Parameter Theory 
This theory is based on the equation of state proposed by Van der Waals. The 
equation was derived as an approximation for non-ideal gases taking account of both 
the attractive and repulsive forces between particles. 19 The repulsive forces assume 
that the particles behave as small but impenetrable spheres. As a result an 
approximate volume (nb) is given to the particles. Thus, the perfect gas law can be 
modified to. 19 
1.1 
Where P is the pressure, V is the volume, T is the temperature, n is the amount of 
substance and R is the gas constant. 
The attractive forces hold the particles together which results in an overall reduction 
in pressure. This reduction of pressure is determined by the frequency of collisions 
with the walls and the impulse of each collision. The actual pressure drop is 
approximately proportional to the square of the density. Therefore, the reduction of 
pressure can be written as a (nIV) 2 , where a is a constant characteristic of each gas. 
Van der Waals equation of state is, 
P = nRT /(V -nb)-c(n/V)2 
or when expressed in terms of molar volume Vm=V/n, 
P = RT/(Vm - b)-an- 2n 
aJV 2 is the internal pressure of the gas. 
m 
12 
1.2 
1.3 
The method for estimating the solubility of a solute in a supercritical solvent applies 
the van cler Waal equation of state for non-ideal gases as its foundation. 
Solubility parameter was first introduced by Hildebrandt and Scott22 for a regular 
solution. It is expressed in terms of the cohesive energy density c, leading to the 
following equation; 
(
M )0.5 [D(Ml _ RT)]O.5 8=J"C=_v = v 
V M 
1.4 
Where, .!lEv is the energy of vaporisation, V is the molar volume, Mfv is the heat of 
vaporisation, M is the molecular weight of the solute or the fluid and D is the density. 
The Hildebrandt Solubility parameter theory applied to a supercritical fluid cannot 
relate to the energy of vaporisation (.!lEv) as vaporisation does not take place under 
supercritical conditions. Using the cohesive energy density from van der Waals 
equation (note that the cohesive energy density is approximately equal to the enthalpy 
of vaporisation per unit volume), and assuming that the solubility parameter for a 
liquid and a gas at liquid density are similar, Giddings extended this theory to 
supercritical fluids by the following equation: 
l.5 
Where Pc is the critical pressure, p is the supercritical fluid density and Pliq is the 
liquid density of the gas. 
If the liquid's solubility parameter is also known then the above equation can be 
simplified to, 
l.6 
Tne reduced soiubility parameter is a term which relates the solubility parameter of 
the solute to that of the supercritical solvent and takes the fo~ 
1.7 
where 0 is the solubility parameter of the supercritical fluid and 00 is the solubility 
parameter of the solute. 
Solubility parameter theory provides an estimation of solute solubility m a 
supercritical fluid. It is fairly simple to use and can give estimates quickly. To 
solubilize a solute compound, the solubility parameter of both the solute and the 
solvent need to have similar values. Therefore, if a supercritical fluid is to be used as 
a solvent, the pressure of the fluid must be higher than the critical pressure, where the 
density becomes similar to that of liquid. 
1.5 Theory of Dissolution Relating to Analyte Solu bility in Supercritical Flu ids 
The dissolution process can be explained by two endothermic and one exothermic 
processes:23 
1. The solid solute molecules interact with neighbouring molecules. For dissolution 
the molecules are separated into isolated component particles. The energy for this 
endothermic process is called the lattice energy and is smallest \-\"hen the solute 
molecules are non-polar. The energy generally increases in the order of increasing 
intermolecular force: non-polar substances< polar substances< hydrogen-bonded 
substances < ionic substances. 
2. The solute component particles are separated from each other and enter the solvent. 
The solvent molecules interact with each other, endothermic energy is necessary in 
order to form a cavity to accommodate the solute molecules in the soh·ent. The energy 
I-t 
necessary for this process is also larger in the order of increasing intennolecular 
interaction in the solvent: non polar solvents < polar solvents < hydrogen-bonded 
solvents. At the same time, the energy is also larger when the volume of the solute 
molecule is larger. This is due to more intennolecular bonds between the solvent 
molecules being broken in order to accommodate more room. 
3. The solute molecules once dispersed in the solvent then interact with the 
neighbouring solvent molecules and the interaction is exothermic. The energy released 
is larger in order of increasing interaction: both solvent and solute molecules are non 
polar < one is non-polar and the other is polar < both are polar < the solute particles 
are solvated by the solvent molecules. 
The overall enthalpy change is exothermic if the energy loss in the first and second 
steps is smaller than the energy gain in the third step. Thus when the solute particles 
are strongly bonded to each other, the solute is only soluble in a solvent in which the 
solute-solvent interactions are large. When solvent molecules are highly associated to 
each other, the solute dissolves well in solvent that will result in strong solute-solvent 
interactions after the component particles are dispersed. 
On the basis of the above we can rationalise the solubility of organic molecules in 
supercritical carbon dioxide as follows: 
Polar molecules tend to have low solubility in supercritical carbon dioxide because the 
energy required to isolate individual molecules (i.e. the lattice energy) is relatively 
high and is not compensated by solute-carbon dioxide interaction as these are 
relatively low (C02 being only able to interact by dispersion forces and dipole-dipole 
interactions). The formation of a ca\ity in the C02 is a relatively low energy proc~ss 
due to the relatively weak interaction between C02 molecules. Hence non-polar 
molecules "ill have high solubility in supcrcritical carbon dio-xidc. 
l~ 
1.6 Basic Principles of SFE 
There are three controlling factors that governs the rate of eA'traction in supercritical 
fluid extraction (SFE), as can be seen in the following t~angle:24 
/ SOlUbility" 
Diffusion Matrix 
Firstly the solute must be reasonably soluble in the supercritical fluid for the 
extraction to be successful. This is particUlarly true at the begining of the eATIaction 
where the rate of extraction is much higher. Control of solubility allows stepwise 
extraction to be carried out. Secondly, the solute must be transported efficiently by 
diffusion from the interior of the matrix. Thirdly, the matrix effect, which means that 
analytes are locked into the structure of the matrix or strongly bound to the surface of 
the matrix. The rate of removal from the matrix using SFE is a function of its 
solubility in the fluid media and the rate of mass transport of the solute out of the 
sample matrix. 
To understand the impact of matrix on extraction rates, four major mass transport 
mechanisms should be considered (figure 1.5):20 
analyte diffusion through the internal volume of the sample 
surface desorption of the analyte 
diffusion of the analyte through a surface boundary layer 
transport in the bulk supercritical fluid phase 
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SF FLOW 
---. 
I = Diffusion through matrix 
2 = Desorption from the surface 
3 = Diffusion through 'SF' surface 
4 = Transport in the SF flow 
Figure 1.5 Mass transport steps for the SFE of an analyte from a porous matrix 
particle 
The diffusion process may simply be normal diffusion of the solute or it may involve 
diffusion of the fluid into the matrix. It should be noted that some matrices swell on 
exposure to supercritical fluids, thus facilitating the mass transport of the analyte 
from within a sample matrix. 
Surface desorption of an analyte by a supercritical fluid is often an important step in 
SFE involving difficult sample matrices. For ~ertain analyte-matrix combinations, the 
solvent power of a supercritical fluid may not be sufficient for a rapid or complete 
extraction. The use of a cosolvent is often required for aiding acceleration of 
desorption of an analyte from the surface of the sample matrix. Diffusion of the 
analyte through a surface boundary layer can also influence analyte extraction. Many 
solid samples \\ill promote condensation of a surface layer of the dense extraction 
fluid at the fluid-solid interface. The density of the adsorbed surface film will partly 
depend on the pressure applied to the supercritical fluid. The development of a 
condensed fluid film at the surface of the sample matrix can aid recovery of certain 
anaJytcs through competitive adsorption at the sample interface as well as inhibit the 
lransport of the anaiyte into the fluid phase. Finally, the transport of the ana1~te in the 
bulk fluid phase is governed primarily by the diffusion coefficient of the anal~ te in the 
fluid medium. As mentioned previously, the diffusion coefficient of solutes in 
supercritical fluids are intermediate between those that they exhibit in liquid and 
gaseous media. This factor is independent of the sample matrix. 
1. 7 Kinetic Modelfor SFE 
In the dynamic mode of extraction, the volume of the supercritical fluid is above the 
solubility limits of the analytes being extracted. In situations like this the rate of 
diffusion out of the matrix is rate limiting. This fact has become the basis for kinetic 
models of SFE. The most recent models proposed are the 'hot-ball model' by Bartle et 
al. 25 (1991) and the model proposed by Pawliszyn (1993) based on mass transfer 
chromatographic theory. 26 
The Hot-Ball Theory 
The hot-ball theory derives its name from the analogy of the mathematical solution of 
dropping hot spherical balls into cold water. The model ignores solubility limitations 
and assumes that the matrix particles are uniform spheres. The distribution of the 
solutes through the matrix at the beginning of the extraction is also assumed to be 
uniform. Assuming the above conditions, the model requires that differential Fourier 
equations27 must be solved. 
The hot-ball theory predicts that the natural logarithm of the mass of solute in the 
sample matrix after the e:\.'traction (m) divided by the initial mass (mo) of solute in the 
sample matrix versus time should have the relation derived in Figure 1.6. 24 
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Figure 1.6 Theoretical curve for the hot-ball S FE model.24 
There are two characteristic parameters on the curve. The first is the time which is 
related to the radius of the sphere by Equation 1.8, where r is the radius and D is the 
diffusion coefficient. The second is the intercept of the linear portion, -I, which has a 
value 0.5 (actually -0.4977) for a sphere. 
1.8 
The graph takes the form of a straight line with slope -lltc ",ith the linear portion of 
the graph beginning at 0.5ic. The initial non-linear part of the graph is explained by 
extraction from mainly the outer part of the spherical matrix. When there is no more 
solute on the surface the extraction becomes an exponential decay. This model has 
been used to predict the time required for total solute extraction for several 
matrices,28 although deviations from the theoretical curve have been observed 
particularly with respect to the intercept, -I. Bartle et al. 25 have attributed these 
discrepancies to irregular spheres and non uniform solute distributions found in 
sample matrices. The hot-ball theory has been adapted successfully for thin films29 
\\"hcre the geometry of the matrix is known. 
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Chromatographic Mass Transfer Kinetics 
The Pawliszyn model26 for the extraction of analytes is based on ,,-ell established 
mass transfer kinetics, the chromatographic elution process and convolution theory. 
Assuming a matrix particle consisting of an organic layer on an impermeable core, 
and that the analyte is adsorbed onto the surface of the core, the mooel considers the 
individual mass transfer steps involved in transporting the anal)te from the core into 
the bulk supercritical fluid. Each of the mass transfer steps is described indiyidually 
and related to their contribution to the height equivalent to one theoretical plate 
(HETP).30 Pawliszyn's model uses five different contributions in calculating the 
overall HETP. The selection of the individual components is designed to reflect the 
extraction process as accurately as possible using the available theory. Therefore, 
there is a contribution to account for slow desorption kinetics from the solid core. 
Also there is a contribution for diffusion through the organic part of the matrix .. The 
analyte migrates in and out of a pore structure of the matrix during the elution. This 
can be described as resistance to mass transfer in the fluid, associated with the porous 
nature of most matrices. Resistance to mass transfer is also the fourth contribution, 
and accounts for eddy diffusion caused by the random pathway of analytes flowing 
through the sample. The final contribution is from an obstruction factor which is 
characterised by the structure of the matrix. 
Chapter 2.0 Application of Supercritical Fluid Extraction and Supercriticai Fluid 
Chromatography in the Pharmaceutical Industry 
2.1 SFE in the Pharmaceutical Industry 
Supercritical fluid extraction (SFE) is widely perceived as a technique for the 
extraction of low to moderately polar compounds. The application of SFE as an 
alternative to distillation and conventional solvent extraction has been considered by 
many industries including the f~ petrole~ synthetic fuel and environmental 
industries.31-40 With increasing concern over the use of chemical solvents in the 
manufacture of phannaceuticals, as well as the need for high quality products, 
alternatives to energy intensive and costly extraction schemes have been sought. 
Phannaceutical compounds are usually: a) highly polar and present at trace levels, b) 
non-volatile and standards for recovery and reproducibility are rigorous, and c) 
matrices are usually quite active and may contain co-extractives. The currently used 
sample preparation techniques for analysis include solid phase extraction, liquid-solid 
extraction, Soxhlet extraction, and liquid-liquid extraction. Recent studies have sho"n 
that the use of supercritical fluids as an extraction medium provides a powerful 
alternative to traditional extraction methods.41 -42 Efficient and selective isolation of 
specific analytes from complex matrices can often be accomplished by using 
supercritical fluids for extraction. The benefits of SFE include faster analysis and 
reduction in sample handling. Due to the high solute diffusivity in the less dense 
supercritical fluid compared to a liquid, the extraction is faster. Other advantages of 
SFE for pharmaceutical compounds include protection from degradation by light. 
heat, or oxygen: high loadability of samples and possibility of trace analysis; 
elimination of hazardous and/or expensive solvents; an<i analysis of aqueous samples 
(serum. urine, and saline solution) "ithout introducing organic solvents. The gentle 
extraction conditions used in SFE compared to more traditional c'-'tractions such as 
Soxhlet e,--traction. also prm ide greater assurance against chemical reaction not ~g 
place during the extraction. This ensures that isolated anal~tes are representative of 
the original sample. Carbon dioxide is the most popular choice for extraction of target 
analytes from solid or liquid pharmaceutical matrices. Although carbon dioxide is a 
non-polar molecule, the lone pairs of electrons on the oxygen atoms (quadruple 
moment) allow the solvation of many polar compounds. Polar organic solvents can be 
added to carbon dioxide as entrainers for enhancing extraction efficiencies. Howevec 
it should be noted that the solubility of analytes in the supercritical fluid or modified 
supercritical fluid does not always ensure its extractibility. The location of the anal\ te 
in or on the matrix is critical, and the interaction of the analyte with active sites on the 
matrix must be disrupted. These features can greatly lengthen the extraction time, 
require higher extraction temperatures and higher modifier concentration. In addition 
to carbon dioxide, other supercritical fluids such as nitrous oxide can also be used as 
extraction fluids. Other than the nature of the extraction fluid, operating conditions 
and parameters of extraction also influence extraction efficiencies. These include 
extraction density, extraction temperature, extraction time, fluid flow rate, the 
inertness of the internal surface of the system, as well as the arrangement and 
conditions of solute trapping. A cold solute trap is usually used in SFE in order to 
enhance the efficiency of trapping the extracted analytes. 
The following sections represent a review of the current literature available on the 
SFE of pharmaceuticals. 
2.1.1 Spiked Animal Feed 
In the pharmaceutical industry, long-term feeding studies of chemical substances 
involves incorporating the target anal)tes into animals feed prior to administration. 
Anal)tical methods are required to monitor the dose level, to verify dosage uniformity 
throughout the sample matrix and to test for anal~ te stability in the feed as part of 
toxicological investigations. Schneiderman et al.-l3 and Messer and Taylo(l4 were 
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among the first to report on the applicability of using SFE as a quantitative method 
for extracting drugs from animal feed matrices. Locke reported extracting menadione 
(Vitamin K3) from spiked rat chow using supercritical carbon dioxide at 8000 psi and 
60°C. Quantitative extraction was achieved within 20 minutes. Collection of the 
analyte was achieved by trapping the expanding supercritical carbon dioxide into a 6 
x 0.25 in i.d. stainless steel tube filled with silica gel. The silica gel was subsequently 
washed with 10 ml methylene chloride. Menadione was determined in the extract 
without any cleanup using reversed phase HPLC with reductive mode electrochemical 
detection. The lowest concentration of menadione extracted quantitatively was 20 
~glg of feed. An average recovery of 90.5% with 2.2% RSD was reported at the 1 
mg/g leveL 
Messer and Taylor44 reported the applicability of extracting a hypolipidermic drug, 
4- trifluoromethyl-2-biphenyl carboxylic acid quantitatively from a spiked rat feed 
matrix at a level of I %. Extraction was performed with supercritical carbon dioxide 
off-line and solid phase trapping followed by solvent rinsing was utilized. An 
optimized method for quantitative extraction of the pure drug was initially developed 
with high reproducibility. The parameters investigated for extraction of the pure drugs 
were as follows: the density of C02, the number of C02 thimble volumes, collection 
trap ( C-18 vs stainless steel) and rinse solvent (50% acetonitrile / 50% water and 
100% acetonitrile). The studies were carried out in triplicate with 100% C02 and the 
trap temperature, the chamber temperature and the nozzle temperature were kept 
constant. Triplicate 100 mg samples of spiked animal feed containing 10/0 drug were 
next extracted using the optimized extraction conditions. The average recovery 
obtained for these extractions was only 68.8% with a RSD of 20.60/0, despite the fact 
that acceptable recoveries and RSDs were obtained with the pure drug. The results 
obtained lead to the authors believe that the problem was with the sample itself rather 
than the poor solubility or extractibility of the anal)te in the supercritical fluid. To 
investigate the inhomogeneity in the "crystalline matrix" causing the poor 
")"' 
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reproducibility, the animal feed was spiked with the drug in a different manner. Rather 
than mixing the drug mechanically as a crystalline substance on a large scale, the drug 
was first dissolved in methylene chloride and a slurry with the pure ground feed was 
prepared. The slurry was then mixed, allowed to dry and was used as the "solvent 
matrix". The dried solvent matrix was then thoroughly mixed. Triplicate 100 mg 
samples of the "solvent matrix" were extracted using the optimized extraction 
conditions. The average recovery obtained for these extractions was 84.0% and the 
RSD of 2.09%. This study showed that the "crystalline matrix" was not homogeneous 
and since the matrix size was only 100 mg, the sample for each replication was not 
always representative. The authors concluded that the less than quantitative recoveries 
may reflect a matrix effect which might be eliminated with the addition of a modifier 
in the extractant phase, where the modifier function would be to compete "ith the 
drug for the active sites of the matrix. In this particular example of SFE of a polar 
drug from an animal matrix, the use of a modifier such as methanol would probably 
have resulted in complete recovery. 
Messer et al.45 reported routine extraction of atovaquone [trans-2-[4-(chlorophenyl) 
cyclohexyl]-3-hydroxyl-1-2-napthoquinon] from rat feed. Initial experiments involved 
extraction of atovaquone from an inert Celite matrix to establish the extraction profile 
of the drug in the absence of the matrix. Spec}fically, after increments of time the 
dynamic extraction was interrupted, the collection trap was rinsed and the resulting 
solution was analysed. Spiked test samples were prepared by spiking 0.20 ml of a 
1.00 mg/ml solution of atovaquone in methylene chloride onto a Celite bed inside the 
extraction cell. The samples were left overnight at ambient conditions to allow solvent 
evaporation. The atovaquone spiked samples were then subjected to a five step 
extraction. Supercritical carbon dioxide was used as the extraction solvent at a flow 
rate of 2 mllmin throughout the extraction protocol. The pressure was held at 350 bar 
and oven temperature at 50°C producing a supercritical fluid density of 0.9 g/ml. The 
trap consisted of stainless steel spheres (l 00 ~m diameter) held at 5°C during 
extraction and 400C during rinsing. The temperature of the variable restrictor was 
kept constant at 55°C during extraction and rinsing. The stainless steel trap was rinsed 
with 1 rnl of acetonitrile for the first 4 steps and 3 ml of acetonitrile for the last step. 
The five steps of extraction carried out were as follows: Step 1. Equilibration (vessel 
pressurised), 2 minutes; dynamic 2 minutes, steps 2 and 3, dynamic 3 minutes, step 4 
dynamic, 4 minutes; step 5 dynamic, 8 minutes. This gave a total dynamic extraction 
time of twenty minutes. The results showed a recovery of 67. I % in the first step and 
an additional recovery of 16.7% in the second step, giving >80% recovery of 
avequone in the first five minutes of the extraction. The total recovery obtained for the 
extraction profile was 95.4% indicating high solubility of atovaquone in supercritical 
carbon dioxide in a reasonable amount of time. It also showed that the stainless steel 
trap was able to hold the analyte during the extraction process and effectively 
delivered the analyte upon application of the rinse solvent. To study the effect of a 
modifier, a second set of extractions was performed with 2 % methanol modifier. 
Experimental conditions were kept the same with the exception of the increasing the 
trap temperature to 70°C to ensure that the methanol peering in the trap was in a 
gaseous state. The results obtained under these conditions showed that the extraction 
recoveries for the combined initial two steps was only 61.8% for methanol-modified 
C02, compared with >80% for the extraction with 100% C02. The lower recovery 
was thought to be due to poor collection efficiency. Consequently, pure C02 was used 
for extracting the spiked drug. Atovaquone was studied at six levels ranging from 
0.0335 to 1.1208%. Sample sizes for extraction were either 250 or 500 mg depending 
on the spike level. Extraction were performed in triplicate and >95% recovery ",ith 
<5% RSD was obtained for all matrices except for the 0.0335% level, which was 
890/0. The authors concluded that the SFE results were comparable to conventional 
extraction results. 
Euerby et al.46 reported the SFE of a novel corticosteroid tipredane at a level of 10 
ppm from rodent diet. A number of collection methodologies were investigated by the 
authors to obtain maximum recovel)' of the anal) te and it was concluded that the 
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direct collection from the back pressure regulator (BPR) through a short length of 
tetrafluoroethylene tubing into a calibrated flask containing 1 ml of methanol. 
stoppered with a small piece of cotton wool to trap any escaped anal) 1e gave the best 
results. The authors investigated the extraction of the tiperadane \\ith and ",ithout the 
presence of ethanol modifier. The flow rate of ethanol was altered, keeping the C02 
flow rate constant to determine the optimum polarity of the SF and the optimum 
collection efficiency. The optimum extraction conditions employed were as follows: 
pressure, 200 kg/cm2, oven temperature 70°C, C02 flow rate, 3.0 mlIIIlin, ethanol 
flow rate, 0.3 ml/min, and BPR temperature 40°C and an extraction time of 2 
minutes. The authors compared the optimized extraction with the more conventional 
extraction procedures of Soxhlet and ultrasonic agitation. The average extraction 
recovery obtained with SFE was 85% with an RSD of 6% compared with 92% 
obtained from Ultrasound (RSD 3%) and 94% Soxhlet extraction (RSD 6%). The 
authors concluded that the advantage of SFE is that the extraction is rapid and no 
preconcentration step was required prior to HPLC analysis. The effect of total flow 
rate of both C02 and ethanol on the extraction recovery was investigated in this 
particular case. It was found that the maximum extraction reovery (85%) was 
achieved at a C02 flow rate of 3 ml/min and increasing the flow rate further resulted 
in a loss of extraction recovery. This was probably due to a inefficient trapping of the 
extracted analyte and complete recovery could probably be achieved with a better 
collection system. 
Williams et al. 4 7 presented a comparison of supercritical, subcriticaL hot pressurized 
and cold solvent extraction of propanolol, tamoxifen and two experimental drugs, ZM 
95527 and ZM 169369 from rodent diet. The experimental conditions employed for 
the supercritical and subcritical fluid extraction were C02-MeOH (85/15 viv or 83/17 
viv) at 70°C and 17.25 MPa. Recoveries obtained by different e:\.1raction methods 
were compared and it was found that hot, pressurised MeOH at 2.0 mVmin and 70°C 
was more efficient for the recovery of ZM 95527, less efficient for the recovery of 
tamoxifen. but not significantly different for the recovery of propanoIoI and ZM 
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169369. The recoveries obtained by the subcritical method were intermediate between 
the SFE and the hot, pressurised MeOH. The authors concluded that ahhough the 
efficiency of these methods was similar to conventional extraction \\ith acidified 
MeOH, the precision obtained by the solvent extraction method was superior to the 
other methods described. 
2.1. 2 F ormu lations 
This is the largest category of pharmaceutical analysis involving the mostly varied 
group of complex matrices, for example ointments, syrups, capsules, infusions, 
creams and tablets. Richter et al. 48 reported the use of chloroform modified C02 for 
extraction of an antihistamine drug from a transdermal patch as a replacement for 
conventional liquid extraction. In the matrix itself, the drug was suspended in a gel 
under an adhesive. Quantitative extraction data was achieved with an RSD of 2.7%. 
A similar study was also reported49 for the extraction of nitroglycerin from 
transdermal patches, where C02 fluid was modified with tributyl phosphate (75/25, 
vol/vol). Methanol was used as the collection solvent after extraction at 450 atrn with 
C02 at 75°C for 30 minutes. The recovery achieved was 99.1% with an RSD of 
2.8%. 
Extraction of triamcinolone from dermatological patches was also attempted by 
Edwardson and Gardner.50 Extractions were carried out with C02 modified \\ith 0, 5 
or 10% methanol at 80°C for 5 minutes. Recoveries of only 10% were achieved. 
However, the authors did not investigate a longer extraction time, different extraction 
temperature or modifier which may have resulted in improved extraction recovery of 
triamcinolone. The SFE of misoprostol, a s)nthetic prostogladin from a 
hydroxypropyl methyl cellulose dispersion was reported by Roston. 5 1 Sample 
components were extracted and subsequently precipitated in the cryofocussing trap 
during the decompression step. Experimental conditions used were 7ooC, C02 density 
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of 0.8 g/ml and extraction time of 4 minutes. Maximum extraction efficiency was 
reported to be only 65%. 
Dean and Lowdon52 reported extraction of megestrol acetate from a tablet 
formulation. Preliminary investigations were first performed by extracting the drug 
from an inert Celite matrix to establish optimized experimental conditions for 
extraction from the tablet matrix. Optimized extraction conditions were first 
developed with 1000/0 C02 at a temperature of 55°C, density 0.81 g/ml and a flow 
rate of 2 mlImin. Subsequent extraction from a tablet formulation using the optimized 
extraction conditions gave a poor recovery. The tablets were ground to aid the rate of 
extraction. A 160 mg tablet was weighed, ground to a powder and 20 mg sub-samples 
were extracted over increasingly longer periods at the optimum conditions described 
previously. The results obtained indicated a maximum recovery of 70.4% after 20 
minutes. Further extractions were carried out with 10% modified methanol-C02 using 
the same optimized conditions and a maximum recovery of 92.8% was achieved after 
20 minutes of extraction time. The authors also presented a direct comparison of SFE 
with a United States Pharmacopoeia (USP) monograph method for the analysis of 
megestrol acetate from the tablet formulation and concluded that the USP method 
provided the analyst with more precise determinations of megestrol acetate from a 
tablet matrix. 
SFE from tablet matrices was also explored by Anderson et al. 5 3 All major 
ingredients from davron tablets were extracted with supercritical carbon dioxide and 
chromatographed with a coupled SFC system. All major active ingredients were 
identified along \\itb binders and excepients used in the tablet formulation., but 
quantitative recoveries were not reported. Ibuprofen tablets were extracted 
qualitatively by supercritical carbon dioxide (pressure 5000 psi. temperature 50°C) 
without any excessive grinding by Nair et al. 54 
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Anklam and Muller55 reported extraction of caffeine and vanillin from tablet 
formulation using supercritical carbon dioxide at 50°C and 350 bar. Tablets were 
ground to a powder and subsamples of 100 mg were mixed with 1 g of sami 
moistened with 100 J.l1 of water prior to extraction. A 5 minute static and 20 minute 
dynamic extraction time was employed. The recovery achieved for vanillin and 
caffeine were 97.7 % and 98.5% with an RSD of 3.1 % and 1.4%. The authors 
concluded that the SFE results were comparable to Soxhlet extraction results. Scalia 
et al. 56 reported the extraction of vitamin ~ vitamin E and their esters in tablet 
preparations using SFE and HPLC. Tablets were powdered and sub samples (l00-150 
mg) were mixed with sea sand (3 ml) and extracted with supercritical carbon dioxide 
at 40°C and 200 atm for 15 minutes. Quantitative extraction data was achieved (> 
95.6%) with an RSD of l.7% and 3.9% for Vitamins A and E, respectively. The 
authors concluded that the SFE method was superior to the existing standard method. 
Howard et a1. 57 successfully demonstrated the application of SFE as a sample 
preparation method for felodipine tablets. Static/dynamic mode SFE together with 
C02 with 8.7% MeOH modifier was used for extraction. The recoveries obtained by 
this method (98.6%) were comparable with traditional liquid extraction method 
(99.7%) and similar levels of drug degradation were observed for both methods. 
Lawrence et al.58 demonstrated the application of SFE for the extraction of several 
benzodiapines (alprazo~ clorazepate, chlordiazepoxide, diazep~ oxezepam, 
tamazepam,triazolam) in solid dosage form. One quarter of a ground tablet or capsule 
sample of various weights was dispersed in 450 mg of Hydromatrix and extractions ( 
5 minute static and 10 minute dynamic) were carried out with C02 modified \\itb 2% 
MeOH at pressure 100 atrn and temperature 65°C. The eluate was collected in 500 III 
of MeOH \vhich was evaporated to dryness before dissolution of the residue in 50 III 
of MeOH. All dosage form extracts were free from matrix components and were 
analysed by GC-MS. Extraction )ields which were sufficiently high to allow GC-
FTIR analysis were only obtained from the dosage forms containing > 1 mg of 
benzodiapeine. 
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Moore and Taylor59 successfully demonstrated the application of SFE for the 
extraction of polymyxin B sulphate from cream and ointment matrices. Cream (200 
mg) was extracted at 55°C and 300 atm for 45 minutes v.ith 5% MeOH modified 
C02 (2 mIlmin). For the ointment, a pressure of 450 atm and temperature 60°C were 
employed at the same flow rate. Average recoveries reported for the cream and the 
ointment were 108% and 136% with an RSD of 5% and 1.9%, respectively. Messer 
and Taylor60 investigated the application of inverse analytical SFE and HPLC for the 
determination of acylvoir from 5% Zovirax ointment. The ointment sample (100 mg) 
was placed between the frits of a SPE tube, and the tube was subsequently transferred 
to the extraction cell. The extraction cell was kept at a temperature of 50°C and C02 
modified with 2% MeOH was used as the extraction fluid at 0.9 mlfmin to extract the 
hydrocarbon-based ointment base. Two portions of 0.01 M-NaOH were used for the 
ultrasonic extraction of the acylvor active component from the inner vessel. An 
average recovery of 99% with RSD 5.3% was reported for ointment containing at the 
50 mg/g of acylvoir. 
Mu1chey et al.61 reported the application of SFE for direct extraction of polar active 
ingredients from liquid matrices. The investigation involved the extraction of 
sulfamethazole and trimethoprim from Septa infusion. The active ingredients of Septa 
infusion contained 16 mg of trimethoprim and 80 mg of sulfamethazole per ml of 
infusion. The active components are dissolved in 40% propylene glycol, 10% ethyl 
alcohol, and 0.3 % diethanolamine with 1 % benzy I alcohol and 0.1 % sodium 
metabisulphite added as preservatives. Extractions were performed in two ways. The 
first method involved extracting septra infusion liquid directly using a modified 
extraction vessel designed to bubble the supercritical fluid before exiting to the trap. 
This method however gave poorer ~ ields as a result of restrictor plugging caused by 
precipitation of sulphamethoxazole when the solution pH was lowered by the 
introduction of C02. The second method involved spiking the active ingredient onto 
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Celite followed by extraction of the drug with 100% C02. This way quantitative 
recovery was achieved for both drugs when the active ingredients were spiked at < 1.0 
mg. Co-extractives of the drug were observed but did not interfere with the HPLC 
assay. 
Hedrick and Taylor62 reported a qualitative study of the hydrochloride salts of 
triprolidine and pseudoephedrine from an aqueous matrix. The anal~ tes were found to 
be insoluble in supercritical C02. A molar excess of tetrabutylarnmonium hydroxide 
was added to 3 rnl of 1 rng/ml solution of both compounds in order to extract the free 
bases fonned with 100% C02. Qualitative static extraction resuhs showed that the 
free bases were extractable from water and chromatography could be achieved under 
supercritical conditions. 
2.1.3 TIssue-Serum-Faeces-Urine-Milk 
The rapid and accurate measurement of ultra trace levels of drugs and their 
metabolites in biological matrices plays a major role in the pharmaceutical 
development process. These measurements of drugs and metabolites provides 
information for the mechanism of action in pharmacology and toxicology studies, as 
well as for clinical development.63 Ramsey ~t al.64 reported using supercritical 
carbon dioxide to extract four veterinary drugs, trimethoprim, hexestrol, 
diethylsilbestrol and denestrol from freeze dried pig-kidney. The use of on-line SFE-
SFC-MS was demonstrated for qualitative analysis of the drugs from the matrix. 
Portions of powdered kidney (1 g) were mixed with methanol (10 rnI), spiked with 
relevant amounts of each drug, sonicated for an hour to allow homogenous mixing and 
then the solvent was dried under nitrogen stream. Extraction was carried out. \\lth 
1000/0 C~ for 8 minutes and then with C02 modified \\ith 200/0 methanol for 0.5 
minutes at a flow rate of 4 mllrnin. During the extraction, drugs were retained in an 
amino-bonded column while the endogenous material was passed to waste. The eluted 
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drugs were detected with high specificity by tandem MS. The authors concluded that 
even though the method showed great potential, the detection limits were not sufficient 
to meet the stringent controls on drug residues in meat for human consumption. 
The solubilization of 5 veterinary sulpha drugs in supercritical fluid media and their 
extraction from spiked chicken liver and swine muscle samples were investigated by 
Cross et al.65 C02, modified with 10-20 % methanol was required and the authors 
concluded that increasing extraction pressure, time and % modifier all facilitated 
greater solubilisation, as does the use of small-diameter extraction cells. The effect of 
temperature varied from drug to drug, but in all cases recoveries were maximized at 
low temperatures. It was found useful to immobilise the water in the animal tissue by 
the addition of diatomaceous earth to the extraction vessel. The authors reported 
recoveries in the mid 90% range at moderate pressures in less than 1 hOUL \\ ith very 
little variation between the set of related sulphonamides. Greater solubilization of 
these drugs could probably be achieved with increasing severity of extraction 
conditions. 
Liu and Wehmeyer66 demonstrated the use of SFE for the direct extraction of drugs 
from plasma prior to analysis. The supercritical fluid was passed directly through the 
plasma samples spiked with either a neutral (flavone) or an acidic drug, ketorolac. 
The addition of an antifoam agent to the plasma prior to extraction was necessary to 
avoid restrictor plugging caused by denaturising of the plasma proteins by the 
supercritical fluid. The effluent from the extraction cell was bubbled through a small 
volume of methanol or into an empty tube to trap the extracted drug. The effect of 
extraction pressure and time on absolute recovery were investigated. The optimum 
extraction conditions used were as follows: pressure 30 MPa, temperature 60°C and 
an extraction time of 20 minutes. For spike levels of 25 ng Iml of 14C-flavone and 
14C-ketoflavone recoveries obtained averaged 98% (RSD of 5.2%) and 80% (RSO 
11.08%) respectively and for spike levels of 100 and 250 ng/ml of 14C-flavone the 
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recovenes obtained averaged 85% (RSD of 5.8%) and 87% (RSD 3.8%), 
respectively. The authors concluded that the absolute recovery, selecti\'ity. precision, 
and accuracy of SFE was comparable to those obtained by conventional liquid-liquid 
extraction. 
SFE coupled with SPE using octadecylsilane cartridges has been subjected to selective 
isolation of ultra trace levels of a drug metabolite, mebervine alcohol, from dog 
plasma.67 In these studies dog plasma was applied directly to the extraction cartridge 
and the cartridge washed to remove protein and then extracted under supercritical 
conditions using 5% methanol modified C02. The extracted metabolite ofmebeverine, 
mebervine alcohol (MEBOH) was trapped by bubbling the effluent from the 
extraction cell through a small amount of 2-propanol. The effects of extraction 
pressure and temperature on analyte recovery were examined. 14[C] MEBOH was 
used to examine the absolute recovery of the SFE/SPE approach. The addition of 
amine modifier to the fluid phase was required to aid extraction. For spiked levels of 
50 nglml, 14[C]MEBOH recoveries obtained averaged 95%. For 10 ng/ml spike level, 
recoveries dropped to 83%. It was reported that these extraction conditions also eluted 
unwanted material from the cartridges themselves. The accuracy of SPE-SFE was 
considered to be comparable to conventional SPE methods. The SPE-SFE procedure 
described by the authors was similar to the SPE procedure, the only difference being 
the use of a supercritical fluid to elute the analyte from the cartridge. Although the 
SFE-SPE method is less time consuming, the SPE method is probably a better choice 
in terms of cleaner extracts and improved extraction recoveries. 
The use of SPE colwnns as a quantitative trapping device was demonstrated by 
Maxwell et al.68 Three antimicrobial drug residues were extracted at 600 bar at 
expanded gas flow rates of 3-4 mlIrnin. Residues were eluted from the SPE column by 
off-line analysis. An integral metering \"alve-collector assembly reduced the loss of 
trace anal}1es in the tissue. 
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Vitamin Kl (phylloquinone) has been extracted69 ~ith C02 at 8000 psi and 60° C 
from commercial soy protein and milk based powered infant fonnulas. Quantitative 
extraction required only 15 minutes and extracts were free of co-extractives from the 
lipophilic materials. Recovery of vitamin Kl obtained from the milk-based powered 
formula was 95.6% with an RSD of 7.4%, and that from a soy protein-based product. 
94.4%, with an RSD of 6.50/0. Application of this method to liquid formulas by using 
a larger extraction chamber packed with Chromo sorb W, to which 7 ml of liquid 
product was added, proved unsuccessful. Ndiomu and Simpson 70 reported the 
extraction of morphine from freeze dried serum samples spiked \\ith 200 Ilg/ml. 
Recoveries of 96.7% with an RSD of 3.2% were obtained compared to 92.2% for 
SPE. In the same study, the authors also reported the successful analysis of morphine 
in placental samples. 
Karlsson et al.71 investigated the application of SFE recovery studies of budeosonide 
from blood plasma matrix. Plasma was spiked with [3H]-budesonide and a 500 tJ.I 
sub sample was deposited onto a filter paper in the extraction thimble. Extractions 
were with pure C02 at 110°C for 30 minutes. The analytes were trapped on to a ODS 
bonded column during extraction. After extraction, the trap was washed with MeOH 
at 40°C and the system was depressurised. The budeosonide extracts were quantified 
using a liquid scintillation counter and the average recoveries reported were >80%. 
Edder et al.72 demonstrated the application of SFE for extracting codeine, 
ethylmorphine and morphine in hair of drug addicts. A sample (50 mg) of pulverised 
hair was extracted with c02IMeOHitriethyiamineiH20 (85/6/6/3) at 0.7 mllmin and 
40°C for 30 minutes. After extraction, the solvent was evaporated and the samples 
were treated with 100 III of p~ Tidine and 100 III of propionic anhydride at 60°C for 30 
minutes. The solvent was evaporated and the residue was dissolved in ethyl acetate 
ready for analysis using GC-EIMS. The recovery obtained for morphine was 93.:'0/0. 
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Comparisons of SFE results with those obtained ,,,ith other extraction techniques were 
also presented. 
2.1. 4 Other Applications 
The potential for SFE as a size reduction method as an alternative to milling and 
extraction of fennentation products were demonstrated by Larson and King.73 In 
particular SFE was shown to be suitable for extraction of mevinol~ a metabolite of 
the fungus Aspergillus terreus from a freeze dried fermentation broth. Ndiomu and 
Simpson 70 demonstrated the potential of SFE for extracting drugs such as papaverine 
and quinone from plant material. The SFE of taxicin as anticancer drugs from dried 
needles of the English yew tree, Taxus baccata was demonstrated by Heaton et al.14 
The optimum extraction conditions for the extraction taxicin were: 10% methanol 
modified C02 at 50°C and 400 atmospheres for 100 minutes. The extraction 
efficiency of SFE was reported to be comparable with liquid solvents and methods 
were developed for quantitative and qualitative monitoring of the extracts. 
Ma et al. 75 (demonstrated the extraction of Chinese herbal medicine, frankincense, 
myrrh and evodiarutaecarpa using supercritica1 carbon dioxide. The optimum 
e)..'traction condition of 20 MPa, 50°C and 40 minutes extraction time yielded good 
extraction efficiency and selectivity, especially for the high molecular weight and 
oxygenated components. 
Liu et al.76 investigated the application of SFE to e)..1ract diosgenin follo\\'ing acid 
hydrolysis from tubers of Dioscorea nipponica. Samples of 0.05 g were extracted 
\\ith pure C02 over a range of range of temperatures and pressures for different 
periods of time. Diosgenin determinations were carried out using capillary GC of 
trifluoroacetate derivatives. Highest recovery was achieved at 3100 psi and -l-l°C for 
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70 minutes, but >82% of this yields was extracted by 40 minutes. The yield were 33% 
lower using conventional light petroleum extraction. 
The potential use of a supercritical fluid other than supercritical carbon dioxide for 
extraction of pharmaceutical compounds was demonstrated by Sauvage et al.77 The 
comparative behaviour of nitrous oxide and carbon dioxide as the supercritical fluids 
was studied for extraction of a halogenated aromatic phenoxy derivative (HAP A) of 
an aliphatic alkane from a dog feed and a halogenated aromatic phenoxy derivative of 
urea (HAD) from a rodent feed. Results were obtained with pure supercritical fluids 
with high solvating power (density of 0.79 glml) and fluids modified \\ith a polar 
modifier (methanol and acetonitrile). The results indicated that with modified nitrous 
oxide, the extraction time of HA U was reduced by a factor of 2. For the extraction of 
HAP A, the total extraction time required was only a few minutes compared to 70 
minutes extraction time by the classical method. 
The use of Freon-22 in supercritical fluid extraction and chromatography was 
demonstrated by Li et al.78 For the extraction of a series of steroids, the extraction 
efficiency with Freon-22 was found to be significantly better with shorter extraction 
time compared to supercritical carbon dioxide. 
Tables 2.1 summanses the results obtained by SFE. 
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Table 2.1 Summary of results obtained by SFE 
Analyte Matrix Extraction Conditions % Recovery Reference 
Menadione rat chow C02 at 8000 psi, 60°C and 92.4% recovered with 2.2% 43 
20 mins RSD at the 1 mglg level 
Hypolipidermic drug rat feed C02; 0.9 glml, 50°C and 30 84.2% revvovered with RSD 44 
nuns 2.1% 
Atovaquone rat feed C02 at 350 bar and 50°C >95 % recovered with <5 0/0 45 
RSD 
Tiperadane rodent diet 10% EtOH modified C02 at 85 % recovered with 6% 46 
200 kglcm2, 70°C and 2 RSD 
nuns 
Propanolol, Tamoxifen, ZM rodent diet MeOH modified C02 at 88.4% with an RSD of 47 
95527 and ZM 169369 70°C, 17.25 MPa 12.9% for propanolol, 86.2% 
with an RSD of 8.1 % for 
tamoxifcn, 84.5% with an 
RSD of 12.1 % for ZM95527 
and 81.2% with an RSD of 
12.2% for ZM 169369. I I 
Antihistamine trandermal patch Chloroform modified CO2 quantitative recovery, 2.7% 4X 
RSD 
Nitroglycerine transdermal patch tributyl phosphate modified 99.1 % recovered with 2.8% 49 
CO') at 80°C and 5 mins RSD 
Triamcinolone dermatological patches MeOH modified CO? 10% recovered 50 
Misoprostol hydroxypropyl C02 at 0.8 glml, 70°C and 4 65 % recovered 51 
methylcellulose mms 
Megestrol Acetate tablet MeOH modified C02 at 0.81 92.8% recovered 52 
_~55°C and 20 mins 
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Davron tablet CO? Qualitative 53 
Ibuprofen tablet C02 at 5000 psi and 50°C - 54 
Caffeine and Vanillin tablet C02 at 350 bar, 50°C and 97.7% recovered for vanillin 55 
25 mins with RSD of3.l%, 98.5% 
recovered for caffeine with 
RSD of l.4% 
Vitamin A and E tablet C02 at 200 atm, 40°C and >95.6% recovered 56 
15 mins 
Felodipine tablet MeOH modified CO2 98.6% recovered 57 
Benzodiapine tablet/capsule MeOH modified C02 at 100 quantitative 58 
atm, 65°C and 15 mins 
Polymyxin B sulphate cream/ointment MeOH modified C02 at 300 108%recovered for the cream 59 . ~ 
atm, 55°C and 45 mins for with 5% RSD and 136% 
the cream, MeOH modified recovered for the ionment 
C02 at 450 atm, 60°C and with 1.9% RSD 
45 mins for the ointment 
Acylvoir ointmmV MeOH modified C02 at 99% recovered with RSD 60 
50°C 5.3% at 50 mglg level 
Sulfamcthoxazolc and septa infusion C02 at 250 atm, 50°C and direct from infusion: 61 
trimcthoprim 100 m1 C02 for direct sulfamethoxazole recovery 
analysis, 0.85 glml, 60°C, 2 5%. After immobolization 
mVmin from Celite. onto Celite: 113% recovered 
with 14% RSD for 
sulfamethoxazole and 85% 
recovered with 10% RS D for 
trimcthoprim 
triprolidinc and aqueous CO2 qualitative 62 
~scudocl'hcdrine 
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Veterinary drugs pig-kidney C02 only and MeOH qualitative 64 
modified at 302 bar and 
75°C 
Veterinary sulpha drugs liver and swine samples MeOH modified CO2 recoveries ranged from 27 to 65 
97% 
Ketorolac and flavone plasma C02 at 30 MPa, 60°C and 98% recovered for flavone 66 
20 mins with RSD 5.2%, 80% 
recovered for ketorolac with 
11.1% RSD 
Mebervine alcohol dog plasma MeOH modified C02 at 350 95 % recovered at the 50 67 
atm, 40°C and 10 mins ng/ml spike level I 
Antimicrobial drug residue liver CO? at 600 bar quantitative 68 
Pollyquinone soy protein and milk based C02 at 8000 psi, 60°C and 95.6% recovered for infant 69 
infant formula 15 mins formula with RSD 7.4%, 
94.4% recovered for soy 
protein with 6.5% RSD I 
Morphine serum CO2 96.7% recovered with RSD 70 I 
3.2% 
Beudeosomide plasma CO) at 110°C and 30 mins > 80% recovered 71 
Cadeinc, Morphine and ethyl hair MeOH, TEA, H20 modified >93.5% 72 
morpJlne C02 at 3 100 psi, 44°C and 
70 mins 
Mevinolin fermentation broth CO) and various modifiers selective extraction 73 
(MeOH, t-butyl amine, acetic investigated 
acid) 
Taxicin needles of yew tree MeOH modified C02 at 400 83% recovered 74 
atm, 50°C and 100 mins 
Chinese herbal medicine plant C02 at 20 M Pa, 50°C and quantitative 75 
40 mins 
- ~~ 
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Diosgenin tubers of Dioscoica C02, range of temperature 76 
and Rressure studied 
-' 
Halogenated aromatic dog feed/rodent feed MeOHlMeCN -modified quantitative 77 
phenoxy derivatives C02,MeOHlMeCN -modified 
N02,C02 and N02 at 0.79 
~ml 
Steroids C02 and Freon-22 quantitative 78 
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2.2 SFC of Pharmaceuticals 
Pharmaceutical compounds are commonly polar, non-volatile and thermally or 
chemically labile. Techniques such as high performance liquid chromatography 
(HPLC) and gas chromatography (GC) are applied for the routine analysis of 
pharmaceuticals. Although supercritical fluid chromatography (SFC) has been kno"TI 
for more than twenty years, it has emerged as a viable technique only recently. SFC is 
a chromatographic technique which exhibits some characteristics of GC and liquid 
chromatography. Unlike GC or HPLC, where the mobile phase dominates the ~-pe of 
detection method employed, SFC utilises mobile phases with physical parameters that 
allow the implementation of either fluid phase or gas phase detectors. This 
multidetector compatibility makes SFC a very attractive separation method for 
analysing complex mixtures. Pharmaceutical industries can reap real benefits from 
SFC for analysis of thermally labile, polar and weakly chromophoric compounds not 
readily amenable for analysis using other techniques. 
The application of SFC for pharmaceutical analysis is widespread and there has been 
numerous review articles published about the analysis of drugs. Bartle et aI.79 
published a review on capillary SFC (cSFC) on different types of samples including 
analysis of five drugs while Wilson et al.80 published a comprehensive on the use of 
SFC and SFE in the pharmaceutical industry. Niessen et aI. 81, Wong et aI.82 and Xie 
et aI.83 published reviews on bioanalytical and biomedical applications of SFC which 
included analysis of drugs. Chester et al.84 and Lubke85 also published reviews on 
SFC and SFE where sections of the review included applications of SFC for drug 
analysis. 
The majority of the published articles on SFC of drugs reported the analysis of test 
solutions from pure compounds (authors often fail to mention about the sample 
matrix). Some articles however. include real matrices such as blood plasma and 
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serum, urine, biological tissues and plants. In some cases, the details were given of the 
different pretreatment required such as derivatization or separation methods 
(extraction, centrifugation, precolumn cleanup treatments) prior to the analysis. Since 
in most papers concentration levels of the compounds analysed are omitted, no 
deductions can be made about the quantitative aspect of the analysis. The following 
sections presents examples of the application of SFC for the analysis of drugs in real 
matrices. 
2.2.1 Urine-Tissue-Biological Fluid 
The application of cSFC with FID detection was investigated by Later et al. 86 for the 
analysis of selected drugs in both standard solutions and complex mammalian urine 
extracts. The authors reported the qualitative analysis of adrenocortical steroids, (e.g. 
prednisone, prednisolone and methyl prednisolone) from an equine urine sample. 
These steroids are used as anti-inflammatory agents in veterinary applications. The 
steroid prednisolone was detected in an ethylacetate extract of an equine urine sample 
following a "therapeutic" dose (level not mentioned) of the compound. The 
chromatographic conditions employed for the analysis were supercritical C02 at 
130°C and pressure programming from 125 atm after a 30 minute hold, to 245 atm at 
50 atm/min, then to 320 atm at 10 atmlmin. The chromatographic column used was a 
18 m x 50 ~m id methylpolysiloxane capillary column. The analysis time reported 
was 20 minutes. 
The same authors also demonstrated the potential for identifying human urine extracts 
of 9-carboxy tetrahydrocannabinol by cSFC with FID. The peak obtained from a 
sample containing ca. 400 ng/rnl of 9-carboxy tetrahydrocannabinol gave an excellent 
signal-to-noise ratio. Supercritical C02 was used as the mobile phase \\'ith density 
programming from 0.25 g/rnl after a 15 minutes hold to 0.40 g/ml at 0.015 g/mVrnin. 
and then to 0.65 glml at 0.01 glml/min at a temperature of 120°C. The column 
employed for the separation was a 15 m x 50 11m id SE-33 column. 
Crowther and Henion87 briefly investigated the application of pSFC with MS for the 
detection of a crude acid extract of equine urine containing phenylbutazone and its 
metabolites. The authors do not mention the concentration levels studied and details of 
the detection limits or sensitivity were not provided. C02 modified with 10 % MeOH 
was used as the mobile phase and the chromatographic column employed was a 20 cm 
x 2.1 mm id diol column. The analysis time reported was ca. 6 minutes. 
Wong and Dellafera88 investigated the use of cSFC with FID for the analysis of 
phenobarbital from serum samples. Phenobarbital was chosen due to its therapeutic 
application as an antieleptic, as well as its potential abuse resulting in overdose cases. 
Barbitone was used as an internal standard. The serum samples containing the drug 
were extracted using both liquid-liquid extraction and SPE prior to analysis by SFC. 
Chromatography was carried out with a 10 m SB-methyl-IO column (50 J.llll id) along 
with a 5 m fused silica column (50 11m id) to provide a retention gap. 
Chromatography was obtained with C02 as the mobile phase at a temperature of 
120°C and both density gradient, from 0.25 to 0.6 gmIml (0.02 gmlml/min) , and 
pressure programming, from 100 to 300 atm (20 atm/min), was employed. The use of 
SPE (solid phase extraction) was necessary to prepare the samples to ensure adequate 
column life. The procedure was used to estimate a patients phenobarbital 
concentration at a level of 20 mg/L. 
Niessen et al. 89 demonstrated pSFC of the mitomycin C in plasma samples with IN 
detection at 360 nm. The plasma samples containing the drug were injected onto a 
short precolumn (10 mrn x 32 mm id, packed with the stationary phase material) 
prior to analysis. After ,vashing and drying the precolumn, the drug was desorbed 
using a mixture of C02 and methanol (88/12. v/y). Chromatography was obtained 
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with a Rosil Cl8 column (5 J.1I1\ 150 x 4.6 mm id). Other columns in,,-estigated were 
silica and aminopropy1 but both failed to elute mitomycin C. The use of a C8 column 
was also investigated but the peak shape obtained was not acceptable. The 
chromatographic conditions employed involved a mobile phase of C02 -methanol 
(88/12, v/v) at a flow rate of 2 mlImin, pressure 30 MPa and a temperature of 500C 
(the compound is unsuitable at temperatures above 60°C). These conditions eluted 
mitomycin C at ca. 2-3 minutes. The detection limit obtained was reported to be 5 
ng/ml. 
David and Novotny90 successfully demonstrated the analysis of steroids androsterone 
and conjugated androsterone compound from both urine (spiked at 10 ng/ml) and 
plasma (spiked at 5 ng/mJ) sample by cSFC. Chromatography was achieved on a 10 
m x 50 ).lm id fused silica column coated with SE-33 ( 0.50 J.1m film thickness). 
Nitrous oxide was used as the mobile phase and pressure programming was operated 
over the range of 75 atm to 315 atm (8 atm/min) at a column temperature of 100°C. 
The analysis time reported for these compounds were in the order of 40-50 minutes. 
Mount et al.91 investigated the use of SFC with ECD for the analysis of the anti-
malarial drug mefloquinone in blood samples. D,L-erythro-a-(2-piperidyl)-2,8,-
bis(trifluromethyl)-4-quinolinemethanol was used as the internal standard and the 
method incorporated partitioning into methyl tert. -butyl ether (MTBE) from an 
aqueous base, back extraction into dilute aqueous acid and final partitioning into 
MTBE from aqueous base. Chromatography was achieved on a 200 x 0.75 mm glass 
lined steel column packed v.ith 7 J.1m Zorbax BP silica gel using supercritical pentane 
containing n-butylamine (0.15%) and methanol (1%) as mobile phase. n-Pentane was 
chosen rather than C02 based on the ease of addition of precise amounts of the 
modifiers to a liquid at room temperature and the reduced response of the ECD to the 
n-pentane compared to C02. The column was conditioned for 4-6 hours at 300° C 
and pressure 2100 MPa for 10-20 minutes at the beginning of each working day_ For 
analysis the column and transfer line were maintained at a temperature of 210°C with 
the ECD at 350°C. Under these conditions the retention times obtained for 
mefloquinone and the internal standard was 8 and 4 minutes, respectively. The 
detection limit obtained was 7.5 nglml in 0.1 rnl blood samples with RSD of3.8-6.5% 
and exhibited good linearity (linear range 100-450 ng/ml). Mount et aL92 also 
reported the application of pSFC with ECD for the analysis of artemisinin in whole 
blood. The blood samples were prepared by liquid extraction and centrifugation prior 
to analysis. The chromatography was performed at 80°C on a 20 cm x 1 mm id. 
Deltabond cyano column with C02 at 17.2 MPa as the mobile phase. The detection 
limit obtained was 20 ng of artemisinin Iml of blood sample. The recovery reported by 
the authors for 480 ng of artemisinin Iml of blood was 81.6% with RSD of 10.3%. 
The main source of variation in the result was thought to be the poor reproducibility 
of injection. 
Ramsey et al93 reported the use of SFE with pSFC-MS-MS for veterinary drugs, 
sulphamethazole and trimethoprim in freeze dried pig kidney spiked at a level of 10 
mg of drug /kg of kidney. The mobile phase composition used comprised of a gradient 
of MeOH with 100% C02 for 8 minutes followed by 20% MeOH modified C02 in 
0.5 minutes and maintained for 10 minutes. The chromatographic column utilized was 
a 100 x 4.6 mm id amino column and the analysis was carried out at a temperature of 
75°C. The authors concluded that although the detection limits (1 mg!kg) obtained by 
this method were not sufficiently low to meet the stringent controls on drug residues in 
meat for human consumption, there is potential for further development of the 
approach. 
Perkin et aL94 demonstrated the application of pSFC 'with MS for the analysis of 
sulphamethazine from a spiked porcine kidney extract. The chromatographic method 
employed comprised of a mobile phase containing 150/0 MeOH modified C02 at a 
flow rate of 4 mlImin and a temperature of 75°C. The column employed for the 
separation was a 100 mm x 4.6 mm id amino column. The analysis time reported 
under these conditions was ca. 4 minutes. 
Pinkston et al. 95 demonstrated the application of cSFC with MS detection for the 
analysis of mebeverine spiked from a dog plasma matrix. The spiked dog plasma 
samples were prepared for analysis by SPE. Chromatography was performed on a 
Dionex 10 m x 50 !lm id SB methyl 100 column with a 0.25 J.Ull film thickness. C02 
was used as the mobile phase at 140°C and pressure programming from 10.1 MPa to 
40.5 MPa at a rate of 10.1 MPaimin. The authors reported excellent recoveries (91-
104%) for spiked plasma samples spiked with 5.95 to 59.5 ng mebeverinelml of 
plasma. The RSD obtained were mostly 10%. 
Wang et a1.96 demonstrated the application of pSFC with UV detection for the 
analysis of camazepam and its metabolites in a liver matrix. The liver microsomes 
were prepared from the treated (80 mglkg) male rats (80-100 g). Camazepam and its 
metabolites were analysed after incubation with rat liver microcosmes and extraction 
of the products into CHCI3. Both achiral column and chiral column were used for the 
analysis of camazepam and eight of its derivitives. Achiral separation was achieved 
with a 25 cm x 4.6 mm id amino column at a temperature of 30°C and pressure 150 
bar. The mobile phase comprised of a gradient of C02 containing EtOH (13% EtOH 
for 4 minutes increased at 30/oimin to 300/0 EtOH). Chiral separations were achieved 
on a 25 cm x 4.6 mm id Chirace1 OD-H column at a temperature of 30°C and a 
pressure of 200 bar. The mobile phase used \vas C02 containing EtOH at a flow rate 
of 2.5 mlImin. No single EtOH concentration was suitable for resolving all the 
enantiomeric pairs in one chromatographic run. Isocratic mobile phase conditions 
were employed for the optimal resolution of each enantiomeric pair \\ith the aim to 
obtain baseline resolution of all the compounds in the shortest possible time. 
Smith et al. 97 briefly reported the separation of ranitidine and its four metabolites, 
isolated from pig and rat liver by SPE, using pSFC with UV. Separations were 
achieved on a 10 cm x 4.6 mm id cyanopropyl bonded silica column at a temperature 
of 71°C and pressure 3200 psi. The chromatographic mobile phase used comprised of 
C02iMeOHlaq.40% methyl amine/water (400/98/1/1, v/v). An analysis time of ca. 8 
minutes was achieved under these conditions. In a further study, the authors also 
briefly reported the potential of pSFC for the separation of ranitidine and its 
metabolites present in rat urine, following SPE. The details of the detection limits, 
RSD or the sensitivity of the method were not provided. 
Simmons et al.98 demonstrated the application of pSFC with UV detection for the 
analysis of phenylbutazone and oxyphenylbutazone in serum. The spiked serum 
samples (20 Jlg/ml of serum) were prepared for analysis by SPE (ODS column). 
Chromatography was performed on a 25 cm x 1 mm id Deltabond ODS (5 J.U11) 
column operated at 85°C and pressure 170 atm with C02 containing 5% MeOH as 
the mobile phase at 240 run. The recoveries reported for phenylbutazone and 
oxyphenylbutazone were 82% and 83.4%, respectively and the corresponding 
detection limits obtained were 0.1 and I Jlg!m1. The use of other columns such as 
silica and cyano were also investigated but failed to give acceptable chromatography. 
Wong et al.99 investigated the use of cSFC with FID for the analysis of cyc1osporin, 
tacrolimus and raparnycin in blood. The blood was prepared for analysis by 
centrifugation with appropriate solvents and SPE (C 18 column). Chromatography 
was performed on a 10m x 50 JlIIl id SB-biphenyl column operated at 70°C and 
pressure programming from 100 to 300 atm at a rate of 10 atm!min with C02 as the 
mobile phase. The quantitation of the cited drugs at therapeutic levels was not 
achieved c:lbe-tv kJw recoveries and sensitivity obtained "ith FID . 
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2.2.2 Formulations 
Jagorta and Stewart 1 00 briefly reported the analysis of diazepam, chlorodiazepoxide 
and their related compounds in Valium tablet and Librium capsule fonn using cSFC. 
Each tablet or the capsule contained 10 mg of the active substance. Chromatography 
was achieved using a SB-cyanopropyl-50 (195 J.llIl id and 0.25 J.1Il1 film thickness) 
capillary column with FID detection. F or analysis of diazepam and its related 
products, nordiazepam, 3-amino-6-chloro-l-methyl-4-phenyl-carbostyril and 2-
methylamino-5-chlorobenzophenone a multi-linear pressure programme was employed 
with C02 as the mobile phase. The temperature gradient in addition with the pressure 
gradient resuhed in baseline separation of all four compounds in under 24 minutes. 
For the analysis of chlorodiazepoxide and its related products, 7-chloro-l,3-dihydro-
5-phenyl-2H-l,4-benzodiazepin-2-one-4-oxide and 2-amino-5-chlorobenzophenone 
the chromatographic conditions employed with C02 as the mobile phase were as 
follows: muhilinear pressure programme with 9 min hold at initial pressure of 200 
a~ then 50 atm/min ramp to 300 followed by 20 atmlmin ramp to 400 atm, then 
hold for 5 min at 400 atm. The oven programme was isothermal at 120°C. Under 
these conditions excellent separation of all the compound were achieved in under 20 
min. Recoveries of 101-1030/0 of the labelled amount were obtained for both 
compounds with RSD of 4.1% and 3.2% for diazepam and chlorodiazepoxide, 
respectively compared to RSD of l.2% and 0.4% obtained from an established HPLC 
method. Jagota and Stewart 1 0 I have also studied the use of cSFC with FID for the 
analysis of ibuprofen, ketoprofen and mefanamic acid in tablet or capsule form. 
Samples were prepared for analysis by dissolving individual tablet ot capsule with 
MeOH followed by sonication. Chromatography was carried out using C02 as the 
mobile phase at 130°C. The column investigated was a SB-biphenyl-30 (10 m x 50 Il 
m id., 30% biphenyl and 70 % methylpolysiloxane). Pressure progranuning was used 
to clute the compounds and the total analysis time recorded was under 20 minutes. 
Jagota and Stewart102 have also reported the separation of selected oestrogens 
(oestrone, equilin, alpha-oestradiol, beta-oestradiol and d-equilenin) and methyl 
testosterone in commercial dosage forms using cSFC with FID. Three different 
commercial dosage forms were investigated. They included one in which <>estrogens 
were conjugated, one in which they were esterifie<L and finally, one containing only 13-
oestradiol. The oestrogens in the conjugated and esterified dosage were converted into 
'free' oestrogens with acid hydrolysis and extracted with chloroform prior to analysis. 
Chromatography was carried out on a 10 m x 50 Jlm SB-cyanopropyl-50 column and 
carbon dioxide density gradient at a temperature of 73°C. The retention times 
obtained under these conditions were ca. 19 minutes. The authors concluded that there 
was no statistical difference in the SFC vs HPLC (table 1) assay results for oestradiol 
in the dosage form at the 95% confidence level. 
Table 1 Comparison of SFC and HPLC data obtained for the analysis of Oestradiol 
tablet 
Labelled amount Amount found (SFC) Amount found (HPLC) 
2.0mg 1.99±0.036 mg 2.07±0.029 mg 
2.0 mg RSD 1.8% (n = 3) RSD 1.4% (n = 3) 
DiMaso et al. l 03 reported the application of SFC for the analysis of sorbitan triolate 
in metered dose inhaler formulations. Sorbitan triolate is used to keep the drugs 
dispersed in the propellant. The sorbitan triolate was separated from other components 
from all formulations tested. Chromatography was achieved on a C-18 bonded packed 
column (5 Jlm Rexchrom, 100 x 2.1 mm id ) with C02 as the mobile phase at 40°C 
and 2400 psi. UV detection was used for the analysis. The experimental formulation 
was designed to deliver 120 J.Lg of sorbitan triolate per dose and the amonut found was 
123 f.LgIburst. A linear calibration curve for peak height as a function of weight of 
sorbitan triolate was obtained between 0.5-10 J.Lg injected on column. The detection 
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limit calculated as three times the peak -to-peak ratio baseline noise was 50 ng per 
injected volume and the RSD values obtained for the peak height was between 1.0-
2.0%. The authors concluded that this methodology is currently being used to 
determine sorbitan triolate droplet size and distribution in metered-dose inhaler 
plumes. 
Masuda et aI. I04 studied coupled SFE and SFC for the determination of fat soluble 
vitamins, retinol and tocopherol in hydrophobic ointments. The sample preparation for 
the ointments involved the following. About 1 g of accurately weighed ointment was 
blended with 9 g of accurately weighed diatomaceous earth powder. A 20 mg 
subsample of the mixture was extracted and chromatographed under the conditions of 
the coupled SFE/SFC system. Supercritical carbon dioxide containing ethanol was 
used as the mobile phase. Chromatography was performed on a Finepak SIL-CI8 (4.6 
mm id x 150 mm, 5 Jlm ODS silica packing) at a pressure of 200 Kg/cm2 and a 
temperature of 40°C. Detection was by UV at 284 run. Typical recoveries reported for 
retinol and tocopherol were 102% and 101.5% respectively. The authors concluded 
that the methodology was viable for quantitative analysis of pharmaceutical 
preparatio~ including fat soluble vitamins. 
Anton et aI. 1 05 reported the application of SFC with UV and ELSD detection for the 
analysis of cromation in both cream and lotion form. Samples were prepared (weights 
were not mentioned) for analysis by dilution with 11IF (tetrahydrofuran) followed by 
filtration prior to injection. Chromatography was achieved on a 270 mm x 2 mm CN 
column (3 ,.un). C02 modified with MeOH was used as the mobile phase for the 
analysis of cromation cream. The cromation lotion contained two additional 
preservatives to that of cream formulation and required the addition of tritluroacetic 
acid and ammonium acetate to the mobile phase. The recovery obtained by the SFC 
method (98.8 % with RSD of O.6%for cream and 99.9% with RSD of 0.6% for 
lotion) was comparable to the existing LC method with faster analysis and fewer 
experimental steps. 
Scalia and Games I 06 demonstrated the analysis of commonly occurring bile acids, 
chenodeoxycholic acid (CDCA) in capsule and ursodeoxycholic acid (UDCA) in 
tablet form by pSFC with UV. Each tablet or the capsule contained 250 mg of active 
substance. Sample processing of the tablet and the capsule involved dissolution of 
individual tablet or capsule with MeOH and filtration prior to injection. Baseline 
separation was achieved was achieved using a phenyl bonded silica column with IN 
as the method for detection at 210 nm. Supercritical C02 modified with 15% MeOH 
was employed as the mobile phase at pressure 200 atm and temperature -+O°e. The 
average recoveries obtained for CDCA and UDCA were 101.6% with RSD of 2.3% 
and 102.0% with RSD of 2.3%. The authors concluded that the proposed SFC 
method is well suited for the quality control assays of medicinal drugs containing 
chenodeoxycholic acid and ursodeoxycholic acid. 
Karlsson et al.107 reported a qualitative method employing pSFC \\ith UV detection 
(240 nm) for the determinaion of a dihydropyridine drug in an emulsion matrix (1 
mg/ml). The influence of various experimental variables such as type and ampount of 
modifier, flow rate and tempertaure on chromatographic perfonnance was studied. 
Optimization of the chromatographic parameters was achieved using experimental 
design and chemometricial methods. Chromatography was achieved on a Hypersil 
(200 x 4.6 mm id) column comprising of a mobile phase of C02 containing 20% 2-
propanol at a pressure of 200 bar at a temperture of 31 0e. 
Strode et al. I 08 demonstrated the application of SFE-pSFC \\ith ECD and UV for the 
analysis of felodipine from tablets. The extracted felodipine was dissolved in MeOH 
prior to analysis and carbazole was used as the internal standard. Chromatography 
was performed on a 2:' em x -+.6 mm id Hypersil Si column (5 ~m) with C02~kOH 
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(6%) as the mobile phase at 45°C. The calibration graph was linear from the 
concentration range of 18-5000 ppm and the limit of detection reported for both 
detectors was 34.4 pg. 
2.2.3 Plants 
Holzer et al. 1 09 demonstrated the applicability of cSFC with FID for the separation 
of eight pyrrolizidine alkaloids (PAs) of the retronecine and otonecine (senecionine, 
integerrimine, senkirkine, neosenkirkine, retrosine, otoserine, hydroxysenkirkine and 
anonamine) from flowering specimens of Senecio anonymus. The fresh plant material 
(weights not mentioned) was subjected to liquid extraction and filtration appropriately 
prior to analysis. SFC separations of the PAs was achieved on a 10 m x 50 J.1m id 
fused silica capillary, coated with a 0.25 J.1m film of SB-Biphenyl-30. The mobile 
phase used was carbon dioxide and linear pressure programming was performed from 
100 to 280 atrn at 3 atmlmin, after an initial isobaric period of 20 minutes. Complete 
separation of the PAs of the retronecine and otonecine was achieved with a detection 
limit of I ng at a signal to noise ratio of 3. 
Balesevich et al. 110 reported the qualitative analysis of indole alkaloids from the 
leaves of Catharanthus Roseus by packed col~ SFC/MS. Samples of fresh leaves 
( I 00 g) were prepared for analysis by extraction with MeOH followed by filtration. 
Separations were obtained on an amino bonded 5 flm Spherisorb 100 x 4.5 mm 
column with C02 and a 5-15% gradient of MeOH at 65°C. Under these conditions 
employed, a complete chromatogram was obtained within 8 minutes ·with 10 major 
components and an estimated 40 alkaloids being detected when a UV monitor was 
used. Overall. three alkaloids were predominant: catharanthine, vindoline and 3',4'-
anhydrovinblastine. Sharp peak shapes and numerous near baseline separations were 
reported. Oesacetox~ vindoline. vindorsine, vindoline and deacetylvindoline. complex 
Asipidospcrrna alkaloids differing only slightly from each other in their functional 
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groups, were easily separated from each other as well as the pharmaceutically 
important bisinodoles leu rosine, 3',4'-anhydrovinblastine and vinblastine which 
chromatographed as a group away from the majority of the components. The use of a 
mass spectrometer in thermospray mode in conjunction with the UV monitor enabled 
an estimation of 60 alkaloids to be detected. When the chromatograph was coupled to 
a mass spectrometer in EI mode, high quality ElMS were obtained, which allowed the 
identification of several alkaloids. 
Berry et al. lll investigated the use of pSFC for analysis of ergot alkaloids in plant 
extracts of CZaviceps purpurea. Gradient pSFC was employed for the analysis of the 
ergot alkaloids of the clavine (agroclavine, festuclavine, elymoclavine, noragroclavine 
I and IT, norchanoclavine, chanoclavine I and IT) with UV (280 nm). The alkaloids 
were chromatographed using an aminopropyl bonded stationary phase (Spherisorb, 5 
J.lm, 100 x 4.6 mm id) and C02 modified with MeOH as the mobile phase. The 
chromatographic conditions used were 10% MeOH modified C02 at a flow rate of 3 
mlJ~ temperature 75°C and pressure 365 bar for 2.5 minutes. The flow rate was 
then increased to 5 m1Jmin and the % MeOH increased to 15% at 2.8 minutes and 
then 20% after 5 minutes. The total analysis time was ca. 11 minutes with the last 
compound (norchanoclavine II) eluting at ca. 10 minutes. The applicability of SFC-
electron ionisation mass spectrometry (ElMS) for the analysis of Claviceps purprea 
was also illustrated at the same chromatographic conditions as before, except a 
column pressure of 396 bar was used. 
The separation of four opium alkaloids (codeine, morphine, papaverine and thebaine) 
from poppy straw extracts by supercritical fluid chromatography using packed 
columns was demonstrated by lanicot et aI. 112 The authors investigated the 
optimization of the separation of seven opium alkaliods in standard mixture using sub-
and supercritical fluid chromatography prior to applying the procedure to poppy stra\l, 
extracts. Chromatography was achieved using a silica (5 ~ LiChrosorb Si 60) 
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bonded phase packed in 120 or 230 x 4.6 mm id stainless steel columns at an UV 
detection at 280 run. The influence of several mobile phase compositions was 
demonstrated by varying the MeOH content, water content and investigating various 
amine modifiers. The retention of alkaloids was reduced with increasing MeOH 
content in the mobile phase. Addition of various amines (methyl, ethyl and 
triethylamine) led to a general decrease in retention and negligible changes in the 
selectivity. The effect of water in the mobile phase was studied both in the presence 
and absence of an amine modifier. With the silica col~ a decrease in retention was 
noticed in the absence of an amine modifier and with increasing water content. The 
mobile phase composition determined for the analysis of these alkaloids on silica 
column was c02-MeOH-methylamine-water 83.37:16.25:0.15:0.23, (w/w). The 
analysis time obtained under these conditions was 11 minutes. 
Yun-hua et al. l13 applied cSFC with FID for the determination of panaxadiol and 
panaxatriol in ginseng and its preparations. The sample preparation involved 
extensive liquid extraction of 0.1 g of ginseng powder (80 mesh) or an appropriate 
amont of its preparations. Methyltestosterone was used as the internal standard. The 
ginseng extracts were purified by a partition column and concentrated by an 
adsorption column and then analysed by SFC. Chromatography was achieved with 
C02 as the mobile phase at 120°C and pressure programming from 10 MPa to 35 
MPa at I MPa Imin. The recoveries of panaxadiol and panaxatriol reported were 
96.3±2.82% (n=6) and 85.1±5.1 % (n = 6) respectively. 
Heaton et al. 74 reported the use of both cSFC and pSFC of SFE extracts of taxicins 
from yew extracts. The authors investigated two different capillary columns (biphenyl 
and carbowax) and two different packed colmnns (ODS and nitrile) at different 
chromatographic conditions. Under optimized conc:fuiollS, the biphenyl colum resulted 
in only partial resolution of taxicin I and II, whereas the more polar carbowax column 
gave baseline resolution \\ithin 30 minutes. Srmilarly. the ODS packed column gave 
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broruL overlapping, poorly-resolved peaks but the more polar nitrile column gave 
greater selectivity with baseline resolution in 12 minutes. 
Tables 2.2 summarises the results obtained by SFC. 
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Table 2.2 Summary of results obtained by SFC 
Analyte Matrix SF Chromatographic Comments Reference 
Conditions 
I Prednisone, prednisolone, unne C02 at 130°C and pressure qualitative 86 
methyl prednisolone programnung 
Column: 18 m x 50 Ilm 
methyl polysiloxane 
9 Carboxy tetrahydro urme C02 at 120°C and density 50 ng/ml detection limit 86 
cannobinol programmmg 
Column: 15 m x 50 Ilm SE-
33 
Phenylbutazone unne MeOH modified CO2 qualitative 87 
Column' 20 em x 2 1 mm 
tiinl 
Phenobarbital serum CO) at 120°C and density qualitative 88 
programmmg 
Column: 10 m x 50 Ilm 
SB-methyl 
Mitomycon C plasma MeOH modified C02 at qualitative 89 
50°C and 30 MPa 
Column: 150 mm x 4.6 mm 
CO~ 
Androsterone and cojugatcd urine/plasma N 02 at 100°C and pressure qualitative 90 
androsterone programmmg 
Column: 10 m x 50 Ilm 
SE-33 
--
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Mefloquinone blood n-pentane containing n- qualitative 91 
butylamine and MeOH 
Column: 200 x 0.75 nun 
Zorbax silica gel 
Artemisinin blood C02 at 80°C and 17.2 MPa 81.6% recovered with RSD 92 
! 
Column: 20 cm x 1 mm of 10.3% at 480 mglmllevel 
Cyano 
Sulphamethazole and pig kidney C02/MeOH gradient at 1 mg/kg detection limit 93 
trimethoprim 75°C 
Column: 100 x 4.6 mm 
Amino 
Su Iphamethazine porcine kidney MeOH modified C02 at qualitative 94 
75°C 
Column: 100 x 4.6 nun 
Amino 
Meberine dog plasma C02 at 140°C and pressure 91 %-1 04010 recovered for 95 
programmmg 5.95-59.5 mglmllevel with 
Column: 10 m x 50 ~ 10% RSD 
SB-methyl 
Camazepam rat liver C02/EtOH gradient at qualitative 96 
30°C and 150 bar I 
Column: 25 em x 4.6 mm 
Chiraeil OD-H 
Ranitidinc pig and rat liver MeOHImethylamine/water qualitative 97 
modified C02 at 71°C and 
3200 psi 
Column: 100 x 4.6 nun 
Cyanopropyl 
--
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Phanylbutazone and serum MeOH modified C02 at 82% phenylbutazone 98 
oxyphenylbutazone 85°C and 170 atm recovered and 83.4% 
Column: 25 cm x 1 rom oxyphenylbutazone 
Deltabond ODS recovered 
Cyclosprin, tacrolimus and blood C02 at 70°C and pressure qualitative 99 
rapamycm programnung 
Column: 10 m x 50 11m 
Biphenyl 
Diazepam and tab let/capsule C02 at 120°C and pressure > I 00% recovered with 100 
chlorodiazepoxide programnung 4.08% and 3.16% RSD 
Column: SB cyanopropyl-50 
Ibuprofen, ketoprofen, capsule C02 at l30°C Quantitative 101 
menfoinic acid Column: 10 m x 50 !lffi I 
SB biphenyl-30 
Oestrogens tablet/capsule C02 at 73°C and density 100% recovered with 1.8% 102 , 
programmmg RSD at 20 labelled tablet and 
Column: 10m x 50 11m capsule 
SB cyanopropyl 
Sorbitan triolates meterd dose inhalers C02 at 40°C and 2400 psi 100% recovered with 1.0- 103 
Column: 100 x 02.1 mm 2.0%RSD 
CJ~ 
Retinol and toeophenol ointment EtOH modified C02 at 40°C 
and 200 kg/cm2 
> 1 00% recovered 104 
Column: 15 cm x 4.6 mm 
ODS 
Cromation cream/lotion MeOH modified CO2 98.8% recovered with 0.6% 105 
Column: 25 cm x 2 mm RSD for the cream and 
Cyano 99.9% recovered with 0.6% 
RSD for the lotion 
-- -- -~ _ .. _----
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Chenodeoxycholic acid capsule/tab let MeOH modified C02 at 10l.6% recovered with 2.3% 106 
(CDCA) and 40°C and 200 atm RSD forCDCA and 101% 
ursodeoxycholic acid Column: Phenyl bonded recovered with 1.9% RSD 
(UDCA) silica forUDCA 
Dihydropyridine emulsion 2-propanol modified C02 at qualitative 107 
31°C and 200 bar 
Felodipine tablet MeOH modified CO2 quantitative 108 
at 45°C 
Column: 25 cm x 4.6 mm 
Silica 
Pyrrolizidinc alkoloids plant C02 and pressure qualitative 109 
progranunmg 
Column: 10m x 50 f.Ul1 
SB b~henyl-30 , 
Indole alkaloids plant MeOHlC02 gradient qualitative 110 
at 65°C 
I Column: 100 x 4.6 mm 
Amino 
Clavinc alkaloids plant MeOH modified CO2 qualitative I 11 
, 
at 75°C and 365 bar , 
Column: 100 x 4.6 mm 
, 
Amino propyl 
Opium alkaloids plant MeOHImethylamine/water qualitative 112 
modified CO2 
Column: 230 x 4.6 mm 
Silica 
- -
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Panaxadiol and panaxatiol plant C02 at 120°C and pressure quantitative 113 
I programmmg 
Column: 10 m x 50 ~ 
I 
SB cyanopropyl 
Taxacins yew tree C02 at 120°C and pressure quantitative analysis with 74 
programmmg packed column 
Column: Biphenyl and 
carbowax capillary 
MeOH modified CO2 
at 60°C 
Column: ODS and nitrile 
packed column 
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Chapter 3.0 Compounds of Interest 
This chapter aims to give background information on the types of compound that have 
been used throught out the experimental protocol. 
3.1 Aims of the Project 
The initial objective of these studies was to assess the factors governing solubility and 
extraction of specific analytes in a supercritical fluid extraction (SFE) using carbon 
dioxide as the solvent. The solubility of an analyte in supercritical C02 gives an 
indication of the relative extractibility of the substance as a function of pressure and 
temperature which is an important consideration in designing operating conditions for 
SFE. Four different antifungals were determined from an animal feed using 
SFE/pSFC. The SFE experiments were designed to optimize extraction conditions for 
the extraction of specific analytes, such as antifungals, from an animal feed matrix to 
allow for the evaluation of the most significant variables influencing extraction. The 
pSFC experiments were performed to evaluate the potential of pSFC with C02 and 
polar modifier as the mobile phase for the analysis of the antifungals from an animal 
feed. Two different methods were also considered for the prediction of steroid 
solubility in supercritical C02. The first method involved the use of chromatographic 
retention measurements to predict the solubility of testosterone in supercritical C02. 
The second method involved the use of partition coefficients in conjunction with a 
calculated solubility parameter as a reasonable means of predicting analyte solubility 
in supercritical carbon dioxide. 
The polarity of an analyte is the key factor that influences its solubility in supercritical 
C02. It is possible to estimate polarity from molecular structure alone. For this 
reason polarity was selected as the key parameter to developing a means of estimating 
solute solubility in supercritical C02. Experimental determination of the solubility of 
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several steroid compounds with a range in polarities in supercritical C02 was carried 
out in order to correlate solute polarity to the solute solubilitv. Polarity can be 
-' -
estimated by the hydrophobicity te~ log P (based on partition coefficients), and also 
of the solubility parameter, 8, estimated using fragmentation constants. Estimation of 
log P through structure activity relationships was investigated with the emphasis on a 
rapid and reliable evaluation of the hydrophobicity. These investigations were carried 
out with an aim to relate analyte solubility in supercritical C02 via the molecular 
structure. This can provide an effective method development in SFE based on 
informed decisions about the solvent strength required to solvate the targeted anal)te. 
A chromatographic method was also investigated based on capacity factor 
measurements for the prediction of testosterone solubility in supercritical C02. The 
capacity factor of a solute is at least qualitatively inversely related to the solvating 
power of the mobile phase for that solute, i.e. the more soluble it is in the mobile 
phase, the less it is retained. The objective of this investigation was to evaluate if the 
measurements of retention times can provide a rapid way of generating solubility data 
for testosterone. 
In SFE, for extraction to be successful, the solute must be sufficiently soluble in the 
supercritical fluid. The rule of SFE is that the lower polarity analytes are soluble in 
greater quantities than those analytes with higher polarities. A matrix material, such 
as animal feed, associated with a particular analyte can have profound effects on the 
successful isolation of target analytes in any SFE experiment. The complexity of the 
extraction process is undoubtedly increased by the introduction of a sample matrix. It 
has been known through other researchers that the interactions between the anal) te 
and sample matrix are the least understood area of the extraction process. In most 
cases the sample matrix is solid and the anal) tes are either adsorbed onto the surface 
or trapped within matrix particles. The addition of a polar modifier or a cosolvent to 
supercritical C02 often enable anal)tes to be efficiently extracted and 
chromatographed from difficuh matrices. The application of methanol modifier \\ith 
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supercritical C02 is demonstrated for the determination of four different antifungals 
from an animal feed. 
3.2 Introduction to Steroids 
The use of steroid hormones in therapy has grown tremendously in the last 20 years, 
since the discovery of semi-synthetic routes for the industrial-scale preparation of the 
most important natural hormones and numerous highly active derivatives. About 200 
steroid hormone compounds and related materials are known to date, representing 
roughly about 10% of the world's total population ofpharmaceuticals.114-120 
Steroid hormones are naturally occumng or synthetic materials consisting of a 
cyc1opentanoperhydrophenantbrene skeleton (figure 3.1) comprising of three fused 
cyc10hexane rings (~ B, C) in a non-linear arrangement and a terminal cyc10pentane 
ring (D). They are amongst the most widely used drugs today. 
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Figure 3.1 The basic ring structure of a steroid 
The parent hydrocarbon related to the cyclopentanoperbydrophenantbrene nucleus is 
called cholestane. There are 17 carbons present in the fused ring (A. B, C and D) 
structure. Virtually all the steroid structures can be related to this backbone or its 
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derivatives. The biological activity of individual steroids \,ill also depend on the 
attached substituents attached to the backbone ring structure. The inclusion of 
additional side chains on the parent compounds and modification of the existing side 
chains account for diversity of physiological activities of the numerous steroids. 
The steroids hormones can be grouped according to their hormone activity and they 
generally fall into four major categories: androgens, progestogens, estrogens and 
corticosteroids. 116 
Androgens - Male hormones. Methyl groups attached to C-I0 and C-13 (making 19 
carbons) and the A ring is aliphatic. The most potent androgenic hormone is 
testosterone and its 4,5-dihydro metabolite. 
Progestogens - Methyl groups on C-I0 and C-13 and COCH3 (e.g. megestrol acetate) 
on C-17 (making 21 carbons). The A ring is aliphatic. 
Estrogens - Female hormones. Methyl group is attached to C-13 (making 18 carbons) 
and the A ring is usually aromatic. The primary hormone is 17 P oestradiol. 
Corticosteroids - Similar to progestogens but with COCH20H side chain on C-17 
(e.g. cortisone). A hydroxyl or ketone group is on C-l1. 
Androgenic hormones are the male sex hormones. Their primary role is in the 
development of the male secondary sex characteristics. The most common androgenic 
hormone is testosterone and its 4,5-dihydro metabolite. Estrogenic hormones are 
female sex hormones secreted mainly by the ovary and are thought to be responsible 
for the secondary female sex character. In addition to estrogens, another important 
hormone of the ovary (or more exactly of the corpus leteum within it) is progesterone. 
Its main function is to prepare the mucous membrane of the uterus for the reception of 
the egg and. after fertilization.. to stop ovulation. 
Corticosteroids are produced in the body by the outer layer of the adrenal gland and 
the adrenal cortex. Their primary function is the regulation of some essential 
metabolic processes of the organism. They fall into two groups: glucocorticoids and 
mineralcorticoids. Glucocorticods, such as, cortisone and hydrocortisone have anti-
inflammatory properties affecting protein, sugar and calcium metabolism, while 
mineralcorticoids, such as aldosterone, affect salt and water metabolism. 
3.2.1 The Analysis of Steroid Hormone Drugs 
To maintain high purity in the manufacture of steroid hormones the pharmaceutical 
industry requires a range of analytical techniques which are both qualitative and 
quantitative. The pharmaceutical analysis of steroids in the present state can be 
outlined by the following methods: 
(1) Qualitative methods, identification - Althou~ some of the classical colour 
reactions 121 are still used for identifying steroids, the most important methods for this 
purpose are now infrared (IR) and UV spectroscopy, and the detennination of the 
specific optical rotation and melting point of the parent hormone and/or its simple 
derivatives. An essential technique for the characterization of the quality of a steroid 
is thin layer chromatography, with semi-quantitative determination of the impurity 
spots. 
Quantitative analysis - Spectrophotometric methods have been established for the 
quantitative analysis of steroid hormone drugs. Direct UV method is used \\;dely. but 
its possibilities are limited. IR spectroscopy is barely used in quantitative analysis. 
The techniques most often applied are visible or ultraviolet methods based on 
chemical reactions. To solve problems, many new selective methods have been 
established where spectrometric and colorimetric methods are increasingly being 
combined \\ith chromatographic separations. 
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As regards to other optical and the electrochemical methods, fluorimetry and 
polarography 122 have found application in relatively narrow fields. For direct 
determination of active hormones in biological fluids and in blood, more sensitive 
methcxls were required than the methods described above. The sensitivity requirements 
were met by the introduction of GC methcxls 123-127, particularly with the advantage 
of using selective detectors such as electron capture detection (ECD) and MS. 
However, the problem with GC is that some hormones may have to be derivatised in 
order to increase the volatility of the compounds. Recently, the use ofHPLC128-I30 
for the analysis of steroids has increased. This is due to the versatility offered by this 
technique where quantitative analysis can be carried out without being affected by the 
low volatility and the thermal stability of the steroid hormones. 
3.3 Azoles 
The discovery of azole in the early 1970's added impetus to the development of 
antifungal drugs; azole antifungals provided the prospect of broad-spectrum, potent 
agents which were found to be relatively well tolerated with patients .131 
Azoles are used both topically and systemically to treat superficial and cutaneous 
mycoses of the type dermatophycoses, ma1as~eziasis, onychomycosis and candidiasis 
involving skin or mucous membranes. I3I The general recommendations are that 
topical azole therapy should be used initially with progression to systemic therapy in 
patients unresponsive to or intolerant to topical applications. In the treatment of the 
systematic infections the azole antifungals offer a new dimension of therapy, 
particularly for systematic mycoses in immunosupperessed patients in whom poor 
clinical and mycological responses are often noticed. The azoles are also known for 
their expanded role in Ole prevention of fungal infection in specific populations of 
immunocomprised patients. 
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All of the azoles posses a five-member azole ring. Fluconazole possess two triazole 
groups, hence is designated as bis-triazole. 
3.3.1 Fluconazole 
Fluconazole, an orally active triazoyl agent, is representative of an important class of 
antifungal drugs for clinical use in superficial and systemic fungal infections. It is 
used for the treatment of superficial candidiasis, including orpharyngeal, oesophagel 
and urinary tract candidiasis and systemic candiasis, including disseminated disease, 
particularly in immunocompromised patients, including children. 132 A similar azole 
compound was also used (UK-47,265) for experimental purpose. Figure 3.2 shows 
the structure oftluconazole and figure 3.3 shows the structure ofUK-47,265. 
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Figure 3.2 Structure of fluconazole 
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Figure 3.3 : Structure ofUK-47,265 
3.3.2 Tioconazole 
Tioconazole,1-{2-[2-cbloro-3-thineyl)methoxy]-2-(2,4-dicblorophenyl)ethyl}-lH 
imidazole, is an imidazole drug commonly used as a broad-spectrum of anti-fungal 
activity including action against dermatophytes, ma1assezia furfur, and candida 
albicans. 133 Tioconazole is active against gram-positive bacteria. It is applied 
topically as a 1 % cr~ lotio~ or powder in the treatment of tinea infections, 
pityriasis, versicolor, and candidiasis. 
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Figure 3.2 Structure oftioconazole 
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3.3.3 Hexaconazole 
Hexaconazole [(RS)-2-(2,4-dichlorophenyl)-1-(lH-I,2,4-triazol-l-yl)-hexan-2-o1}, is 
a broad spectrum systemic fungicide with eradicant and protectant acti\ity used for 
controlling a wide range of fungal diseases in cereal. 134 The compound is active 
mainly against basidiomycetes and ascomycetes where it is a potent inhibitor of 
ergosterol biosynthesis. As systemic fungicide it is transported in the xylem and there 
is no evidence of phloem activity. 
CI 
OH 
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CI y-CH2CH2CH2CH3 
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Figure 3.4 Structure ofhexaconazole 
3.4 The Determination of Drugs from an Animal Feed Matrix 
The analysis of drugs from an animal feed is crucial as part of the chronic toxicity 
studies in the development stage of a drug. 135 Figure 3.5 shows a block diagram of a 
drug from screening to marketing. 
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Phase 1 Studies in Man 
Human Pharmacokinetics 
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Drug t.4onitoring 
Forensic Toxicology 
Figure 3.5 Flow diagram showing different stages from discovery to marketed stage 
for a drug. 
Once the drug has been screened and Sho\\l1 a promising phannacological effect the 
next step in drug research is generally to establish its safety by carrying out 
toxicology tests in animals. Initial toxicology tests involve the administration of 
increasing single doses of a drug to groups of animals (acute toxicology) to establish 
the toxic doses of single administrations. The nex1 stage is called the chronic toxicity 
stage. In this phase it is impractical to dose large animals or an animal or an 
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individual basis everyday. In this situation the dose is introduced in animals' feed or 
drink. This method can be potentially error prone. The animals may not eat and drink 
to the same extent: if the food is not mixed correctly then the actual dose offered to the 
animals may be different; if the mix is not homogeneous, the animals may be selective 
in their eating, taking either consistently more, or consistently less, than nominal dose. 
A large error can also be introduced if it is necessary to mix the diet a long time ahead 
of the dosing time allowing the possibility of the drug decomposing in storage in 
contact with the diet. 
The assay of the drug substances from the feed matrices is therefore necessary to 
monitor dosage levels, verify dose uniformity throughout the feed mix and confirm the 
drug's stability in both the short and long term. Animal feeds are complex mixtures of 
prote~ lipids, glucicide, cellulose and mineral matter and if co-extracted the 
coextractives can interfere in the quantitative determination of the analyte of 
interest.77 Extensive sample clean-up is also required to obtain a final sample 
sufficiently concentrated enough to be detennined quantitatively. Various means of 
sample preparation are currently being investigated to extract the drug substances 
from animal feed prior to assay.1 36-139 These methods include liquid-solid 
extraction, solid phase extraction, Soxhlet-type extraction and liquid-liquid extraction. 
The use of supercritical fluid extraction to determine analytes from the animal feed 
matrices has been investigated only briefly for several pharmaceutical compounds and 
was discussed in chapter 2 section 2.1.1. Chapters 8 and 9 focus on the use of 
supercritical fluid extraction for the determination of fluconazole, tioconazole, UK-
47 265 and hexaconazole from the animal feed matrix. , 
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Chapter 4.0 Instrumentation and Experimental Procedure 
4.1 Characterisation of SFE and SFC Instrumentation 
To perform SFE or SFC, the instrumentation required includes a pump, valves, 
detector cell, oven, a restrictor devices and extraction cell or separation column. The 
basic instrumentation for SFE/SFC can be built from either a HPLC or GC set up 
without any major modifications. The device that characterises a supercritical fluid 
instrument is the restrictor or back pressure regulator which is not found in HPLC or 
GC systems. 
4.1.1 Restrictors 
There are three different types of back-pressure device currently used in SFE and 
SFC: 
1. Fixed restrictor (e.g linear, crimped, integral, fritted) 
2. Mechanical -feed back regulator 
3. Electrical-feedback regulator 
Table 4.1 compares these types of the back-pressure devices and their 
characteristics. 140 
Type Dead volume Applications 
fixed restrictor «nL cSFC 
mechanical-feedback regulator >ml large scale SFE 
electrical-feedback regulator -10 J.lI SFE and pSFC 
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4.1.1.1 Fixed Restrictors 
Fixed restrictors are the simplest form of restrictor consisting of a capillary tube 
having an appropriate diameter and length for the required back pressure and flow 
rate used. 140 They have a small dead volume to meet appropriate requirements for 
columns with an internal diameter of less than 50 J.llll. Several types of capillary 
restrictors have been used having linear, crimpe<L tapered, converging or diverging, 
integral and fritted ends.141 The major advantage of these simple restrictors is 
cheapness, however, the restrictor to restrictor back pressure reproducibility is poor 
and the restrictors are prone to blockages due to the condensation of the solute along 
the tube length. Fixed restrictors are used mainly for capillary SFC and anal)tical 
SFE. 
4.1.1.2 Mechanical-Feedback Regulators 
This type of restrictor is used for large-scale SFE and packed SFC. It is a complex 
regulator consisting of a pressure sensing device and a needle valve.1 42 The valve 
needs to be heated to prevent the supercritical fluid from being frozen in the flow path 
by the temperature reduction due to adiabatic expansion. The regulator controls the 
back pressure irrespective of the mass flow ~e of the supercritical fluid making it 
more conveninent than fixed restrictors. The disadvantage of this type of regulator is 
high cost and large dead volume, a few mL to several tens of mLs, that does not allow 
fractionation of solutes in a fluid from an extraction cell in SFE. 
4.1.1.3 Electrical-Feedback Regulator 
This type of regulator consists of a needle valve and a pressure sensing de\;ce The 
pressure signal controls the opening of the needle \ -aIve so that the pressure is 
maintained at the preset value.1 43 In general, this type of valve controls the flow 
resistance of the valve by changing the gap ben.veen the valve and the seat. Some 
regulators are equipped with an electronic pressure sensing device and a motor-driven 
needle valve. Satio et al. l44 developed a new back pressure regulator based on high 
speed switching of the fluid flow by periodically opening and closing the flow path of 
a solenoid valve. The regulator prevents blockages in the flow path which are possible 
because precipitated solutes and dry ice from the carbon dioxide are continually 
trapped and forced to pass through the valve. To maintain the required back pressure 
the valve is used with a pressure transducer. 
4.1.2 Off-line SFE 
SFE can be performed using two different approaches, off-line and on-line. In this 
chapter, the methodology of off-line extraction will be discussed where the anal)tes 
are extracted using SFE and collected in a device independent of the chromatography 
or any other instrumental analysis. In various stages of the experimental work, off-line 
SFE was performed and the extracts were analysed by a variety of methods. The final 
product of an off-line SFE experiment consisted of the extracts dissolved in a few 
millilitres of an appropriate solvent making it compatible with all conventional 
chromatographic techniques. 
Off-line SFE involves relatively simple experiments and requITes basic 
instrumentation. For SFE to be successfuL the target anal)1es must be controlled 
through three key phases. Firstly, the analytes must be partitioned from the sample 
matrix into the bulk of the supercritical fluid. This step is governed by the 
physicochemical interactions of the anal)tes, sample matrix, and the supercritical 
fluid, as described in chapter I by the SFE e:\.1raction triangle. Secondly, during the 
e:\.1ractio~ the anal)tes must be swept away from the matri.x and out of the extraction 
cell. Thirdly, the anal)tes must be efficiently collected from the supercritica1 fluid in a 
form that is compatible for subsequent analysis. Accuracy is required for all three 
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steps in order to obtain quantitative recoveries. The first step is involved in finding 
optimized SFE conditions that can best remove the target anal)1es from the matri.x 
into the supercritical fluid. An understanding of the partitioning processes helps to 
choose appropriate experimental conditions including pressure, temperature and 
modifier. Steps two and three are essentially plumbing parameters. The fluid flow rate 
required to sweep the analytes from the extraction cell in step 2 helps to determine the 
pumping rate requirements, the maximum extraction cell size required and the ~ pe of 
restrictor used to control the fluid flow rate. Step 3 involving the collection of the 
analyte after the extraction is nearly always performed by depressurizing the 
supercritical fluid through a flow restrictor. 
4.1.2.1 Instrumentation/or SFE 
Instrumentation for analytical-scale SFE is available from a number of suppliers, and 
there are several instrumental differences among manufacturers. The acceptance of 
SFE as an analytical technique is partially impeded by the lack of confidence that 
analytical SFE methods can be reproduced on various types of instrumentation. 
In principle, the instrumentation for SFE consists of five basic components: (I) a 
source of fluid (C02 in this case), (2) a pressure controlled pump, (3) an oven for 
temperature control of the extraction cells, (4) a region for the decompression of the 
supercritica1 fluid, and (5) a collection region for trapping the analytes as they 
precipitate during the decompression step. Various levels of complexity can exist on 
each of the lateer parts and choices should be made relating to the ~l>e of extraction 
work that instrument is to be used for. 
The pump is used to deliver the supercritica1 fluid to the extraction cell. Generally, the 
extraction pressures required are in the range of 100 to 680 atm or 1.500 to 10,000 
psi. The pumping system chosen must be able to supply an uninterrupted supply of 
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fluid during the entire length of the extraction. Both syringe pumps and reciprocating 
pumps have been successful in meeting the requirements. The oven must be capable of 
uniformly heating the extraction cell as well as any associated connecting tubes. It is 
important to preheat the fluid before it reaches the cell, especially if high flow rates or 
large extraction cells are required. The extraction cell is constructed of an inert 
substance capable of withstanding high pressures. The region where the 
decompression takes place is important for the complete recovery of the extracted 
analytes. The most commonly used decompression devices are valves, back-pressure 
regulators, small i.d. orifices, or pieces of small i.d. capillary tubing, usually fused 
silica. During the decompression, a great deal of cooling takes place due to the Joule-
Thompson effect. This cooling can often cause precipitation of the analyte and 
plugging the decompression region or restrictor. This is usually avoided by heating the 
decompression region to help prevent restrictor plugging. The collection region, like 
the decompression region, plays an important role in analyte recovery in SFE. A wide 
variety of methods for trapping analytes have been documented in the literature 
including collection in liquid solvents, 145-147 collection on solvent resin traps, 148-
149 collection on cryogenically cooled surfaces,150 collection directly into 
chromatographic columns via on-column or splitlsplitless injection ports.151-154 The 
configuration of the trapping region is often determined by the modes of extraction, 
either on-line or off-line. Off-line SFE was performed with a Jasco SFE system 
throughout the whole experimental protocol and will be discussed next. 
The Jasco SFE System 
The basic instrumental parts of the Jasco system consists of the following: 
Pumps: Jasco 880-PU intelligent HPLC pump, one with cooling jacket on pump head 
Oven: Jasco 860-CO 1 cm extraction cell, pre-beating coil and rbeod}ne s\\itching 
valve. 
Back pressure regulator: Jasco 880-81 
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A schematic representation of the Jasco system is given in figure 4.1 
CO2 Cylinder 
Coolant Ci rculator 
Pulse 
__ ~_Dampner 
Cell 
Pump Oven 
Bond Elut 
/ Cartridge 
Back Pressure Regulator 
Figure 4.1 Schematic ofa Jasco SFE system. 
The supercritical fluid pump head is cooled by means of a jacket set between -5 to -
10°C. A second pump is available for addition of modifier to the C02. Pressure is 
allowed to build up until the desired pressure and temperature is reached. The 
supercritica1 fluid flow is introduced into the extraction cell by manually switching a 
rheodyne valve. The back pressure regulator maintains the required pressure and 
hence the density of the supercritical fluid in the system. The supercritica1 fluid used, 
C02, a gas at ambient conditions, is vented from the collection device while the 
extracted analytes are retained. Screw cap glass vials (25 ml) with rubber septa at the 
top are introduced as the collection device. The metal pipe at the restrictor can pierce 
through the rubber septum. A h)podennic needle with a C18 Bond Elut cartridge also 
pierces through the septum in order to trap any escaping anal) te and to allow C02 to 
vent to atmosphere. This collection system reduces the escape of anal}tes during 
extraction. 
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4.1.2.2 Dynamic and Static SFE 
SFE can be perfonned using three different modes: 1. dynamic mode in which the 
supercritical fluid is continuously flowing through the extraction ceR 2. static mode in 
which the cell is pressurized with supercritical fluid and the extraction is allowed to 
proceed without any outflow of the supercritical fluid until the extraction is finished 
and 3. a combination of static followed by dynamic extraction. As far as the 
instrumentation is concerned, the only difference between these methods is the 
inclusion and use of additional valves near the inlet and outlet of the extraction cells 
for perfonning static extractions. 
4.1.3 Instrumentation for SFC 
Supercritica1 fluid chromatography (SFC) can be performed using either capillary 
columns or packed columns. In the last few years, research in SFC has led to two 
different approaches. Not only are there two different kinds of columns, but the 
stationary phases, the instrumentation and the typical applications are also different 
for the two forms of the SFC. Supercritica1 fluid chromatography instrumentation 
resembles both GC and HPLC equipment and because of this, it has been possible to 
take advantage of technological developments from both techniques. Capillary SFC 
was developed on principles based on capillary GC, where packed column SFC was 
based on the principles of conventional HPLC systems, including high-pressure 
pumps, stainless steel tubing, injection valves, and columns with few modifications, or 
none at all. A circulating bath or a refrigerating unit maintains a constant temperature 
for the supercritica1 fluid inside the pump reservoir. 
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4.1.3.1 Instrumentation for cSFC 
Capillary SFC utilizes an open column which is a narrow, capillary tube, in which a 
film of a stationary phase is coated on the inside \vall. The entire volume of the 
column, except that occupied by the stationary phase, is available for the flowing 
mobile phase. For a given stationary phase, three dimensions are importan~ the inner 
diameter of the column, the thickness of the stationary phase film and the length of the 
column. The diameter of the column affects the mobile phase flow through the 
column, the sample loadability, the permissible injection and detection volumes and 
the pressure drop over the column. All these effects have consequences for cSFC 
instrumentation. The basic components of an SFC include a pump, a computer for 
control and data collection, and finally the column. 
As the temperature, pressure, and mobile phase composition of the supercritical fluid 
contribute to resolution and retention, the micro computer controls the pump by 
regulating the pressure/density ramping of the mobile phase. It can also control the 
oven temperature (if manufactured by the same company), injection mode, and 
possibly data acquisition, storage and manipulation. Normally the pumps are S)TInge 
pumps requiring a down time for refill after the reservoir has been emptied and they 
can deliver high and low flow rates ",ith almost no pulsation. Injection of samples into 
the cSFE column requires a high pressure injection valve and is usually placed in a 
separately heated thermostatted unit, or kept at ambient temperature. The columns for 
cSFC have inner diameters of 50 ~ and require syringe pumps to establish a stable 
flow. A restrictor is required to maintain supercritical conditions along the entire 
length of the col~ as well as to control the flow rate. Depending upon the detector 
design, the restrictor is placed either immediately after or prior to detection. Detectors 
from either HPLC or GC can be used for SFC particularly \\ith C02 as the mobile 
phase. The flame ionization detector has receiyed the most interest for capi~' SFC 
as it is both reliable and sensitiye. 
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Carlo Erba Mega series SFC 
All cSFC experimental work was performed with a Carlo Erba Mega Series cSFC 
(figure 4.2) and the instrumentation will be discussed next. 
Cooler Injection valve 
Syringe 
pump 
Detector 
r---_, 
Oven with column 
Figure 4.2 Schematic of a capillary SFC System. 
Data handling 
The major components of the instrument consists of a Syringe pump, a GC oven., a 
FID and a recorder. 
The syringe pump was capable of delivering pulse-free delivery of the mobile phase 
needed at the extremely low flow rates. The _syringe pump discharge pressure was 
controlled with a micro computer. The control system was capable of programming 
the pressure or density of the mobile phase during a chromatographic experiment over 
a preselected pressure and/or density range. The sample was introduced into the 
mobile phase stream by a sample introduction valve. The mobile phase sweeps the 
sample onto the analytical colwnn contained in the oven. The column was maintained 
at the desired mobile phase temperature in the temperature controlled 
chromatographic oven. A columnlFID detector interface was placed between the 
column and the detector. llris column detector interface reduced the column pressure 
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to atmospheric pressure in a smooth depressurization step. Finally, the detector signal 
was sent to the chromatographic data system. 
4.1.3.2 Instrumentation for pSFC 
Packed SFC utilizes a column similar to a HPLC column. The four relevant 
parameters in pSFC are the effect of particle size, the stationary phase, the column 
inner diameter and the column length. The instrumentation for a packed SFC system 
also is very similar to a HPLC system, except that there is a back pressure regulator, 
which pressurizes the mobile phase above its critical pressure, and a column heater is 
employed to keep the mobile phase above its critical temperature. The back pressure 
regulator maintains the system pressure through the detector for pSFC. Packed 
columns allow a much higher sample loading and can be adapted to a given detection 
volume by varying the column diameter without affecting the resolution making them 
compatible with UV detectors. 
All pSFC was performed with a home made system which was built in the laboratory 
and will be discussed next. The basic components of the pSFC system consisted of the 
following: 
Gilson 305 Master pump and slave pumps (HPLC pumps) 
Dynamic Mixer 
Manometric module 
Oven 
Jasco intelligent UV Nis detector 
Jasco back pressure regulator 
In our laboratory, a pSFC has been constructed from a Gilson SFE system \\ith a 
Jasco UVNis detector and back pressure regulator. Figure 4.3 shO\\'s a schematic 
diagram of the SFC system. 
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1. Gas cylinder. 2. Cooling jacket.3. Master pump .. 4. Slave pump, 
5. Dynamic mixer. 6. sample introduction valve .. 1. oven .. 
8. separation column .. 9. detector and 10. back pressure regulator. 
Figure 4.3 A schematic diagram of the SFC system. 
The cooling of the reciprocating pump was achieved by means of a cooling jacket (-20 
to -5°C) on the pump head to allow chromatographic operation of C02 as the mobile 
phase. An organic modifier was introduced into the eluent system by the second pump. 
Direct on-line mixing was achieved by the dynamic mixer. The temperature of the 
mixer fluid was kept at the desired chromatographic temperature by the use of the 
oven where the separation takes place. The injection valve is used for an introduction 
of the sample into the column. The eftluent from the column flows into the detector 
and then into the back pressure regulator. The flow resistance of the back pressure 
reguJator is automatically changed so that the system pressure is kept constant at the 
preset value. The pressure of the fluid is released by the back pressure regulator and 
the fluid containing the extracts flows out from the outlet as the ordinary gas. 
82 
4.2 Units Used for Pressure 
At present, there are various units for measuring (a variety of units such as psi, atm., 
bar, kg/cm2, and Pa) pressure. In spite of the recommendations for using the SI units, 
Pa is not yet well accepted by many scientists and engineers. Since specific equations 
require specific units, and data cited from the literature uses different units, it was 
decided to use all of these units as they appear in the original sources. For the reader's 
convenience, a unit conversion chart is given in table 4.2. 
Table 4.2: Pressure unit conversion chart. 
kg/cm2 atm bar MPa 
I k~cm2 1 0.9678 0.9807 0.09807 
latm 1.0332 1 1.0133 0.10133 
1 bar 1.0197 0.9869 1 0.1 
1 MPa 10.197 9.869 10 1 
Ipsi 0..01031 0:.06W5 0.06895 0.006895 
'-." 
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psi 
14.22 
14.70 
14.50 
145 
1 
.. 
Chapter 5.0 : Estimating Steroid Solubility using Log P and Solubility Parameter 
Theory 
The aim of this part of the thesis is to test the hypothesis that the hydrophobicity of a 
solute can be correlated directly to the solubility of that solute in the supercritical 
state. In supercritical fluid extraction (SFE), it is thought that the hydrophobic nature 
of a molecule can be closely related to its solubility in the supercritical phase. As \\ith 
many phannaceutical compounds, steroids have a widely varying hydrophobicities, 
ranging from completely insoluble in water to being highly soluble in water. It is 
expected that they will follow similar trends in supercritical C02 solubility. The use 
of partition coefficient in conjunction with a calculated solubility parameter as a 
reasonable means of estimating steroid solubility in supercritical C02 is demonstrated 
in this chapter. 
5.1 Definition of Partition coefficients 
The partition coefficient of a substance X is defined as the ratio of the concentrations 
of a solute equilibrated between two immiscible phases, typically an oil and an 
aqueous phase at a given temperature. 
P = [X]org/(X]aq 
Thus, from a qualitative standpoint, the partition coefficient can be defined as a 
measure of the solutes preference for the oil phase over aqueous phase, often referred 
to as lipophilicity or hydrophobicity. Hydrophobicity is normally measured using the 
logarithm of the partition coefficient in octanol-\vater systems (logP or 10gKow). 
From a more fundamental standpoint, the partition coefficient may be described in 
terms of solutes cohesive and adhesive interactions \\ith the respective solvent. ISS 
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Hence, partition coefficients can provide information on the intermolecular forces of 
the solute in solution. 
5.2 Quantitative Structure-Activity Relations in Drug Design 
Compared with a decade ago, tremendous progress has been made towards a rational 
basis for drug design. It is well known that the fundamental requirements for a 
particular kind of drug action are dependent upon the structure of the molecule and the 
location of the receptor. An effective drug has to satisfy three requirements. First, it 
must have a size, shape, and electron distribution complementary to that of the 
receptor. Second, it must have a lipophilicity-hydropbilicity balance that "ill ensure 
that it reaches the tissues where the receptor is located. Thirdly, it must accumulate 
selectively in the cells. These considerations lead to the establishment of relationships 
between the biological activity of a drug and its physical and chemical properties. 
These are called structure-activity relationships (SARs) and, if they can be expressed 
numerically, they become quantitative structure-activity relationships (QSARs). 
SAR methods are nowadays of unquestionable importance in drug design. The 
objective of QSARs in drug design is to optimize the activity of drugs. QSAR models 
quantify biological activity in terms of molecular structure and provide useful forms 
of data reduction that assists in the rational design of compounds which appear 
optimum for therapeutic purposes. The molecular stucture coding in QSAR may take 
the form of quantum mechanical indices, topographical descriptors (chemical graph 
theory) or molecular fragments. The relationships between these mathematical models 
or descriptors is extrapolated to predict the activity of drugs. 
Partition coefficients have been used to model the biological activity of both specific 
and non-specific drugs. Octanol water partition coefficients have been accepted as a 
favourable method of estimating the lipophilic character of organic compounds. 156-
158 Th· fr . IS arose om the assumptIon that the octanol phase may resemble organic 
material in lipid tissues of living organism. 
The activity of both specific and non-specific drug activity are of interest in QSAR 
studies. Specific drug action may be based on the specific site receptor, whereas non-
specific drug action can be based on the disruption of gross structural features of the 
body, such as a lipid membrane. Non-specific contributions can be obtained by direct 
measurement of the equilibrium concentration of a drug partitioned between two 
immisible phases, such as, octanol and water. The measurement of drug activity can 
be made more specific by using a fragmentation method proposed by Hansch and 
Leo,159 where the interactions of the drug molecule with the biological systems are 
obtained by application of established thermodynamic principles based on additive 
correlations using substituent constants for component parts of the molecule. 
QSAR models differ primarily in the manner in which the 'structure' (S) tenn is 
elucidated and quantified. Models follow the general fonn: 160 
A = f(S) 
where S represents either an empirical or theoretical structural parameter for the total 
molecular structure or selected substructural fragments and A represents the 
magnitude of the measured dependent parameter (biological activity in QSAR). 
There are two types of QSAR models: "Free - Wilson" or "Hansch". In the Free -
Wilson model, the bioactivity is related to contributions from individual substituents 
on the drug molecule. 161 The QSAR studies then ascertain those substituents 
providing the greatest contributions. The Hansch-Leo approach is also kno\\TI as the 
"linear free energy model" and S is encoded as combinations of various physico-
chemical characteristics (hydrophobicity. molecular weight. refracti\;ty, steric 
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influences) of the collection of structural analogs used in the study. Hansch and Leo 
approach is the most popular method for drug design as it is easier to screen novel 
molecular structures for drug activity by this method. 
5.3 Measurement of Partition Coefficient 
The experimental determination of LogP is governed by the acid-base behaviour of the 
compound concerned. Non-ionisable compounds are generally uncomplicated 
excepting that very large P values can cause difficulties when the aqueous phase 
concentration is so low that errors in assay can arise. A great number of 
pharmaceuticals, however, exhibit acid-base behaviour, and therefore partition into an 
organic solvent will be influenced by the compounds pKa. 
The direct methods are straight forward, and are either 'batch' or 'dynamic' techniques. 
'Batch' includes the 'shake flask method,162-166 and the 'slow stirring,167-168 
method. The dynamic procedure involves a solvent extraction flow cell ('filter 
chamber'). All these direct methods require the compound concerned to have a 
chromophoric group (for spectrometric assay) or to be amenable to potentiometric 
titration. Care and precision are required in the measurement to obtain accurate values 
of P since it is a ratio and small errors in con~ntration measurement resuh in greater 
errors in P. For example, sufficient time must be allowed for the attainment of 
equilibrium (this can take up to several days); the aqueous buffer and octanol phases 
should be fully equilibrated with each other before the dissolution of the compound-
otherwise volume changes result. 
5.3.1 Shake Flask Method 
The "shake Flask" method is probably the most widely used technique for measuring 
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log P. This method is however time consuming and requires a series of steps. Firstly, 
a known amount of solute is dissolved in the most appropriate phase of the solvent 
pair. The second phase is added next which involves adding usually 2 to 10 ml of 
octanol and 10 to 25 m1 of water 162-166 and the solute is partitioned by shaking the 
two phases together. The shaking time reported for the procedure have been varied in 
the literature from 30 seconds to 12 hours162-166 but approximately 30 minutes 
appears to be the most appropriate. The phases are separated under gravity for 2 to 12 
hours followed by centrifugation (10 to 45 min at 1500 to 12000 rev/min162-166) 
and the concentration of the solute in both phases is determined by any available 
analytical technique (GC, HPLC, UV-Vis etc.). 
5.3.2 Reversed Phase HPLC 
RP-HPLC retention data are currently playing a significant role in the determination 
of log P. lbis method is based on the fact that a linear correlation exists between the 
retention of a compound in a reversed-phase chromatographic system and its partition 
coefficient. 16 7 -171 
It has been implied that the partitioning of a chemical between organic and aqueous 
phases of a RP-HPLC column correlates with the partitioning which takes place 
between various phases of the environment. 168 It is also assumed that partition 
coefficients determined by the RP-HPLC method reflect true partitioning behaviour in 
biological systems due to the fact that the mobile and the stationary phases in the RP-
HPLC resemble the aqueous and non-aqueous phases in biological systems, in 
contrast to the traditional octanol-water partitioning method. Octanol is an isotropic 
liquid in which the size and the shape of the solute molecules are not the determinants 
of the partitioning process. In contrast. biomembranes are anisotropic, and the 
molecular size and shape and the orientation of functional groups plays a role in the 
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partitioning process. Furthermore, the former is a static system, while the latter is the 
dynamic system. The RP-HPLC is both anisotropic and d)namic.168, 172 
RP-HPLC can be performed on commercially available analytical columns packed 
with a solid stationary phase consisting of a non-polar organic surface layer, such as 
C8 or CI8 alkyl chains, covalently bound to silica patricles. The transportation of the 
solutes through the columns involves partitioning between the hydrocarbon stationary 
phase and the mobile phase consisting of water with an organic solvent. The solutes 
are eluted out of the column according to their hydrophobicity. The water soluble 
compounds are eluted first and the oil-soluble compounds are eluted last in 
proportion to their hydrocarbon-water partition coefficient. 
The chromatographic parameter commonly used for correlating octanol-water 
partition coefficient with measured HPLC data is the capacity factor, k'. The capacity 
factor ranging typically between 5 and 10 for a number of reference compounds is 
usually required to give a desired range of octanol-water partition coefficients. The 
log k' values of the reference compounds are plotted against their log octanol-water 
partition coefficient values and this correlation plot is used to estimate log partition 
coefficient values of the test compounds. 
5.3.3 Available Methods/or Calculating Octanol-Water partition Coefficients 
Most of the experimental methods for the determination and estimation of octanol-
water partition coefficients have only limited use for hydrophobic compounds and are 
also error prone. In addition.. the experimental determination of many pharmaceutical 
compounds are often extremely difficult. In view of the experimental difficulties, a 
number of calculative methods have been developed based on mathematical treatment 
of the molecular structure for the rapid determination of logP. These molecular 
appfoa(hes can be di\ided into two categories. Firstly. those which use molecular 
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fragments and secondly, those based on an atomic approach. The former approach is 
preffered. The use of a fragmental approach has been viewed from two different 
prospectives. The first approach, described as a constructionist approach, was 
developed by Hansch and Leo whereas the later meth<><L proposed by Rekker, uses a 
reductionist approach. In each case, the molecular fragments are used to derive a log 
P value. These molecular fragmental contributions are available in tabular form for 
each approach. 
5.3.3.1 Hydrophobic Substituents Constants (llansch-Fujita) Method 
The first methodology for calculating 10gP was proposed by Fujita et al. 173 in 1964. 
Log P was considered to be an additive constitutive property and numerically equal to 
the sum of the 10gP of the "parent" solute plus a 7t term which represented the 
difference in 10gP between a particular substituent and the hydrogen atom which it 
replaced. Thus the 7t for substituent can be defined as 
7t(X) = 10gKowRX - 10gKowRH 
where 10gKowRX is octanol-water partition coefficient of a derivative, 10gKowRH is 
octanol-water partition coefficient of a parent compound, and 7t(X) is the hydrophobic 
substituent constant that can be defined as a contribution of substituent X to 
hydrophobicity when replacing hydrogen atom H by X ( for example, 7t(CI) = 
logKowC~5CI -log OwC6H6: 7t(CI) = 2.84 - 2.13 = 0.71).159 A positive value of 
7tmeans that relative to H, the substituent favours the octanol phase. A negative value 
of 7t shows its hydrophillic character relative to H. If 1\vo or more substituents are 
added to the parent compound, the equation takes a different form: 
10gKowRXIX2 ...... Xn = logKowRHH ..... H + I1t(X)n 
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Values of 1t for various substituents were determined on the basis of careful Iv 
measured octanol-water partition coefficient and tabulated. 167 ,173 
This proposed 1t system of Fujita et al. I73 was first applied only to substitution on an 
aromatic ring where the hydrogen atom being replaced was definitely of a 
hydrocarbon nature. Later this methodology was attempted by several other 
investigators where calculations were carried out with compounds where the hydrogen 
was clearly part of a polar moeity, such as a hydroxyl or amine. The results obtained 
were often prone to error. In additio~ not all 'aromatic hydrogens' could be substitued 
without some correction factor, 1t for a substituent which is capable of hydrogen 
bonding is greater when it replaces a hydrogen on an electron-deficient ring than when 
replacing one of benzene's hydrogens. 
5.3.3.2 Hydrophobic Fragmental Constants (Rekker) Method 
The 'Fragmental' approach to the calculation of log P was pioneered by Rekker and 
his colleagues. 159 One of the approximations used in the hydrophobic substituents 
system is that the hydrophobicity of a hydrogen atom in the octanol-water system is 
close to zero, and thus a 10gKow of a compound can be obtained by summing the 1t 
constants. However, it was found at a later date that the hydrophobicity of a methyl 
group was significantly greater than that of a methylene group. 159 Following this, 
Rekker developed a new approach to calculate the logKow values based on this 
subsequent equation: 167 
n 
log Kow = ~ an!n 
1 
where a is a number of occurrences of a fragment f, of the structural type, n. The 
hydrophobic fragmental constant f, is the contribution of a constituent part of a 
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structure to the total hydrophobicity of a molecule. 157 A close relationship between 
this system and the previously described system can be demonstrated when 
considering their fundamental equations together: 
7t (X) = 10gKowRX - logKowRH 
fX = log KowRX - fR 
2fH = log KowH-H 
fX = 7t (X) + fH 
By definition, adding the fragment constant of hydrogen to the 7t constant for any 
substituent gives the fragmental constant for that substituent. 173 
Careful study of the experimental 10gKow values enabled the determination of f 
constants for various fragments. 167,174 A number of fragments, such as CH3, CH2, 
CH, NH2, NH, C6H5, OH, 0, COOH, and COO were defined as primary fragments: 
they originate from regression analysis of partition coefficients and have known 
standard deviations. Inclusion of any fragments in regression analysis implies the 
availability of at least 4 or 5 different structures wth reliable experimental logi<ow 
values. Other fragments, defined as secondary fragments, were calculated on the basis 
of 10gKow values of "parent compounds" and f constants of primary fragments. A 
number of correction factors were also introduced to this system to account for 
various interactions between the functional groups. 165 
5.3.3.2 Leo-Hansch Fragmental Constants Method 
Not long after Rekker's hydrophobic fragmental constant system, Leo-Hansch 159 
developed a system using a very few carefully measured 10gKow values for simple 
structures to calculate the fragmental values for the most basic and useful constants, 
such as the fragmental value for the hydrogen atom or carbon atom. The fragmental 
value for the hydrogen atom was estimated from the assumption that in the H 2 
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molecule, the atom is not involved in any interactions and can be considered as an 
ordinary one. A carefully measured l~w value for H2 is 0.45, therefore, fi-I = 0.22 
and is considered as the cornerstone of the system. The fragmental value for a carbon 
atom in an alkyl chain is another fundamental constant required in logKow 
calculations. The adopted approach was through the carefully measured logKow 
values of methane and ethane. The values obtained for l~wCH4 = 1.09 and 
lo~wCH3CH3 = 1.81. Two routes are then available for calculating value ofCH3: 
fCH3 = logKowCH4 - fi-I = 1.09-0.225 = 0.825 
fCH3 = 1I21ogKowCH3-CH3 = 112[1.81] = 0.905 
Rounding off the average value of 0.885 to 0.89 and the £H value to 0.23 the 
following values are obtained 
fCH2 = fCH3-fH = 0.66 
fCH = fCH3-2fH = 0.43 
fC = fCH3-3fH = 0.20 
Thus, in this method, the fragment constants fH = 0.23 and fC = 0.20 are regarded as 
the only fundamental ones required to calculate all alkane structures. The other 
factors (F) that affect the partitioning equlibrium in the more complex solutes are 
taken into account where simple summations of fragments fail. In the Leo-Hansch 
fragmental constant method, Rekker's basic equation is extended to: 
n m 
log Kow = L anfnn + L bmF m 
1 1 
where F represents a factor that affects the partitioning equilibrium in a solute where 
summation of fragments does not lead to acceptable results and b is the number of 
occurrences of factor F .Hansch and Leo proposed a set of correction factors in order 
to achieve correct calculation of lo~w values. 159 Among these are corrections for 
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chain l~ branching and unsaturation, nng SIZe, aromaticity and hydrogen 
bonding. 
5.3.3.4 Rekker's Revisedf-System 
In the previously described Rekker's f-system, a so called "magical constant" was 
introduced as a way of compensating discrepancies between experimentally 
determined log Kow values and calculations achieved by fragment addition. It was 
noticed that this difference could be expressed in terms of a value 0.289, which was 
called the "magic constant". The Rekker's f-system equation was restated 'with the 
addition this constant: 
logKow = I:f + Lim XCM 
where CM is the magic constant and kn is expressed as the frequency of CM occuring 
in a structure under consideration. 174 
5.4 Calculation of log P Values for Steroids 
The method adopted for calculating 10gP 17? in this thesis is a computer based 
approac~ ClogP. The Hansch-Leo approach is implirnented in the ClogP software 
package, based on the experimentally derived values for simple fragments within 
structures. Log P can then be obtained by dividing a compound into a series of these 
fragments, followed by simple surrunation of their hydrophobicity parameters. 
5.5 Determination of Fedors Solubility Parameter in the Supercritica/ Phase 
Solubility parameter theory was discovered over thirty years ago as a method for 
describing the solvent power of compressed gases.22 The theory provides the means 
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to predict the quantitative behaviour of solutes in dense fluid supercritical solvents. 
There are several methods available for calculating the solubility parameter. These 
have been evaluated by Kingl76 who concluded that a 10% variance between 
different methods is commonplace. Perhaps the simplest method of calculating the 
solubility parameter is based on a group contribution method as proposed by 
F edors .177 The main advantage of this method is that it allows the estimation of the 
solubility parameter from only a knowledge of the solutes molecular structure. 
Structurally complex solutes can thus be calculated without prior knowledge of their 
thermodynamic properties. The Fedors method has been related to solubility in 
supercritical carbon dioxide by King and Fredrichl78 via the reduced solubility 
parameter proposed by Giddings. 179 King concluded that a large body of SFE data 
could be correlated, in a quantitative manner, to changes in the molecular structure. 
The solubility parameter, <>2, was described by Hildebrand in terms ofthermodynarnic 
properties on mixing of dilute solutions.22 For a compound with low molecular 
weight this was found to be related the substances energy of vaporisation ~v at a 
given temperature, and the molar volume at that temperature V. The solubility 
parameter is related to these two physical properties by equation 5.1 
5.1 
The heat of vaporisation is often measured to calculate the energy of vapourisation. 
The following equation relates the energy of vaporisation to the heat of vaporisation 
(equation 5.2). 
~\"=MIv-RT 5.2 
Where, R is the gas constant and T is the absolute temperature 
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The boiling point of a substance can be used to calculate the MIv using an empirical 
method proposed by Hildebrand [equation 5.3]. 
Llliv = Tb2 + 23.7 Tb - 2950 5.3 
Where, T b is the boiling point at standard pressure. 
When a substance, such as a solid, possesses a very low vapour pressure, then 
difficulty arises in measuring either the energy of vaporisation or the boiling point of 
that substance. The Hildebrand method of estimating the solubility parameter is only 
practical if the numerical values T b and T c are accessible. This situation is 
uncommon for complex and novel compounds. 
An alternative method for estimating solute solubility is based on the summation of 
atomic group contributions. The methods used in this thesis to calculate the solute 
solubility in the supercritical phase is that proposed by Robert Fedors. 
By exarnmmg the vast amount of molar volume and energy of vaporisation 
information available for liquids Fedors found that a general system for estimating 
both the ~v and V could be set up. The system assumes, like the other systems, that 
the group contributions of individual functional groups on a molecule can be summed 
to give an overall estimate of the solubility parameter. 
As explained above, the solubility parameter is calculated from the expression 82 = (~ 
Ej / V)0.5 where ~ is the energy of vaporisation at a temperature of 25°C and V is 
the corresponding molar volume. Fedors concluded that by examining a vast amount 
of data for simple liquids, both the ~ and V values could be estimated for more 
complex molecules by adding the group contributions of the various fragments of the 
whole molecule. Using Fedors proposed method the solubility parameter of a series of 
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steroids with ranging polarities was also calculated [table 5.1]. Table 5.2 shows an 
example calculation of solubility parameter by the Fedors Method for Testosterone. 
Table 5.1 List of CLogP and solubility parameter values for different steroids. 
Steroid Solubility CLogP 
parameter 
megestrol acetate 10.44 3.904 
betamethasone-17,21 11.42 2.872 
dipropionate 
clobetasone 12.09 1.907 
clobetasol 12.66 1.919 
hydrocortisone 14.09 0.66 
prednisolone 13.04 0.444 
pregnelone 10.72 3.907 
testosterone 11.16 3.349 
testosterone propionate 9.95 4.784 
prednisone 13.48 -0.018 
b~onevalerare 12.19 2.897 
4-androstene-3, 17 dione 10.3 2.887 
betamethasone 13.83 0.806 
testosterone acetate 9.94 4.255 
cortisone acetate 12.08 0.7 
beclomethasone dipropionate 11.53 3.108 
clobetasol propionate 11.66 2.952 
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Table 5.2 Example calculation of solubility parameter for Testosterone. 
Contribution AEvper V per fragment Fragment Fragment V for 
fragment AEvfor Testosterone 
Testosterone 
CH3- 1125 33.5 2250 67 
CH2- 1180 16.1 9440 128.8 
CH- 820 -1.0 3280 -4 
HC= 1030 13.5 1030 13.5 
C- 350 -19.2 700 -38.4 
C= 1030 -5.5 1030 -5.5 
C-O 4150 10.8 4150 10.8 
OH 7120 10 7120 10 
Ring Closure 250 16 1000 64 
5-6 atoms 
Conjugated 400 -2.2 400 -2.2 
double bonds 
Total 30400 244 
82 = (tllivN)0.5 = 11.16 
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5.6 Steroid Solubility Prediction Using Clog P and Solubility Parameter 
A plot of solubility parameter versus Clog P is shown in figure 5.1. This plot can be 
indicative of the probable solubility of steroids in supercritical carbon dioxide. It can 
be deduced from the plot that steroids (table 5.3 ) appearing on the top left hand 
corner are in the soluble region, the steroids appearing in the middle region are in the 
intermediate solubility region and the steroids in the bottom right hand comer are in 
the insoluble region. 
99 
5 
4.5 
4 
3.5 
Q. 3 
E:1I 2.5 
c 2t ..J U 1.5 
o~l -Q.~.~ 
Plot of Clog P Against Solubility Parameter For Selected 
Steroids 
III 1 
a2 
-3 _5 
a6 
1114 .~7 119 III 10 
II 11 II 13 
II 12 1I~~5 
I I I I I I I I 
10 10.5 11 11.5 12 12.5 13 13.5 
Solubility Parameter 
I 
14 
Figure 5.1 Plot of CLogP against solubility parameter for selected steroids. 
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Numbcrs represent the stcroids I = testosterone propionate, 2 = testosterone acetate, 3 = megestrol acetate, 4 = 4-androstene-3, 17-dione, 5 = pregnenolone, 6 = 
testosterone, 7 = bec1omethasone dipripionate, 8 = betamethasone dipropionate, 9 = c1obetasol propionate, 10 = betamethasone valerate, 1 1 = c1obetasone, 12= 
cortisone acetate, 13 = clobetasol, 14 = hydrocortisone, 15 = prednisolone, 16 = betamethasone, 17 = prednisone 
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Table 5.3 Prediction of steroid solubility m supercritical C02 usmg solubility 
parameter and Clog P. 
Steroid Predicted Solubility in 
Supercritical CO2 
megestrol acetate soluble 
betamethasone-17,21dipropionate soluble 
clobetasone intennediate 
clobetasol intennediate 
hydrocortisone insoluble 
prednisolone insoluble 
pregnelone soluble 
testosterone soluble 
testosterone propionate soluble 
prednisone insoluble 
b~onevruerate soluble 
4-androstene-3, 17 dione soluble 
betamethasone insoluble 
testosterone acetate soluble 
cortisone acetate intennediate 
beclomethasone dipropionate soluble 
clobetasol propionate soluble 
5. 7 Conclusion 
A prediction of steroid solubility in supercriticru carbon dioxide is described, based on 
the solubility parameter theory and the hydrophobic te~ ClogP - This data is only 
quruitative and does not estimate supercriticru conditions, such as temperature and 
pressure. The plot identifies trends in steroid solubility and later in the thesis the 
solubility of some of the selected steroids will be measured (chapter 7) which 
supports the trend indicated in this chapter. 
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Chapter 6.0 The Use of a Chromatographic Method to Predict Solubility of 
Steroids in Supercritica/ Carbon Dioxide 
6.1 Introduction and Aims 
One of the initial goals of the project was to attempt to find a relationship between 
solubility of an analyte in supercritical carbon dioxide and chromatographic retention. 
The aim of this study was to provide a simple relationship between the capacity factor 
and the solubility of testosterone in supercritical carbon dioxide. Testosterone was 
selected as it is a commonly used pbannaceutical compound and as it is more complex 
than other analytes commonly used for this type of research such as naphthalene. 
There was also literature solubility data available for testosterone at different 
temperatures and pressures. 
The use of chromatographic retention data to predict physical chemical properties, 
such as, molar volume and solubility is well established in quantitative structure 
activity relationship (QSAR) studies. 180 Also, chromatographic retention data are 
easily available in the literature and they are also easy to generate. Chromatography, 
in itsel£ is a partitioning process and can be defined as a separation method based on 
different distributions through different interactions of solutes with a mobile phase and 
a stationary phase, which are in equilibrium. In the case where the mobile phase is a 
supercritica1 fluid, the chromatography is defined as supercritical fluid 
chromatography (SFC). The variable operating conditions for SFC provide the 
supercritica1 carbon dioxide mobile phase with sufficient variability in solvating 
ability. SFC retention measurements can provide important physiochemical 
information including the capacity factor of the component under investigation. The 
capacity factor is proportional to the partition coefficient of the anal~ te which in itself 
is an important factor which directly facilitates the modelling of extraction / 
separation. 18I Equilibrium properties, such as, partial molar volume and solubilities 
are also related to the partition coefficient. 180 Therefore by directly measuring the 
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capacity factor for a component an estimation of the analyte solubility in supercritical 
carbon dioxide can be obtained. Previous work 182 has sho\\n that under selected 
conditions e.g. at constant temperature and for a particular column, the capacity 
factor for a particular solute is inversely proportional to its solubility in the mobile 
phase. This relationship can provide a rapid way of generating solubility data from 
capacity factor measurements providing the proportionality constant relating the two 
quantities are known. 
6.2 Principles of Chromatographic Separation 
Chromatography is essentially a physical method of separation m which the 
components to be separated are distributed between two phases, one of which is 
stationary, while the other percolates through it in a predefined direction. The 
chromatographic process occurs as a resuh of repeated sorption/desorption 
interactions during the movement of the sample components along the stationary bed, 
and the separation is due to the differences in the distribution constants of the 
individual sample components. 
The column accommodates the two phases: the stationary phase, which is integral in 
the col~ and the mobile phase which is transported through it. Separation is 
achieved because different sample components show different distributions over the 
two phases. Those solutes which are preferentially distributed in the stationary phase 
remain in the column longer than those that are distributed in the mobile phase. 
Consequently, individual solutes will be eluted from the column in order of their 
increasing distribution coefficients with respect to the stationary phase. The solutes 
are distributed between two phases to different extents because the molecular 
interactive forces between the solute molecules and those of the two phases are 
different for each individual solute. For those solutes distributed preferentially in the 
stationary phase, the forces between the solute molecules and stationary phase 
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molecules are much greater than the forces between solute molecules and those of the 
mobile phase. Conversely, solutes distributed preferentially in the mobile phase 
exhibit greater forces between them and the mobile phase than they do \\ith the 
stationary phase. 183 
The density of the mobile phase is the most important parameter to influence the 
separation in SFC.1 84 The influence of density on the solvent properties can be 
demonstrated using the concept of solubility parameter. 179 Using this concept, the 
solubility parameter of a solvent depends on its density and can vary from 0, up to 10 
at high densities. To solubilise a substrate, the solubility parameter of the substrate 
and the solvent should be nearly equal. At low solvent densities, the solubility 
parameters of the mobile phase in the SFC are low compared to those of the substrate, 
but they increase proportionally with increasing density. Therefore, the capacity 
factor, k (the degree of retention of a solute), decreases at higher densities indicating 
higher solvent strength. 
6.3 Retention Times and Capacity Factors 
A solute, i, distributes itself over the two phases, mobile phase and stationary phase 
resulting in a total quantity, qi.m, to be present in the mobile phase and a quantity, 
qi.s, to be present in the stationary phase. The solute molecules which find themselves 
in the mobile phase will be transported through the column at the same speed (u) as 
the molecules of the mobile phase. However, this is only a fraction of all the solute 
molecules, so the average speed for all solute molecules \\ ill be only a fraction of u 
given by 
Vi = [qi.m / (Qi.m + qi.s )] . u 6.1 
where, vi, is the migration spee<L the average speed at which the solute band travels 
through the column. 
The time, irj, needed for the solute band to elute from the column is determined from 
the column length and average migration speed: 
t . = L Iv· f.1 1 6.2 
Similarly, the time which a mobile phase molecule will spend in the column is 
6.3 
where to is the hold-up time, mobile phase time, or unretained time. 
Combination of the two equations gives, 
6.4 
by definitio~ the capacity factor (ki) of the solute, i, is 
6.5 
and hence 
6.6 
The quantity, q, of the solute, i. in one of the phases is the product of the average 
concentratio~ c' of the solute, i, in that phase (where the average is taken along the 
length of the column) and the volume of that phase. Hence the capacity factor 
equation becomes 
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ki = q i.s / q i.m = [c' i.s / c' i.m] . Vs / Vm 6.7 
The ratio c' i.s / c' i.m is a constant if the distribution isotherm (a plot of Ci.s \'s Ci.m) 
is linear. The distribution coefficients (partition coefficient in terms of concentration 
CKc», may be defined as, 
Tl" . - ('.; / ('.; "'~.1 - -1.S -l.m 6.8 
Kc may be independent of the solute concentration, but will always be a function of 
the temperature and pressure. If the distribution isotherm is linear, ICc will also equal 
the ratio of average concentrations in equation (6.3.7) and hence 
6.9 
Equation 6.3.9 relates retention in chromatography (k) to a thermodynamic parameter, 
the partition coefficient (Kc). The partition coefficient strongly depends on the 
operational parameters of SFC. The phase ratio V s / V m is a characteristic of the 
column and is one of the factors that determines the retention, k, in chromatography. 
The phase ratio can be influenced by varying several parameters, for example, the 
type of column (packed or capillary), the column diameter etc. 
6.4 The Effect o/Operational Variables on Retention in SFC 
In SFC, the typical effect of variables such as density (p), or pressure (P), 
temperature (T), and composition (X) on retention is shown in equations 6.10-6.12. 
where Ws are solute~ependent coefficients. 185 The first order coefficients are almost 
invariably negative for density and composition: they can be positive or negative for 
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reciprocal temperature, depending on whether the solute exhibit GC like or LC like 
behaviour i.e. whether the solute is volatile/poorly solvated or non-volatilelhighly 
solvated. The second order coefficients are usually negative or smaller: they are often 
neglected over the relatively narrow, but practical range of densities or mobile phase 
composition typically employed for most samples. Assuming all other variables are 
constant, equations 6.10-6.12 show that the retention may be reduced by increasing 
density (or pressure), temperature (T), or the amount of stronger component in the 
supercritical fluid mixture (modifier). Since the retention of different solutes does not 
depend on these variables in precisely the same way (i.e. the first and/or second order 
coefficients in equations 6.10-6.12 are generally not the same for different solutes), a 
change in selectivity frequently accompanies a change in these variables, particularly 
temperature and composition of the modifier. 
In k' = 130 + 131P + 132p2 
In k' = 130' + 131'/ T 
Ink' = 130" + 131 "X+ 132"x2 
6.10 
6.11 
6.12 
F rom thermodynamic and other considerations, density has been shown to be more 
fundamental variable than pressure. For those supercritical fluids for which density 
can be predicted from pressure via an accurate equation of state, it is easy to attain an 
accurate and precise density by simply controlling the pressure and temperature. 
6.5 Experimental Section for the Capacity Factor Analysis of Steroids by cSFC 
Capacity factor measurements were obtained usmg a Carlo Erba capillary 
supercritical fluid chromatography system with a flame ionisation detector. The 
steroids under investigation were testosterone, megestrol acetate and pregnenolone 
(Figure 6.1). All steroids were provided in pure form by Pfizer Central Research, 
Sandwich.. Kent. The sample preparation for these steroids involved simply dissolving 
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the pure steroids in MeOH. The final concentration of the analytes injected were 1000 
ppm. The chromatographic columns used in this study included the fol1o,,"IDg, a 50 m 
x 50 JlIIl id biphenyl (0.25 JlIIl film thickness) and a 10 m x 50 ~ id SB-
Cyanopropyl-50 (0.25 JlIIl film thickness). The solutions of the samples were 
introduced onto the column using split injection. 
Testosterone 
Pregnenolone 
Me COMe 
OCOMe 
Megestrol Acetate 
Me 
Figure 6.1 Structure of selected steroids. 
6.6 Results and Discussion 
Initially capacity factor measurements were detennined (table 6.1) for testosterone 
using a biphenyl column at various temperatures and pressures. 
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Table 6.1 List of capacity factor measurements for testosterone at vanous 
temperatures and pressures using a biphenyl column. 
Temperature (OC) Density (2fmI) Pressure (MPa) Capacity factor (k) 
55 0.817 24.18 0.56 
55 0.772 20.75 0.90 
55 0.718 17.32 1.66 
55 0.671 15.63 3.03 
55 0.629 13.97 5.50 
80 0.772 32.6 0.51 
80 0.750 30.4 0.60 
80 0.718 27.6 0.81 
80 0.671 23.9 1.37 
80 0.629 21.6 2.15 
90 0.772 37.2 0.37 
90 0.718 31.5 0.62 
90 0.671 27.2 1.04 
90 0.629 24.6 1.12 
90 0.519 19.4 1.49 
100 0.772 41.3 0.33 
100 0.718 35.5 0.50 
100 0.671 30.6 0.84 
100 0.629 27.6 1.24 
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In SFC, once the mobile and the stationary phase have been selected, the retention of a 
solute as measured by the capacity factor, k, is controlled by variables such as 
density or pressure, temperature and composition.I 85 The initial study with 
testosterone involved investigating the relationship between capacity factor with 
density, temperature and a function of density I temperature (table 6.2) by regressing 
In capacity factor against density, 1 I temperature and density I temperature. The 
derived equation obtained (r = 0.93, r2 = 0.86) was as follows, enabling capacity 
factor for testosterone to be calculated providing the density and the temperature are 
known. 
Ink=-21.41 + [15.72 x density] + [9511.52 I temperature] -
[8365.67 x density I temperature] 6.13 
In SFC, the degree of retention of a solute is also inversely proportional to the 
solvating power of the mobile phase for that solute, i.e. the more soluble a solute is in 
the mobile phase the less it will be retained. I82 On the basis of this, a similar 
relationship was derived between solubility with density, temperature and a function 
of density I temperature for testosterone using available literature solubility data 186 
for testosterone at specific temperatures (35, 40, 45 and 55°C, table 6.3) and 
pressures. The derived equation (r = 0.97, r2 = 0.95) was of the form: 
In solubility = 23.45 - [17.1 x density] - [13356 I temperature] 
+ [8639.9 x (density / temperature)] 
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6.14 
Table 6.2. List of 1n capacity factor values for testosterone at specific density and 
temperature. 
Ink Density lItemperature Density I temp. 
(el ml) (K) (el ml.K) 
-0.579 0.817 0.00305 0.00249 
-0.105 0.772 0.00305 0.00235 
-0.507 0.718 0.00305 0.00219 
1.109 0.671 0.00305 0.00204 
1.709 0.629 0.00305 0.00192 
0.215 0.63 0.00270 0.00169 
0.174 0.67 0.00270 0.00180 
-1.109 0.77 0.00270 0.00206 
-0.693 0.72 0.00270 0.00193 
0.315 0.67 0.00283 0.00190 
-0.211 0.72 0.00283 0.00204 
-0.681 0.77 0.00283 0.00218 
-0.511 0.75 0.00283 0.00212 
0.765 0.63 0.00283 0.00178 
-0.994 0.77 0.00275 0.00212 
-0.478 0.72 0.00275 0.00201 
0.039 0.67 0.00275 0.00185 
0.113 0.63 0.00275 0.00174 
0.398 if 0.52 0.00275 0.00143 
11 I 
Table 6.3. List of literature In Solubility and lIsolubility data for testosterone at 
specific density and temperature. 
In solubility lIsolubility density 1/ temp density / temp. 
(literature (mole fraction) (g / mI) (K) (g / mi. K) 
values) 
-14.187 1449275.0 0.329 0.00314 0.00103 
-13.62 819672.0 0.554 0.00314 0.00174 
-12.500 269542.0 0.671 0.00314 0.00211 
-11.060 63452.00 0.724 0.00314 0.00228 
-10.890 53476.00 0.761 0.00314 0.00240 
-10.290 29377.00 0.791 0.00314 0.00249 
-10.130 25619.00 0.814 0.00314 0.00256 
-10.080 23958.00 0.834 0.00314 0.00262 
-9.770 17507.00 0.857 0.00314 0.00269 
-9.680 16008.00 0.873 0.00314 0.00274 
-12.630 305810.0 0.671 0.00319 0.00214 
-12.150 189753.0 0.744 0.00319 0.00238 
-10.900 53967.00 0.770 0.00319 0.00246 
-10.710 44743.00 0.796 0.00319 0.00254 
-10.770 47348.00 0.796 0.00319 0.00254 
-10.380 32341.00 0.830 0.00319 0.00265 
-10.120 24863.00 0.861 0.00319 0.00275 
-9.930 20467.00 0.882 0.00319 0.00282 
-9.790 17937.00 0.889 0.00319 0.00284 
-12.990 438596.0 0.658 0.00325 0.00214 
-11.830 136799.0 0.748 0.00325 0.00243 
-11.340 84034.00 0.786 0.00325 0.00255 
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-10.820 49776.00 0.811 0.00325 0.00263 
-10.560 38700.00 0.832 0.00325 0.00270 
-10.360 31646.00 0.851 0.00325 0.00276 
-10.280 29189.00 0.870 0.00325 0.00282 
-10.130 25107.00 0.882 0.00325 0.00286 
-10.010 22207.00 0.898 0.00325 0.00292 
-9.900 19889.00 0.908 0.00325 0.00295 
-14.760 2564103.0 0.244 0.00305 0.00074 
-13.870 1052632.0 0.373 0.00305 0.00114 
-12.690 324675.0 0.524 0.00305 0.00159 
-11.680 118483.0 0.630 0.00305 0.00192 
-11.200 72886.00 0.672 0.00305 0.00205 
-10.610 40535.00 0.719 0.00305 0.00219 
-10.070 23624.00 0.752 0.00305 0.00229 
-9.940 20721.00 0.775 0.00305 0.00236 
-9.690 16160.00 0.802 0.00305 0.00244 
-9.570 14265.00 0.820 0.00305 0.00250 
Equation 6.13 was used to calculate the capacity factor for all available literature 
solubility data for testosterone at the four temperatures (35, 40, 45, and 55°C). All 
literature solubilities were then recalculated to take temperature and density into 
consideration using equation 6.14. 
A direct relationship was then deduced between capacity factor (k) and solubility for 
testosterone by plotting In capacity factor against In calculated solubility (table 6.4). 
This can then be used as a solubility predictor for testosterone for any capacity factor 
value. 
In solubility = ( In k - 11410)/ 1.085 6.15 
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Table 6.4. List of In k, In calculated solubility (using equation 6.15) and In literature 
solubility for testosterone. 
In capacity factor In calculated In literature 
solubility solubility 
5.199 
-15.015 
-14.757 
3.937 
-13.823 
-13.867 
2.460 
-12.427 
-12.691 
1.432 
-1l.448 
-11.683 
1.021 
-1l.059 
-11.192 
0.561 
-10.625 
-10.610 
0.229 
-10.320 
-10.070 
0.033 
-10.108 
-9.934 
-0.261 
-9.858 
-9.690 
-0.407 -9.692 
-9.566 
l.942 -12.707 
-12.991 
0.912 -1l.722 -1l.827 
0.447 -1l.306 -1l.339 
0.191 -11.032 -10.815 
-0.049 -10.801 -10.564 
-0.267 -10.594 -10.362 
-0.484 -10.386 -10.282 
-0.637 -10.254 -10.132 
-0.804 -10.079 -10.008 
-0.919 -9.969 -9.898 
5.015 -15.237 -14.187 
2.633 -12.971 -13.617 
1.395 -11.793 -12.505 
11.t 
0.834 -11.260 -11.058 
0.442 -10.887 -10.887 
0.124 -10.585 -10.288 
-0.119 -10.353 -10.127 
-0.331 -10.152 -10.084 
-0.574 -9.920 -9.770 
-0.744 -9.759 -9.681 
1.591 -12.173 -12.631 
0.787 -11.406 -12.154 
0.501 -11.133 -10.896 
0.215 -10.860 -10.709 
0.215 -10.860 -10.765 
-0.159 -10.503 -10.384 
-0.226 -10.177 -10.121 
-0.450 -9.957 -9.927 
-0.890 -9.833 -9.795 
Solubility predictions were then carried out for testosterone at the four temperatures 
and compared with the literature solubility data. Figures 6.2-6.5 shows plots of 
-
literature solubility against predicted solubility. The correlation coefficient and the 
slope obtained for testosterone were 0.991 and 0.890 ± 0.096 at 35°C, 0.988 and 
0.870 ± 0.123 at 40°C, 0.989 and 0.852 ± 0.101 at 45°C and 0.995 and 0.848 ± 
0.066 at 55°C at 95 % confidence limits respectively. All plots show reasonable 
correlation between the literature and predicted solubility and these figures show that 
the slope and the correlation coefficient do not differ significantly from the "ideal" 
values of 1 and I respectively. Solubility isotherms were then constructed (figures 
6.6-6.9) for testosterone at the four different temperatures. 
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Figure 6.4 Plot of Literature solubility vs Predicted solubility 
for Testosterone at 31S·K 
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Figure 6.5 Plot of Literature solubility vs Predicted solubility 
for Testosterone at 32S-K 
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All the data presented shows that the solubility model can be used as a reasonable 
solubility predictor for testosterone at the different temperatures. The validity of the 
proposed model was further checked by carrying out capacity factor measurement for 
testosterone at temperature 55°C. Solubility predictions were carried out (table 6.5) 
using equation 6.15 for both measured capacity factor and calculated capacity factor 
using equation 6.13 . 
Table 6.5 Comparison of Predicted solubility against Literature solubility. 
Density Measured Solubility Calculated Solubility Literature 
(gIml) capacity (mole fraction) capacity (mole fraction) Solubility 
factor (k) using measured factor using using calculated (mole fraction) 
(k) eq. 6.13 k 
(1 x 10-5) (1 x 10-5) (1 x 10-5) 
0.817 0.56 4.62 0.67 3.94 
0.772 0.90 2.98 1.03 2.63 
0.718 1.66 1.70 1.75 1.62 
0.671 3.03 1.00 2.78 1.06 
0.629 5.50 0.56 4.18 0.73 
The results indicated that the model can be used as a solubility predictor for 
testosterone, although there is an increasing error at higher densities. This was 
expected due to the difficulties in measuring the capacity factor accurately as the 
testosterone peaks obtained were severely tailed and broad (figure 6.10-6.11 ) and this 
error was reflected in the solubility model. Also, at high densities testosterone 
becomes more soluble in the supercritical carbon dioxide mobile phase and hence 
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7.01 
4.83 
2.47 
1.37 
0.84 
smaller capacity factor is obtained giving potentially greater error due to small 
retention times. The peak tailing may have been possibly caused by adsorption 
interaction in the column . The peak tailing behaviour arises when there are strong 
interactions between the solute and the stationary phase, but the solute/solute 
interactions are relatively weak. Initially, the amount of solute adsorbed onto the 
stationary phase increases rapidly as the concentration in the mobile phase is 
increased until a monolayer of solute molecules is formed on the adsorbent. As the 
interactions between solute molecules are w~ the adsorption ceases with the 
formation of the monolayer. The amount adsorbed remains constant despite the fact 
that the concentration in the mobile phase is increased further. Hence the distribution 
coefficient Kc is large at low em values but decreases as em increases. This means 
that the rate of migration is not the same across the band. and the center of the band 
which has a higher concentration, moves more rapidly catching up with the front 
leaving the tail behind. 
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Figure 6.10 Example cSFC trace of testosterone obtained at 55·C and a density of 0.63 g/ml. 
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Figure 6.11 Example cSFC trace of testosterone at 55'C and a density of 0.772 g/ml. 
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The solubility values obtained were not absolute values and predictions of solubility 
can only be accounted for using the biphenyl column. An attempt was made to find a 
similar relationship between testosterone and SFC retention measurements by using a 
different stationary phase to see if it affected the accuracy of prediction and also to 
see if the model could be extended to other compounds. 
The interaction of testosterone with a polar cyanopropyl column was significantly 
different and the model does not account for this factor. The model is also restricted 
for solubility predictions for testosterone only as different analytes have different 
affinity towards a stationary phase and is demonstrated on figures 6.12-6.13. 
Correction factors will have to be introduced to take into account for the interaction of 
testosterone with different stationary phases if predictions were to be carried out using 
the same model. The effect of retention on different statinary phase was established 
(figure 6.14) by measuring the capacity factor oftestosteone at different pressures and 
temperatures, but at constant density of 0.63 g/ml using a biphenyl column and a 
cyanopropyl column. The results showed (table 6.6) that testosteone was less retained 
on the more polar cyanopropyl column. A similar effect was then observed with 
megestrol acetate (table 6.7, figure 6.15) and pregnenolone (table 6.8, figure 6.16). 
Unfortunately, due to instrumental breakdown and lack of time no further 
investigation was possible. 
Table 6.6 The capacity factor results obtained for testosterone using two different 
columns. 
Temperature (OC) k (biphenyl column) k (cyanoj)roJ!Y1 column) 
100 l.24 0.44 
90 l.49 0.61 
80 2.15 0.81 
70 2.88 1.13 
55 5.50 2.03 
Table 6.7 The capacity factor results obtained for megestrol acetate using two 
different columns. 
Temperature (OC) k (biphenyl column) k (cyanoj)ropyl column) 
100 l.5 0.49 
90 l.85 0.67 
80 2.51 0.87 
70 3.54 1.24 
55 6.42 2.24 
Table 6.8 The capacity factor results obtained for pregnenolone using two different 
columns. 
Temperature (OC) k (biphenyl column) k (cyanopropvl column) 
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A solubility model based on capacity factor measurements was presented for the 
prediction of testosterone solubility in supercritical C02. The column utilized for the 
capacity factor measurements was a biphenyl column and solubility predictions were 
canied out for four different temperatures for which literature data exists. The 
solubility predicted appeared to correlate reasonably well \\ith the literature solubility 
128 
data based on capacity factor measurements carried out with the biphenyl column 
only. Changing the column changed retention of testosterone significantly and the 
model did not hold. It was assumed that the model will not extend to different steroids. 
It was shown that interactions of different analytes with different stationary phases are 
significantly different and for the model to hold for different analytes and different 
stationary phases, correction factors will have to be introduced to take into account of 
all the interactions. Chapter 7 presents an accurate way of measuring solubility of 
steroids in supercritica1 C02. 
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Chapter 7. 0 Solubility Determination of Steroids in Supercritical Carbon Dioxide 
7.1 Introduction and Aim 
The solubility of an analyte in supercritical C02 gives an indication of the relative 
extractibility of the substance as a function of pressure and temperature. The 
solubility gives the concentration of solute in equilibrium with the pure solute. This 
part of this thesis reports the solubility data of a series of steroids v .. ith a range of 
polarities using UV analysis following extraction with supercritical C02. The 
objectives of the experiments were to provide increased knowledge on the solubility of 
steroid honnones in supercritical carbon dioxide, and at the same time, to back up the 
hypothesis that the solubility of a molecule can be predicted using ClogP and 
solubility parameter theory. 
7.2 Experimental Methods for Obtaining Solubility 
There are several experimental methods available to determine solubilities of anaIytes 
in supercritical fluid and the methods can be classified in two different ways. The first 
method relates to the way in which the saturated solution is obtained, which can be 
static or dynamic, i.e., in a closed cell or in a flmv system. The second method is 
involved with how the solution is analysed. These methods can be grouped into four 
different categories: gravimetric, spectrometric, chromatographic, and miscellaneous 
(e.g. titration after extraction). Of the techniques mentioned, the gravimetric method is 
the most widely used. This method involves the production of a saturated solution by 
passing the supercritical fluid over the solute in an extraction cell, dropping the 
pressure to precipitate the solute, and weighing it. The chromatographic method is the 
second most popular technique. Most chromatographic methods used are 
modifications of the gravimetric method. For example, in one ~ -pc of modification., the 
solute is precipitated as before in a trap, containing a solvent. The solute is then 
130 
washed out of the trap, made to volume, and analyzed by any suitable 
chromatographic method, such as GC, TLC and HPLC. A different type of 
chromatographic method involves the use of chromatographic retention measurements 
in SFC to produce qualitative solubility data. The other experimental methods 
available to determine solubility are attempts to find alternatives, but none of these 
have yet been generally accepted. Spectroscopic techniques can offer convenience if in 
situ analysis is carried out by making absorption measurements in the UV directly in a 
high pressure static equilibrium cell, but here the effect of the supercritical fluid on the 
absorption properties often complicates the procedure. 
7.3 Solubilities of Analytes in Supercritical Fluids 
The solubility of a solute can be described either as the mole fraction of solute in 
solution, x, or by the amount (as moles or mass) of solute per volume, expressed in 
terms of concentration, S, at saturation.24 The relationship between these quantities is 
trivial and involves the density of the solution in moles per unit volume. As the 
solutions are dilute, it is assumed to be the density of the pure fluid. Therefore, S can 
be expressed in moles per unit volume by the following equation;24 
S=xN 7.1 
where V is the molar volume of the pure fluid. 
The solubility of a substance in a supercritica1 fluid can be explained by two factors, 
the volatility of the substance and the solvating effect of the supercritica1 fluid. Figure 
7.1 shows the schematic of the solubility of a substance at constant temperature as a 
function of pressure and in terms of mole fraction. 24 
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Figure 7.1 Schematic diagram of supercritical fluid solubility against pressure at 
constant temperature. 24 
At very low pressures (sections A-B), x falls as the solute is diluted by the fluid. 
Thereafter, in section B-C, a rapid rise in x is noticed at a threshold pressure 
characteristic of the solute-fluid syste~ which is a pressure somewhat above the 
critical pressure of the fluid. This takes place due to the rapid rise in density. The next 
two features mayor may not occur for any particular system, especially if a narrow 
pressure range is employed. A fall in section C-D may occur because as higher 
pressure is approached, the repulsive forces may squeeze the solute out of solution. 
The rise in D-E takes place for moderately volatile solutes, if there is a critical line in 
the mixture phase at higher pressures.24 
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7. 4 Experimental Section 
The Jasco SFE system was used in these experiments to measure the solubility of 
steroids gravimetrically. A sample of pure steroid (10 mg ) was mixed with Celite, an 
inert support, and placed in a sample cell. The sample cell was made of stainless steel 
(10 em x 5.0 mm i.d.) with a volume of - 2.0 ml. Celite does not exhibit matrix 
effects and was a suitable surface to investigate the solubility of pure compounds. 
Extracted analytes were collected in a glass vial placed underneath the BPR outlet. A 
small volume of solvent (methanol was used in all cases) was placed at the bottom of 
the collection vial for dissolution of the analyte. Analysis of the extracts was 
performed using a Shimadzu UV NIS spectrometer equipped with 1.0 em path length 
silica cells for all measurements. Quantification was achieved by diluting all extracted 
steroids and measuring the absorbance against a five-point linear calibration graph. 
The steroids investigated (figure 7.2) were testosterone, testosterone-l 7 -propionate, 
beclomethasone-I 7,21-dipropionate, betamethasone-I 7,2 l-dipropionate, cortisone 
acetate, hydrocortisone, prednisolone, prednisone and megestrol actetate. Steroids 
were provided in pure form by Pfizer Central Research, Sandwich , Kent and Glaxo 
Manufacturing Services, Barnard Castle, Co. Durham. 
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Figure 7.2 Structures of the investigated steroids. 
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Extraction conditions: 
The SFE collection system used required the supercritica1 solvent to be pumped 
through the sample cell in dynamic extraction mode. However, all steroid extractions 
utilised a two minute static extraction period prior to dynamic extraction for 10 
minutes at a pump flow rate of 1 ml min-I. The static extraction allowed the 
supercritical fluid to penetrate the sample increasing the natural partitioning of the 
analytes into the solvent. The 10 minute extraction time provided enough mass 
transfer to enable the analytes to be collected in a small amount of solvent at the end 
of the back pressure regulator. The internal volume of the extraction cell being swept 
slightly more than 6 full times with supercritica1 fluid. The mole fraction solubility is 
dependent on the volume of carbon dioxide used in the extraction and is calculated as 
follows: 
mole fraction extracted = 
[moles of analyte extracted]/[moles of analyte extracted + moles of C02 used] 
for a 10 minute extraction at 1 ml min- I a volume of 10 ml of carbon dioxide is used. 
Therefore the number of moles of carbon dioxide used is given by 
moles of C02 = 
[volume of C02 (ml) x density of liquid C02 (g/ml)]/ mwt of C02 
where the density of liquid C02 is 0.93 gmt-I. 
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An example of the mole fraction solubility calculation for testosterone at temperature 
55°C and pressure 149 kg/cm2 is as follows: 
Weight of testosterone extracted = 1.2 x 10-3 g. 
Molecular weight of testosterone = 288.41 
Mole fraction = 1.2 x 10-3/288.41 = 4.16 x 10-6 
Moles of C02 = (10 x 0.963)/44 
= 0.211 
Mole fraction weight extracted = [4.16 x 10-6]/[4.16 x 10-6 + 0.211] 
= 1.95 x 10-5. 
7. 5 Results and Discussion 
Steroid Solubility Studies 
In this part of the thesis, the solubility data for a series of steroid hormones, including 
testosterone, for which literature data exists is reported. A direct comparison is given 
from the data available from the literature for testosterone and the experimental data 
accumulated during the course of this work. Thus allowing the robustness of the 
experimental method to be evaluated. 
7.5.1 Initial Studies using Testosterone 
Testosterone, like all other steroid hormones shares the same basic four ring 
cyclepentanoperhydrophenantbrene structure. It is know to be soluble in supecritical 
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Testosterone's solubility was detennined by Kosal et al. 186 using apparatus capable 
of extracting greater quantities of solubilised solid than the Jasco instrumentation used 
in this case. However, a comparison was undertaken between experimentally 
measuremented solubility and reported literature solubility by Kosal at 55°C over a 
range of 10 different pressures. Table 7.1 shows shows that the mole fractions 
experimentally determined for testosterone are similar to that of the literature values. 
This is verified by the isotherms of both experimental and literature values. 
The establishment of this close correlation for the two sets of results was necessary 
before other steroid compounds could be extracted using the same method. The fact 
that the extraction method and the chosen method of analysis provided very similar 
results to the literature values lead to the conclusion that this was a suitable method of 
solubility determination. The greatest variance from the literature values was observed 
at the lower pressures studied. Errors in this region are thought more likely due to the 
very small solubility shown by testosterone and the other steroids at the resulting 
density conditions. 
7.5.2 Steroid Solubility Studies: Extension to other Steroids 
The solubility results for testosterone propionate, betamethasone dipropionate, 
beclomethasone dipropionate, cortisone acetate, hydrocortisone, prednisolone, 
prednisone, and megestrol acetate are shown in tables 7.1-7.10 with the solubility 
isotherms at temperatures and pressures studied in figures 7.3-7.12. The solubilities of 
all the steroids investigated in this chapter were already predicted using 
CLogP/solubility parameter theory in chapter 5 and the predictions were as follows: 
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Steroid Predicted Solubility in 
Supercritical CO2 
megestrol acetate soluble 
betamethasone dipropionate soluble 
cortisone acetate intennediate 
beclomethasone dipropionate soluble 
hydrocortisone insoluble 
prednisolone insoluble 
testosterone soluble 
testosterone propionate soluble 
prednisone insoluble 
The qualitative data obtained from chapter 5 identified trends in steroid solubility in 
supercritical carbon dioxide. Figure 7.13 shows the solubility isotherm of all nine 
steroids at 55°C which compare agreeably with the experimentally determined values 
for nine steroids in supercritical carbon dioxide. It was observed that steroid hormones 
can be solvated in greater amounts as their polarity decreases and the molecule 
becomes more hydrophobic, for example, steroids such as testosterone propionate and 
testosterone are more soluble in supercritica1 carbon dioxide than steroids such as 
hydrocortisone and prednisone. 
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Table 7.1 Comparison of Literature and Measured Solubilities for Testosterone 
at 55°C 
c 
0 
''fi 
ID 
... 
-~ 
0 
E 
C1 
0 
-J 
Pressure Literature value at 55°C Measured value at 55°C 
k2 cm-2 mole fraction mole fraction 
84.00 0.039E-05 0.009E-05 
101.00 0.095E-05 0.027E-05 
116.00 0.308E-05 0.752E-05 
132.00 0.844E-05 0.998E-05 
149.00 1.370E-05 1.951E-05 
164.00 2.471E-05 2.350E-05 
181.00 4.230E-05 3.011E-05 
200.00 4.830E-05 4.791E-05 
215.00 6. 190E-05 6.251E-05 
23100 7.011E-05 7.490E-05 
Figure 7.3 Comparison of literature solubility and measured 
solubility for testosterone at SS·C 
-2 
70 90 110 130 150 170 190 210 230 250 
-3 
-4 II II ill II II 8 
-5 , 
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• 
-7 
I • 1esms1erone atSSC ! ~ 
-9 IS literature solubility 
-10 
-11 
Pressure (kg/cm2) 
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Table 7.2 Experimental results for the extraction of Testosterone at 55°C and 100°C. 
Pressure 
kgcm-2 
231.00 
215.00 
200.00 
181.00 
164.00 
149.00 
132.00 
116.00 
101.00 
84.00 
-2 
-3 70 
4 
c 
0 
·u -5 
" ... ~ 
-CIl 
0 -7 
E 
C7l ~ 
0 
-9 
-10 
-11 
TESTOSTERONE at 55°C TESTOSTERONE at lOOOC 
mole fraction mole fraction 
0.009E-05 9.050E-05 
0.027E-05 8.530E-05 
0.752E-05 6.390E-05 
9.981E-05 3.940E-05 
1.951E-05 2.460E-05 
2.350E-05 1.640E-05 
3.0 11E-05 0.197E-05 
4.791E-05 0.156E-05 
6.251E-05 0.082E-05 
7.490E-05 0.046E-05 
Figure 7.4 Plot of log mole fraction vs pressure for 
testosterone 
90 110 130 150 170 190 210 230 250 
• Ii • III Ii III 
• • ill! I!I , ~ 
• 
• testosterone atSSC I 
I 
Si testosterone at10Crc i 
pressure (kg/cm2) 
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Table 7.3 Experimental results for the extraction of Testosterone Propionate at 55°C 
and 100°C. 
Pressure 
kg cm-2 
231.00 
215.00 
200.00 
181.00 
164.00 
149.00 
132.00 
116.00 
101.00 
84.00 
-2 
-3 70 
-4 
c 
0 ~ 
·il 
11:1 
.0 ~ 
-
.! 
-7 0 
E 
-8 0\ 
0 
-9 
-10 
-11 
TESTOSTERONE TESTOSTERONE 
PROPIONATE at 55°C PROPIONATE at lOOOC 
mole fraction mole fraction 
9.100E-05 9.951E-05 
8.250E-05 8.530E-05 
7.580E-05 7.390E-05 
6.350E-05 5.360E-05 
4. 130E-05 1.650E-05 
2.620E-05 0.122E-05 
1.650E-05 0.564E-05 
1.310E-05 0.131E-05 
0.701E-05 0.100E-05 
0.BIE-05 0.056E-05 
Figure 7.5 Plot of log mole fraction vs pressure for 
testosterone propionate 
90 110 130 150 170 190 210 23) 250 
II II II • , • 
• • 
III! 
• II!! , I!!I lSI 
• testosterone propionate at 55·C 
III testosterone propionate at 100·C 
pressure (kg/cm2) 
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Table 7.4 Experimental results for the extraction Betamethasone Dipropionate at 
55°C and 100°C 
Pressure 
kg cm-2 
231.00 
215.00 
200.00 
181.00 
164.00 
149.00 
132.00 
116.00 
101.00 
84.00 
-2 
-3 
4 
c 
0 
-5 
'u 
a:J 
-6 .. 
-CD 
-7 0 
E 
~ -8 
0 
-9 
-10 
-11 
BETAMETHASONE BETAMETHASONE 
DIPROPIONA TE at 55°C DIPROPIONATE at lOOOC 
mole fraction mole fraction 
7. 120E-05 6. 190E-05 
5.890E-05 5.550E-05 
2.660E-05 2. 120E-05 
1.890E-05 1. 190E-05 
1.400E-05 0.899E-05 
0.500E-05 0.311E-05 
0.171E-05 0.0085E-05 
0.021E-05 0.003E-05 
-
-
-
-
Figure 7.6 Plot of log mole fraction vs pressure for 
betamethasone dipropionate 
90 110 130 150 170 190 210 230 250 
• • II Ii II , 
• betamethasone dipropionate I 
I 
at55'C I 
II betamethasone dipropionate 
at Hxrc 
pressure (kg/cm2) 
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Table 7.5 Experimental results for the extraction of Beclomethasone Dipropionate at 
55°C and 100°C 
Pressure 
kg cm-2 
231.00 
215.00 
200.00 
181.00 
164.00 
149.00 
132.00 
116.00 
10l.00 
84.00 
-2 
-3 70 
-4 
c 
0 
-5 
·13 
I!:J 
... ~ .... 
~ 
-7 0 
E 
C1I ~ 
.E 
...g 
-10 t 
, 
-11 1 
BECLOMETHASONE BECLOMETHASONE 
DIPROPIONA TE at 55°C DIPROPIONATE at lOOOC 
mole fraction mole fraction 
4.880E-05 3.090E-05 
3.410E-05 1.250E-05 
2.990E-05 1.010E-05 
2.590E-05 8.950E-05 
1.100E-05 6.010E-05 
0.911E-05 0.321E-05 
0.471E-05 0.080E-05 
0.233E-05 0.055E-05 
0.055E-05 0.012E-05 
0.019E-05 -
Figure 7.7 Plot of log mole fraction vs pressure for 
beclomethasone dipropionate 
90 110 130 150 170 190 210 230 250 
• • " • 1& , III: iii IS 
III III ~ 
• 
&'I lSi 
III mI ;... ! II beclomathasone 
I dipropionalle at55·C 
i 
IS beclomethasone 
dipropionate at 1 (XrC 
pressure (kg/cm2) 
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Table 7.6 Experimental results for the extraction of Cortisone Acetate at 55°C and 
100°C 
Pressure 
kg cm-2 
231.00 
215.00 
200.00 
181.00 
164.00 
149.00 
132.00 
116.00 
101.00 
84.00 
-2 
-3 70 
-4 
c 
0 
-5 
·u 
a:3 
... 
-6 
-II) 
-7 0 
E 
-8 t7I 
0 
-9 
-10 
-11 
CORTISONE ACETATE at CORTISONE ACETATE at 
55°C lOOOC 
mole fraction mole fraction 
2.550E-06 2.3lOE-06 
2.010E-06 1.910E-06 
1.550E-06 1.450£-06 
1.490E-06 1.320E-06 
1.420E-06 1.250E-06 
1.200E-06 1. 110E-06 
0.550E-06 0.490E-06 
0.451E-06 0.351E-06 
0.281E-06 0.225E-06 
0.145E-06 0.I11E-06 
Figure 7.8 Plot of log mole fraction vs pressure for 
cortisone acetate 
90 110 130 150 170 190 210 230 250 
III II II iii • 
Il!:I II II 
• cortisone acetate atSS"C 
I!C cortisone acetate at 1CX)"C 
pressure (kg/cm2) 
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Table 7.7 Experimental results for the extraction of Hydrocortisone at 55°C and 
100°C 
Pressure 
kg cm-2 
231.00 
215.00 
200.00 
181.00 
164.00 
149.00 
132.00 
116.00 
101.00 
84.00 
-2 
-3 70 
4 
c 
0 
-5 
·u 
«I 
-6 ... 
-II) 
-7 C 
E 
-8 ~ 
0 
-9 
-10 
-11 
HYDROCORTISONE at HYDROCORTISONE 
55°C lOOOC 
mole fraction mole fraction 
8.770E-07 7.340E-07 
7.810£-07 6.440E-07 
6.160£-07 5.020E-07 
5.350£-07 4.570E-07 
2.750£-07 1.640E-07 
1.900£-07 1.390E-07 
1.370E-07 0.631E-07 
0.592E-07 0.025E-07 
0.059£-07 -
0.019E-07 -
Figure 7.9 Plot of log mole fraction vs pressure for 
hydrocortisone 
90 
, 
• 
110 130 150 170 190 210 230 250 
• 
II I 
II • 
I • hydrocortisone at55·~ . 
I 1m hydrocortisone at 100 C : 
pressure (kg/cm2) 
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Table 7.8 Experimental results for the extraction of Prednisolone at 55°C and 
100°C 
Pressure 
kg cm-2 
231.00 
215.00 
200.00 
181.00 
164.00 
149.00 
132.00 
116.00 
10l.00 
84.00 
-2 
-3 
-4 
c 
0 
-5 ti 
a:I 
-6 .. 
-cu 
-7 "0 
E ~ CJl 
0 
-9 
-10 
-11 
PREDNISOLONE at 55°C PREDNISOLONE at lOOOC 
mole fraction mole fraction 
12.900E-08 9.860E-08 
11.800E-08 8.580E-08 
9.720E-08 7.010E-08 
6.550E-08 5.400E-08 
4.590E-08 3.290E-08 
3.890E-08 1.460E-08 
2.650E-08 1. 130E-08 
1. 110E-08 0.905E-08 
0.355E-08 0.005E-8 
0.112E-08 -
Figure 7.10 Plot of log mole fraction vs pressure for 
prednisolone 
70 90 
• 
• 
110 130 150 170 190 210 230 250 
, II Ii 
IS 
pressure (kg/cm2) 
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II II II 
• prednisolone at SS·C . 
I 
D prednisolone at 100'C I 
I 
Table 7.9 Experimental results for the extraction of Prednisone at 55°C and 100°C 
Pressure 
kgcm-2 
231.00 
215.00 
200.00 
181.00 
164.00 
149.00 
132.00 
116.00 
101.00 
84.00 
-2 
-3 
-4 
c 
0 
-5 
·U 
111 
-6 ~ 
-Q) 
-7 C 
E 
-8 ~ 
oS! 
-9 
-10 
-11 
PREDNISONE at 55°C PREDNISONE at lOOOC 
mole fraction mole fraction 
6.090E-07 5.880E-07 
4.311E-07 3. 130E-07 
2.610E-07 1.910E-07 
1.290E-07 1. 120E-07 
0.798E-07 0.788E-07 
0.365E-07 0.341E-07 
0.161E-07 0.140E-07 
0.060E-07 0.050E-07 
0.014E-07 0.005E-7 
0.011E-07 -
Figure 7.11 Plot of log mole fraction vs pressure for 
prednisone 
70 
III • R!i 
110 130 150 170 100 210 230 250 
II " 
• prednisone at55·C 
&'i prednisone at 100'C 
pressure (kg/cm2) 
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Table 7.10 Experimental results for the extraction of Megestrol Acetate at 55 cC and 
100°C 
Pressure 
kg cm-2 
231.00 
215.00 
200.00 
181.00 
164.00 
149.00 
132.00 
116.00 
101.00 
84.00 
MEGESTROL ACETATE MEGESTROL ACETATE 
at 55°C at lOOOC 
mole fraction mole fraction 
5.310£-05 5.540£-05 
5.170£-05 5.070£-05 
4.930£-05 4.360£-05 
3.820£-05 2.950£-05 
2.340£-05 2.330£-05 
1.360£-05 1.270£-05 
0.716£-05 0.606£-05 
0.232£-05 0.109£-05 
0.109£-05 
0.064E-05 
Figure 7.12 Plot of log mole fraction vs pressure for 
megestrol acetate 
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Figure 7.13 Solubility isotherm for nine steroids at 55·C 
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7.6 Conclusion 
This chapter presented solubility results for a series of steroids ,vith ranging polarities 
in supercritica1 carbon dioxide. As expecte<L the solubility of the steroids increased 
with increasing the density of the supercritical fluid. The experimentally detennined 
values of the steroid solubility in supercritica1 carbon dioxide obtained in this chapter 
relate favourably with the predicted steroid solubility in supercritica1 carbon dioxide 
based on the ClogP/solubility parameter theory. 
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Chapter 8.0 The Determination of Fluconazole by SPElHPLC, SFElHPLC and 
SFElGC from an Animal Feed Matrix 
8.1 Introduction and Aims 
Sample preparation of phannaceutical compounds is often more difficuh and time-
consuming than the actual analysis procedure. Furthermore, extraction of an anal~te 
from a matrix is generally the most time-consuming step of sample preparation and 
leads to relatively inefficient analyte recoveries. Off-line SFE provides an alternative 
to traditional Soxhlet or liquid extraction methods. The present method for the 
isolation of fluconazole from the animal feed involes time consuming liquid 
extraction/solid phase extraction. 137 The objective of this study was to investigate the 
use of supercritical fluid C02 to extract fluconazole from spiked animal feed matrix. 
The SFE method is also compared with the established SPE method. 
8.2 Optimization Parameters of SFE 
There are two basic requirements that must be fulfilled to successfully perform off-
line analytical supercritical fluid extraction. Firstly, the extraction parameters must be 
chosen correctly, given that the analyte is soluble in the extraction fluid. Even at this 
point, strong matrix interactions may preclude direct extraction of the analyte. 
Secondly, the collection system used must be efficient to trap all of the analytes during 
extraction. 
For an SFE to be successful. the main operating variables relevant to extraction must 
be controlled. This is particularly true if extractions are to be carried out at pressures 
and temperatures near the critical region where a small change in either pressure or 
temperature has a noticeable difference in the supercritical C~ density as 
demonstrated by the phase diagram in Chapter 1 section 1.2. Designing meaningful 
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SFE involves considering several variables, other than temperature and pressure, 
which are important for obtaining a final reproducible extraction. Table 8.1 is a list of 
possible variables which are of greatest importance for optimi zing an extraction with 
supercritical fluids. 
Table 8.1 List of possible variables for SFE. 
Supercritical Modified Sample Instrumental Sample 
fluid supercritical variable parameters accumulation 
fluid 
choice selection SIZe choice mode of 
of modifier of extraction extraction, e.g. 
cells on-line or off-
line 
pressure concentration matrix extraction cell choice of 
temperature collection, e.g. 
dry collection or 
solvent 
collection 
temperature particle size extraction cell choice of 
geometry collection 
solvent 
flow rate type of analyte type of 
restrictor 
restrictor 
temperature 
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Some of these variables listed will depend on the instrumentation availability, but 
most of them are common to all types of supercritical fluid extraction. The four main 
variables for SFE are considered to be the extraction pressure, temperature, time and 
the flow rate. 187 However, interactions between two, or even several variables are 
quite possible. An experimental design approach was considered for e:\.1raction of 
fluconazole to account for the possible interactions between the four main operating 
variables of SFE. 
8.3 Experimental design 
The term experimental design can be defined as a test or a series of tests in which 
meaningful changes are made to the input variables of a process or a system so that 
the reasons for changes in the response may be identified. 188 Experimental design can 
act as a statistical means of obtaining the greatest amount of information in the fewest 
number of experiments. 
In order to design a successful experimental design technique there are several factors 
which must be considered. 
1. Identifying the factors which may affect the resuh of an experiment 
2. The choice offactors and the levels at which the factors will be studied 
3. Designing the experiment so that the effects of uncontrolled factors are minimized 
4. Choice of experimental design 
5. Using statistical analysis to separate the effects of the various factors involved. 
The extraction efficiency for SFE will be found dependent on one or more of the 
variables listed in table 8.1. However, the relative contribution of each factor "ill not 
be equal and the most important factors must be chosen carefully when designing an 
experiment. Once the relevant factors are identified it is important to keep all the other 
factors as constant as possible hence reducing the chances of systematic error. Also. 
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before designing the experiments, an understanding of the final objectives of the 
experiment is necessary. The reason for this is that there are several possibilities to the 
design of experiments and it is not possible to find the relevant a approach unless the 
final objectives are defined. Statistical methods should be used to manipulate the 
information obtained from experiments so that the resuhs and the conclusions are 
drawn in an objective manner. Graphical representations are often used for 
interpretation of results. 
8.3.1 Factorial Designs 
Factorial designs are an efficient way to study the factors of an experiment where two 
or more factors can affect the final response of the experiment. Factorial designs can 
be defined as the exploration of all possible chosen factor levels. The effect of a factor 
is the change in response produced by a change in the level of factor. This is 
commonly known as the main effect and it refers to the primary factors of interest in 
an experiment. When interactions between factors exists, the difference in response 
between the levels of one factor is not the same at all levels of the other factor. Where 
factor interaction is possible an experimental design is required which will allow 
estimation of both the main effects and the interactions. Factorial designs are very 
efficient and allow the effects of a factor to be estimated at several levels with respect 
to the other factors. Hence, factorial designs allow for conclusions to be drawn over a 
range of experimental values. 
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8.3.1.1 2k Factorial Designs 
These are the most commonly used factorial designs and consider all factors at two 
levels, i.e. high and low level. The number of treatment combinations, i.e. experiments 
undertaken is 2k, where k is the number of variables under investigation. For example, 
to design an experiment with 2 variables there must be four experiments undertaken 
for a non-replicated study. Table 8.2 shows the treatment combination matrix for a 2k 
design known as the design matrix. 
Table 8.2 The treatment combination matrix for a 2k design. 
Treatment Variable A Variable B 
combinations! or level level 
experiment 
1 high high 
2 high low 
3 low high 
4 low low 
For each treatment of combination (experiment), a response Y (experimental 
measurement of the dependent variable) is observed. A 2k design allows estimation of 
all the main effects and the interaction effects of the following type model 
y B 
o 
+Bx 
I 
+ B 2 X 2 • • • • B k X k + B 12 X I X 2 + B x x .... 23 2 3 
Here BO is the intercept. Bi are the coefficients representing the model parameters and 
Xi are the variables. Note: that this design is linear and does not account for any 
curvature in the experimental response. 
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8.3.1.2 Fractional Factorial Design 
The main problem with a factorial design is that the number of experiments required 
for a full factorial design is equal to the power of the number of factors involved in the 
experiments. This means that for a 2k design with four variables (k = 4) requires a 
total of 16 experiments for all b coefficients to be estimated unambiguously. If 
replicate experiments are required for estimating experimental errors the total number 
of experiments becomes large. 
If information on higher order interactions can be assumed to be negligible, it is 
possible to omit a significant number of experiments by using a fractional factorial 
design. Fractional factorial designs allows to neglect certain interactions ,,1th very 
small B coefficients. This sort of decision can be made from process knowledge if an 
interaction can be assumed to be unlikely. An example of a fractional factorial design 
is a 2(k-l) or a half factorial design. This type of design would require only the half 
the number of experiments of a fu1l2k design. So, when k is considered at 4. the total 
number of experiments is reduced from 16 to 8. One problem in using a factorial 
design to determine which factors have a significant effect on the responses that, for 
factors which are continuous variables, the effect depends on the high and low levels 
used. If the high and low levels are too close together, the effect of the corresponding 
factor may be found not significant. On the other hand, if the levels are further apart 
they may fallon either side of the maximum, and still give a difference in response 
which is not significant. 
8.3.1.3 Response Surface Methodology 
The response surface methodology (RSM), is nonnally dependent on several 
variables, and the idea is to find the optimum response within a given area of the 
variable range. The RSM uses statistical and mathematical techniques to model and 
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analyse data prior to displaying the infonnation graphically. In RSM, the relationship 
between the response and the independent variables is usually unknown. A model is 
built which accounts for the observed response. this is generally achieved by using a 
polynomial equation. Process knowledge can be used to arrange the model either as a 
low or a high order polynomial. It is also possible to use a model which incorporated a 
mixture of both higher and lower modelled polynomials and these terms are called 
mixed models. 
8.4 Optimization of Main Operating Extraction Parameters: Pressure, 
Temperature, % Modifier and Extraction Time 
The extraction efficiency for SFE has been assumed to depend on a number of 
experimental factors e.g. pressure, temperature, time of extraction and flow rate. 
However, in cases, where the polar analtyes are bound or locked into a mat~ the 
presence of a modifier is known to be essential for successful extraction. The role of 
modifier is thought to be two fold. Firstly, the modifier increases the polarity of the 
extraction fluid and thus competes with the drug for the active site on the matrix. 
Secondly, the modifier acts to decrease the adsorption of solutes on the surface of the 
matrix by increasing the swelling of the matrix which in tum increases the likelihood 
of solute diffusion out of the matrix. Thus, ~designing an experimental design for 
analytes should involve consideration of all these variables in order to obtain 
maximum extraction efficiency. 
A fractional factorial design based on response surface methodology was designed for 
extraction of fluconazole from an animal feed matri.x. Four variables were considerecL 
pressure, temperature, time and % modifier. Flow rate was kept at a constant value of 
2 mVrnin in order to keep the number of experiments down. 
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8.5 Experimental Section for the Analysis of Fluconazole by SPElHPLC, 
SFElHPLC and GC 
Instrumentation for the Analysis of Fluconazole 
The HPLC system consisted of a Gilson model 305 master pump and slave pump, 
Gilson 805 S monometric module, Gilson 811 B dynamic mixer, Anachem OMRON 
E5CS column oven, Jasco UV 975 UV-VIS detector, LDC-Milton Roy Integrator. 
The analysis of the fluconazole SPE extracts of animal feed were performed using a 
published method by Pfizer. 137 Chromatography was achieved on a 10 em x 2 mm , 
5 f.LIll C8 Spherisorb analytical colurrm at 35°C. The mobile phase was 25175 
methanol/water. It was filtered and degassed by vacuum and sonication. The mobile 
phase flow rate was 0.4 ml min-I. The column eluent was monitored for UV 
absorption at a wavelength of 21 0 nrn. 
The columns investigated for the analysis of SFE fluconazole animal feed extract were 
a 20 em x 4.6 mm., 5 f.LIll C18 Spherisorb and a 15 em x 4.6 mm 5 f.1II1 eN Spherisorb 
as well as the 10 em x 2 mrn, 5 f.LIll C8 Spherisorb. 
The GC system used was a MEGA series Carlo Erba system (CU600) with a flame 
ionisation detector. All samples (2 J.11) were injected using on-colurnn injection into a 
15 m long x 0.3 mm diameter capillary column coated with DB5 stationary phase of 
0.2 J.1ID thickness. Propiophenone was used as the internal standard. 
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The temperature ramp used for the GC programme was as follows: 
4~C 2 min 
Solvent elution 
15 min 
The GC-MSD system consisted of a Hewlet Packard 5890 series 2 GC with 5972 
MSD. Samples were injected on-column with an Hewlett Packard 7673 autosampler. 
The GC conditions were the same as described above and the separation used a 25 m 
long x 0.22 mm diameter capillary column coated with a film of BPX5 stationary 
phase of 0.25 f.1II1 thickness. Single ion monitoring was carried out with ions being 
monitored at mass 77 and 105 amu for propiophenone and 127 and 224 amu for 
fluconazole. 
Supercritical fluid extraction was undertaken on a Jasco Supercritical fluid extraction 
system. After the completion of each extraction, the extracts were made up to volume 
in methanol ready for analysis. 
Reagents 
Fluconazole reference standard was obtained from Pfizer Central Research 
(Sandwich, Kent, U.K). For the SPE-HPLC analysis, stock solutions of fluconazole 
(1 mg ml- l ) were prepared in methanol/water (75/25) and stored at 4°C. Working 
solutions containing 2, 5, 8, 10, 12 and 15 J..Lg ml-1 fluconazole were prepared by 
diluting the stock solution. The correlation coefficient for the peak areas against 
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concentration was 0.999 (n = 5). While for GC-FID analysis stock solutions of 
fluconazole were prepared (10 mg m1-1) with an internal standard (250 mg ml- l ) and 
stored at 4°C. Working standards were prepared by serial dilution over the range, 50 
- 400 Jlg ml-1. An aliquot (20 Jll) of internal standard (propiophenone) was added to 
each of the working standards and the extracts analysed by GC-FID. The calibration 
plot for GC-FID showed linearity over the chosen range with a correlation coefficient 
(r) of 0.974 (n = 5). The peak height ratios of sample/standard was used to quantify 
the extracts. For the GC-MSD analysis, stock solutions of fluconazole (1 mg ml-1) 
were prepared in methanol/water (75/25) with an internal standard (25 mg 
m1-1) and stored at 4°C. Working solutions containing 5,10,15,20 and 25 fJ.8 ml- I 
fluconazole were prepared by diluting the stock solution. An aliquot (20 JlI) of internal 
standard (propiophenone) was added to each of the working standards and the extracts 
analysed by GC. The correlation coefficient for the peak areas against concentration 
was 0.999 (n = 5). The peak area ratios of fluconazole and the internal standard were 
used for quantitation by GC-MSD. The extraction recovery was determined by 
comparing the peak area ratios of the extracted samples \\ith that of a 100 % 
standard. Methanol and water of HPLC grade were used throughout. Supercritica1 
fluid grade carbon dioxide (Air Products, Sunderland) of certified purity 99.995% 
was used for extraction. 
Solid Phase Extraction Methodology 
A method was adopted from literature published by the manufacturer of fluconazole 
for the extraction of fluconazole by SPE.137 A fluconazole standard of concentration 
20 J.Lg ml-1 in dichloromethane was prepared which corresponded to a spike level of 
40 mg drug kg- I of feed. The following procedure was followed for the extraction. A 
portion of feed (5 g) was accurately weighed in a glass jar and spiked with 10 ml of 
the fluconazole standard (20 J.Lg ml- I in dichloromethane). The jar was capped, 
shaken vigorously and the unopened container was then left overnight to allow the 
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solvent to evaporate. The spiked samples were extracted with 20 mJ of 
dichlorometbane at room temperature by stirring \\'ith a magnetic stirrer for 1.5 hrs. 
The slurry mixture was vacuum fihered and the filtrate was quantitatively transferred 
to two cyano - propyl (500 mg) SPE cartridges (Bond-Elute, Jones Chromatography 
Ltd., Hengoed, U.K.) of 2.8 ml capacity, connected in series using a manual adapter 
and preconditioned with dichlorometbane. The washings were collected and put 
through the cartridges again to ensure that all of the fluconazole was trapped onto the 
chromatographic packing material. Both cartridges were then left to dry under 
vacu~ the eluent was discarded and fluconazole was eluted with 20 ml of solvent 
MeOHlH20 (35/65). The eluent was quantitatively transferred into a 25 ml 
volumetric flask and made to volume with the appropriate solvent. The procedure was 
repeated five times and a blank extraction was also prepared. All extracts were 
analysed by HPLC using with UV -visible detection using a five-point calibration plot. 
Supercritical Fluid Extraction Methodology 
The extraction efficiency of SFE for the recovery of fluconazole from rodent feed was 
determined at two levels, 109 of drug Kg-I of feed and 500 mg Kg-I of feed. The 
spiked feed samples of known fluconazole content were prepared by adding aliquots 
of the fluconazole standard in dichloromethane to a 1 g weighed sample of animal feed 
in a glass jar. These jars were capped, shaken vigorously and the contents were left to 
dry overnight in an open jar. The spiked sample was quantitatively transferred to a 
cell and the extraction was carried out to investigate SFE variable dependance. The 
flow rate of extraction was maintained constant at 2 ml min-I throughout the 
experimentation. The collection vial contained a few drops of methanol and two 
cyanopropyl-propyl Bond Elut cartridges were placed in series at the exit to prevent 
any loss of fluconazole. Following extractions, all extracts were made up to volume in 
a 25 ml volumetric flask. The SFE ex'tracts obtained at the 500 mg of drug Kg-I of 
feed level were analysed by GC-MS, while the extracts obtained at the 10 g of drug 
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Kg-I of feed were analysed by GC with flame ionization detection. All SFE extracts 
were filtered through a 0.45 !JlIl membrane filter prior to analysis. All experiments 
were done in duplicate. 
8.6 Results and Discussion 
8.6.1 SPE-HPLC 
The SPE method was utilized to selectively extract fluconazole from the feed prior to 
reversed phase HPLC and to simultaneously transfer the fluconazole from the 
hydrophobic extraction solvent to an essentially aqueous phase, compatible with 
reversed phased chromatography. The animal feed extracts of fluconazole obtained 
from the SPE were visibly clean and the extracts were analysed by the hplc method 
suggested by pfizer .13 7 The results obtained gave a mean fluconazole recovery of 
99.1% (98.1%, 100.7%,97.9%, 100.20/0,98.7%) with a RSD of 1.3 0/0. The method 
described provides a convenient way of determining fluconazole quantitatively. The 
final solution obtained using this method was both sufficiently concentrated and also 
free from coextractives making it compatible with HPLC analysis. 
Figure 8.1 shows a SPE-HPLC chromatogram of fluconazole in an animal feed 
extract. 
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fluconazole 
Signal 
o 1 .2 3 4 5 
Time (min) 
Figure 8.1 A typical SPE-HPLC chromatogram of fluconazole in an animal feed extract 
using a Cs colurrm and a mobile phase containing 25175 methanol/water. 
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8.6.2 SFE-HPLC of Flu con azole from Animal Feed Matrix 
Preliminary Extraction of Fluconazole from Celite matrix 
Extraction of fluconazole from a Celite matrix was performed to determine the 
extraction profile of fluconazole in the absence of any matrix effects from the animal 
feed. In order to maximise the information available from the minimum number of 
experimental results the use of an experimental design approach was pursued. The 
experimental design selected was a fractional factorial 2 k-l design. TIlls involved the 
use of a simple model of the form: 
8.1 
where, Y is the response (percentage extracted) ; Vb v2, v3 and v4 are the four main 
variables selected: pressure, temperature, time of extraction and percentage methanol, 
respectively; b I, b2, b3 and b4 are the parametric coefficients; bo is the intercept. 
The experimental conditions were chosen at two levels, a high level and a low level. 
The pressure was at 250 kg/cm2 and 110 kg/cm2, temperature was at 80°C and 40°C, 
time of extraction was considered at 20 minutes and 5 minutes and % modifier was 
considered at 20% and 00/0. All extractions were performed in duplicate. All extracts 
were analysed by HPLC at the same chromatographic method described for the SPE. 
The results obtained (table 8.3) indicated that fluconazole can be quantitatively 
extracted from Celite provided that the temperature and the % modifier are maintained 
at high levels. 
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Table 8.3: Percentage recovery data for the HPLC analysis of fluconazole from Celite 
using a fractional factorial design. All experiments were done in duplicate. 
Pressure Temperature Time 0/0 MeOH 0/0 Recovery 
(kg cm-2) (OC) (mins) 
250 80 20 20 98.2 
250 80 5 0 7.3 
250 40 5 20 70.0 
110 80 5 20 90.1 
110 40 20 20 76.4 
110 40 5 0 10.91 
110 80 20 0 11.4 
250 40 20 0 3.7 
170 65 10 10 96.6 
Extraction of Flu con azole from the Animal Feed Matrix 
The major problem to be overcome in the development of SFE procedures for 
fluconazole in animal feed is that of obtaining a final sample that is sufficiently free 
from endogenous materials that fluconazole can be determined quantitatively. The 
investigation into the extraction of fluconazole from the animal feed began "ith the 
extraction of blank animal feed. The study involved extractions of the blank animal 
feed matrix at 80°C, 250 kglcm2, 20 % MeOH for 20 minutes at flow rate of 2 
mJJrnin. This was necessary in order to ensure that no compounds extracted from the 
matrix itself would interfere ,\>ith the HPLC analysis. These extractions produced a 
yellow precipitate in the extract thus showing that part of the matrix was indeed 
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mobile and therefore extractable. The analysis of the fihered SFE ex1:racts indicated 
that the presence of the precipitate in the collection solvent interfered with the existing 
HPLC method used for the analysis of the SPE extracts of fluconazole. 
8.6.3 Method Development fOT HPLC 
A HPLC method development was neecesary to establish a quantitative method for 
the determination of fluconazole from the animal feed. Blank extractions of animal 
feed (1 g) were carried out at a pressure of 250 kg/cm2 , temperature 80°C with 20% 
methanol for 40 minutes at a flow rate of 2 mlImin and the extracts (25 mls) were 
spiked with known amounts offluconazole standard (at spike levels of 100-500 mg of 
drug/kg of feed). These experimental conditions were chosen based on the results 
obtained from Celite matrix where the highest recovery was achieved under these set 
of conditions. Three different approaches were investigated in order to achieve a 
HPLC method for the quantitation of fluconazole 
Initially a HPLC method suggested by Pfizer (the manufacturer of fluconazole) was 
tried. 137 This was based on a 10 em x 2 mm C8 column, UV detection at 210 nm 
and a binary mobile phase containing 25175 MeOHJH20. Unfortunately, co-
extractives from the animal feed severely interfered with the fluconazole peak. 
Systematic HPLC method development was carried out in an attempt to improve the 
separation of the fluconazole peak. 
8.6.3.1 Effect of Mobile Phase Composition 
The simplest approach was first tried where the mobile phase composition was varied. 
The mobile phase was altered to MeOHlH20 (20/80) and MeOHlH20 (15/85). 
This was carried out to investigated if reducing the MeOH concentration increases 
interaction of the anal) 1e ",ith stationary phase and if the fluconazole peak can be 
166 
separated from the rest of the interfering peaks. The result was peak tailing of 
fluconazole and the fluconazole peak was not resolved (figure 8.2). A C18 (2 em) 
guard column was also placed before the Cg column to increase the retention of 
fluconazole but did not resuh in any advantage. 
Signal 
fluconazole 
Time (min) 
F · 8 2 Example chromatogram of a fluconazole animal feed 19ure . ." 15/85 
extract using a C8 colunm and a mobile phase contammg 
methanol/water. 
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8.6.3.2 Effect of Additives 
Fluconazole is a weak base. It is known that basic anahtes can interact \\$ silanols 
on the column packing and this can influence resolution and peak shape, e.g cause 
peak tailing. It was therefore decided to investigate the effect of blocking the silanols 
by adding a amine modifier to the mobile phase to see if this would significantly affect 
the peak shape of the fluconazole peak. The same silanol effects that resuh in band 
taiJing can also be manifested as changes in retention. The addition of varying 
amounts of amine modifier can often result in changes in band spacing. When basic 
compounds are observed to tail due to silanol interactions, the an amine modifier such 
as triethylamine is often added. Triethylamine was introduced in the mobile phase 
[MeOHl50 mM triethylamine buffer at pH 7.0] and different mobile phase 
compositions were also tried to obtain higher selectivity and sharper peak but the 
results were not different (figure 8.3) from what had been found previously. 
Next, addition of an ion-pair reagent was tried to influence the separation of the 
fluconazole from the interfering co-extractives. The retention in ion-pair HPLC can be 
described as the formation of an ion-pair between a sample ion and the ion- pair agent 
in the mobile phase, followed by hydrophobic association of the ion-pair with the 
stationary phase. An ion- pair reagent (5 Mm heptanesulphonic acid) was introduced 
to the MeOHl50 mM triethylamine mobile phase but baseline resolution of 
fluconazole (figure 8.4) was still not achieved. 
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Signal 
fluconazole , 
• • • • • 
o 2 4 6 8 
Time (min) 
Figure 8.3 Example SFE-HPLC trace of a fluconazole animal feed 
extract using a Cs column and a mobile phase containing 85/15 
50 mM TEA buffer/methanol. 
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fluconazole 
Signal 
Iii j 
o 2 4 6 
Time (min) 
Figure 8.4 Example SFE-HPLC trace of a fluconazole animal feed 
extract using a C& column and a mobile phase containing 15/85 
methanol 50 mM TEA, 5 mM heptanesulphonic acid. 
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8.6.3.3 Effect of Stationary Phase 
Different columns were to be investigated as a change in the nature of the stationarY 
phase generally affect both retention and selectivity. The existing C8 column was 
replaced with a C 18 column (20 cm) which was slightly more retentive than the C 8 
column and the flow rate was increased from 0.4 mlImin to 1 mlImin. Different 
MeOHJH20 mobile phase combinations were examined and it was possible to delay 
the retention of fluconazole to 9 minutes so it would not interfere \\ ith the 
coextractives eluting at the baseline. However, the fluconazole peak was broad and 
could not be separated from an interfering small peak using single wavelength 
detection (figure 8.5). 
MeCN was used instead of MeOH to investigate if it would result in sufficient change 
in peak spacing, but no noticeable difference in the chromatogram was noted. 
Replacing a C 18 column with a different column, such as phenyl or cyano usually 
results in a change in band spacing and it was decided to change the C 18 column for a 
more polar CN column and as before different mobile phase compositions of 
MeOHlH20 were studied as it cannot be assumed that the same mobile phase that 
was optimized for the C8 column will also ~e optimum for the cyano column. The 
difference in column polarity had the greatest in changing the band spacing as it was 
found that a mobile phase composition of 15/85 MeOHlH20, flow rate of 1 ml/min, 
detection at 210 run with a 15 cm cyano column gave the best chromatographic 
separation of fluconazole from other ~xtractive peaks (figure 8.6 ) but still was not 
considered acceptable below 500 mg of drug/kg offeed. 
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Signal 
fluconazole 
o § to 
Time (min) 
Figure 8.5 A typical SFE-HPLC trace of fluconazole in an animal feed extract 
using a C18 column and a mobile phase containing 20/80 methanoVwater. 
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Signal 
fluconazole 
o 2 
Time (min) 
Figure 8.6 &ample chromatogram obtained for a SFE-HPLC animal 
feed extrac:t ~ a CN colunm and a mobile phase compositioo of 
15/85 metbaI)ol/water. 
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8.6.3.4 Effel of C02 Pre-Extraction as a Clean-up for Animal Feed 
Following these investigations it was decided to study if it was possible to extract the 
coextractives prior to extracting fluconazole. Pre-extractions of interfering compounds 
was studied with pure C02 only (different experimental conditions. i.e different 
pressure, temperature and extraction time were investigated). It ,vas found from these 
investigations that C02 alone failed to extract any coextractives (figure 8.7) that 
interfere with the fluconazole peak and introduction of MeOH modifier (20%) in the 
extraction after C02 clean-up extracted the endogenous materials from the animal 
feed (figure 8.8). Hence problems arise with SFE where addition of MeOH as a 
modifier is required to aid extraction but at the same time the extracts contain a vast 
amount of endogenous material from the feed which interferes with the HPLC 
analysis. The other problem faced with the HPLC analysis of the SFE extracts is that 
although the samples were filtered prior to injection, the normal column life time was 
reduced significantly (typically 1-2 weeks). 
Because a satisfactory HPLC analysis could not be developed GC analysis was 
investigated. Immidiately, GC afforded excellent selectivity required for the analysis 
of fluconazole from the animal feed extract. 
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() 
\- -.~ 
5 
Time (mm) 
-10 
Figure 8.7 Example chromatogram obtained from C02 only extraction 
-1 hour, 80C and 250 Kglcm2, using a Cs column and a mobile phase 
containing 15/85 methanoVwater. 
17S 
Signal 
'-
I 
o 
fluconazole 
5 10 
Time (min) 
Figure 8.8 Example chromatogram obtained for a SFE 
fluconazole animal feed extract with 20% methanol for 
40 minutes after 1 hour C02 only extraction using a 
Cs column and a mobile phase of 15/85 methanol/water 
8.7 SFE-GC 0/ Fluconazole/rom an Aninwl Feed Matrix 
SFE is sufficiently powerful to extract other materials from the matrix. which interfere 
with analyte determination. The nature of the co-extracted material prevented 
quantitative analysis by HPLC with UV detection. Because of this GC was used for 
all subsequent analysis. It had been noted previously that fluconazole could be 
analysed using GC. 190-193 In order to facilitate analysis and detection at high and 
intermediate spilcing levels it was necessary to use GC separation \\ ith either flame 
ionization or mass selective detection. However, in order not to be sensitivity 1imited 
(particularly in the case of GC with FID detection) the spiking level of fluconazole 
was done at the 10 g kg-I (high level). With the GC-FID analysis, baseline resolution 
of fluconazole, from the endogenous material co-extracted from the feed, was 
achieved with the conditions described at a retention time of 19 minutes (figure 8.9). 
An intermediate spiking level of 500 mg kg- I was also prepared and these extracts 
were analysed by GC with MSD detection. It is apparent howeveL that the inherent 
sensitivity of GC-MSD will allow lower spiking levels to be analysed. Figure 8.10 
shows the GC-MSD trace of an animal feed extract of fluconazole. 
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,/' fluconazole 
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o 12'5 .25 
Time (min) 
Figure 8.9 A typical SFE-GC-FID trace ofa fluconazole animal feed extract. 
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fluconazole 
188 
11.58 J8.88 18.58 
Time 
Figure 8.10 A typical SFE-GC-MS trace ofa fluconazole animal feed extract 
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SFE of Fluconazole from Animal Feed using Experimental Design 
Spiked fluconazole animal feed was prepared according to the procedure described in 
the experimental section and a fractional factorial design carried out as discussed for 
the Celite extractions in the previous section at the two different spike levels. The 
extraction time was extended, within the design, from 20 miTIs to 40 mins in order to 
compensate for any potential matrix effects. The resuhs obtained for both levels of 
feed are shown in Tables 8.4 and 8.5. 
Table 8.4 : Percentage recovery data for the GC-FID analysis of fluconazole (lOg kg-
I of feed) from an animal feed using a fractional factorial design. All experiments 
were done in duplicate. 
Pressure Temperature Time 0/0 MeOH 0/0 Recovery 
(kg cm-2) (OC) (mins) 
250 80 40 20 87.0 
250 80 5 2 76.6 
250 40 5 20 79.0 
110 80 5 20 90.9 
110 40 40 20 80.5 
110 40 5 2 16.9 
110 80 40 2 22.3 
250 40 40 2 27.3 
170 65 20 10 974 
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Table 8.5: Percentage recovery data for the GC-MSD analysis offluconazole (500 mg 
kg-I of feed) from an animal feed using a fractional factorial design. All experiments 
were done in duplicate. 
Pressure Temperature Time 0/0 MeOH 0/0 Recovery 
(kg cm-2) (OC) (mins) 
250 80 40 20 99.6 
250 80 5 0 5.3 
250 40 5 20 82.7 
110 80 5 20 99.7 
110 40 40 20 72.5 
110 40 5 0 5.1 
110 80 40 0 16.8 
250 40 40 0 5.8 
170 65 20 10 100.3 
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It should be noted that the percentage methanol was considered at three levels 0 10 
, 
and 20 % in the case of the 500 mg kg-I level whereas at the 109 kg-I level it was 
considered at 2, 10 and 20 %. Multilinear regression was used to calculate the 
coefficients in equations (8.2 and 8.3) . The coefficients are reported in Tables 8.6 and 
8.7. 
Table 8.6 Coefficients of regression and standard error of linear equation (8.2) for the 
GC-FID analysis of fluconazole from animal feed (10 g kg-l level). 
Variable Descriptor Beta standard b standard t(4) 
error error 
pressure Vl 0.2115 0.2605 0.0974 0.1199 0.8120 
temperature v2 0.3166 0.2605 0.5090 0.4188 1.2153 
time V3 -0.1980 0.2605 -0.3647 0.4797 -0.7603 
%MeOH V4 0.7389 0.2605 2.6472 0.9332 2.8366 
Tab Ie 8.7 Coefficients of regression and standard error of linear equation (8.3) for the 
GC-MSD analysis of Fluconazole from animal feed (500 mg kg-1 1evel). 
Variable Descriptor Beta standard b standard t(4) 
error error 
pressure VI 0.0198 0.2460 0.0109 0.1363 0.0893 
temperature V) 0.1817 0.2146 0.4054 0.4 788 0.8467 
time v3 -0.0164 0.2137 -0.0419 0.5463 -0.0767 
%MeOH v4. 0.9070 0.2139 4.0620 0.9582 4.239o.l 
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p-Ievel 
0.4623 
0.2911 
0.4894 
0.0470 
p-Ievel 
0.9398 
0.4449 
0.lJ42" 
0.0133 
Significance is detennined by a t-test with a probability (P) of 0.05 at the 95% 
confidence level with 4 degrees of freedom. In Tables 8.5 and 8.6, a coefficient ,\ith a 
p-Ievel of less than 0.05 or a t-test of greater than 2.78 will be considered significant. 
In both cases the results obtained indicate that percentage methanol was the only 
significant variable for the extraction of fluconazole from the animal feed matrix. The 
difference in the b coefficients (-0.3647 and -0.0419 for the 10 g kg-I and 500 mg 
kg-I spiking levels, respectively) reflect the influence that the percentage methanol -
time of extraction interaction has on extraction recovery. The consequence of the 
addition of a small amount of methanol (2 %) as opposed to C02 only had a 
pronounced effect on extraction recovery (Tables 8.4 and 8.5). The model for the 10 g 
kg-I extraction results is: 
Percentage recovery of fluconazole =-4.751 + 0.097 (pressure) + 0.509(temperature) 
-0.365 (time of extraction) + 2.647 (percentage methanol) 8.2 
r = 0.8535 (r2 = 0.7286) at the 95% confidence interval 
Whereas, the model for the 500 mg kg- I results is as follows: 
Percentage recovery of fluconazole = -11.813 + 0.010 (pressure) +O.405(temperature) 
-0.042 (time of extraction) + 4.062 (percentage methanol) 8.3 
r = 0.9199 (r2 = 0.84620) at the 95% confidence interval. 
Equations 8.2 and 8.3 can be used to predict percentage recovery of fluconazole from 
an animal feed matrix for any given pressure, temperature, time of extraction and % 
methanol at the two specified levels. 
A typical response surface was generated for fluconazole (figure 8.11) showing the 
effect of temperatu~  percentage methanol, as modifier. on extraction recovery. 
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The percentage extraction efficiency repeatability for the isolation and cleanup of 
fluconazole from animal feed followed by GC with either FID or MSD detection was 
determined to be 87.0% (RSD 8.4%) at the 10 g kg-I level and 91.0% (RSD = 
13.2%) at the 500 mg kg- I level. In each case the number of replicates was ten. 
Figure 8.11 shows the response surface obtained from the SFE-GC-FID analysis of 
fluconazole and figure 8.12 shows the response surface obtained from the SFE-GC-
MSD analysis of fluconazole. 
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Fi,?ure 8.11 Percentage Recovery of Fluconazole from animal feed using SFE-GC-FID 
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Figure 8.12 Percentage Recovery of Fluconazole from an animal feed using SFE-GC-MS 
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This study clearly demonstrated the ability of supercritical C02 to quantitatively 
extract fluconazole from an animal feed matrix. The problem lies with the analysis of 
an SFE extract. The recovery of fluconazole from animal feed was determined., using 
a fractional factorial design approac~ to be dependent upon the addition of modifier 
in the extraction fluid. The modifier's function is thought to be two fold. Firstly, the 
modifier increases the polarity of the extraction fluid and thus competes with the drug 
for the active site on the matrix. Secondly, the modifier acts to decrease the adsorption 
of solutes on the surface of the matrix by increasing the swelling of the matrix \vhich 
in tum increases the likelihood of solute diffusion out of the matrix. 
8.8 Conclusion 
A comparison of SPE with SFE for the isolation and cleanup of fluconazole from 
animal feed has been made. The inter-dependence of the extraction procedure on the 
method of analysis was effectively demonstrated. The unselective nature of SFE, when 
methanol-modified supercritica1 C02 was used., prevented analysis by HPLC with UV 
detection. Quantitative recovery of fluconazole was possible using GC \\ith either FID 
or MSD detection at the 10 g kg-I and 500 mg kg-I spike levels, respectively. 
However, the inherent sensitivity of GC-MSD should allow lower spike levels to be 
quantified. SPE-HPLC was shown to be an effective method of isolating and 
analysing fluconazole from animal feed at a low spike level (40 mg kg-I). 
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Chapter 9.0: The Determination of Antifungals by SFEIPacked SFC from Animal 
Feed Matrix. 
9.1 Introduction and Aims 
Supercritica1 fluid chromatography is complementary to both gas chromatography and 
high performance liquid chromatography for the analysis of pharmaceuticals, and like 
HPLC, does not require vapourisation of the sample. The operating conditions of 
pSFC are mild and so it is able to handle thermally labile drug substances. 
Antifungals such as fluconazole, tioconazole and UK-47,265 are commonly analysed 
by HPLC. In Chapter 8, the use of HPLC and GC for the analysis of fluconazole has 
been discussed. The objective of this study was to evaluate the potential of pSFC 
using MeOH modified carbon dioxide for the analysis of four antifungals follmving 
the SFE of these compounds from an animal feed matrix. 
Packed column SFC is most useful in combination with high density mobile phases. In 
general, the closer the SFC resembles LC, the more similar will be the column 
technology and the required instrumentation. As is the case with LC, SFC can be used 
for the routine analysis of samples. By applying specific sample preparation 
techniques or specific detection methods, complicated separation problems may be 
reduced to simple chromatograms by using pSFC. 
9.2 The Main Optimizing Parameters ofpSFC 
One of the key features of SFC is its flexibility. Optimisation of a fluid 
chromatographic separation can be obtained by altering a variety of parameters. The 
main operating variables (table 9.1) for optimization of a SFC separation arc as 
follows: 
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Table 9.1 The main operating variables for optimization of a SFC separatI' on. 
selection of a stationary phase 
selection andlor prvgI of the mobile phase 
optimisation of the analysis temperature 
addition of a modifier 
eluent composition 
flow rate of the mobile phase 
pressure 
It is apparent from studying this list that in SFC, there are more parameters which can 
influence separations than in any other chromatographic method. Besides variations of 
stationary and mobile phases, retention, selectivity, and resolution are easily optimised 
by adjusting temperature, pressure, and the density of the mobile phase. Mobile phase 
density is thought to be the key parameter in SFC and most separations are performed 
using variations in density. Pressure programming can be used as the same way as 
density programming to elute components of high molecular weight or to shorten 
analysis times. Temperature is often used as a second parameter to improve resolution 
in density or pressure programmed SFC analyses. At constant density, analyses are 
faster at higher temperatures. At constant pressure, short analyses are obtained at 
temperatures slightly below, or well above, the critical temperature of the eluent. 
Maximum retention and resolution are found at temperatures somewhat above critical. 
The solvent strength of the mobile phase can be adjusted either by choosing a suitable 
eluent or by adding a suitable second eluent component. 
Even with so many operating parameters to vary, method development in SFC is easy 
and does not require much time. Once the choice of stationary and mobile phase is 
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made which are suitable for the analytical problem, retention as well as selecti\ in· and 
resolution may be adjusted by varying density, pressure and / or temperature. 
9.3 Retention Behaviour in SFC 
Under the isobaric conditions in SFC, the mobile phase strength increases \\itb the 
density of the supercritical fluid. The lower the temperature, the higher the density 
becomes, and hence the shorter the retention times obtained. Increasing the column 
temperature therefore results in longer retention times of solutes. However, when the 
column temperature is much higher, contributions of vapour pressures of solutes 
become greater and retentions become shorter due to the vapour pressure contribution. 
Even though solutes are not volatile, the solutes often melt by heat and then are 
solubilized, resulting in shorter retentions. In this temperature region, contributions of 
vapour pressure and density change contribute in an opposite way, offering higher 
selectivity for separation. 
Under isothermal condition, the higher the pressure, the higher the density is obtained. 
Since higher the density, the higher the solvating power becomes resulting in shorter 
retention times as the pressure goes higher. 
9.4 Addition of Modifier Solvent 
In SFC, a small amount of an organic solvent is often added to the supercritica1 fluid. 
The role of the modifier is thought to be two fold. Firstly, to deactivate active sites of 
the packing material (typically silanols of silica gel) and secondly to increase the 
solvating power of the fluid. 
While using a silica gel stationary phase in adsorption mode, the solute molecules 
compete with modifier molecules in adsorption onto the active sites. Therefore. the 
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retention behaviour is dependent on the degree of affinities of the sample solute and 
the modifier molecule to the stationary phase. In general, a polar soh-ent such as 
alcohol is used for deactivating the stationary phase. Addition of alcohol also 
increases the solvating power of the mobile phase. 
When using a bonded stationary phase in the partition mode, such as ODS-silica, 
addition of a modifier increases the solvating power of the mobile phase. Accordingly. 
the partition of the sample solute shifts toward the mobile phase, resulting in shorter 
retention time. 
In both modes, addition of a modifier decreases the retention_ Increasing the modifier 
concentration as a function of time works in a similar manner to gradient elution in 
HPLC. 
9.5 Experimental Section 
Reagents 
Tioconazole, fluconazole and UK-47,265 were provided in pure form by Pfizer 
Central Research, Sandwich, Kent. Hexaconazole was provided by Zeneca 
Agrochemicals, JeaIIots Hill, Berkshire. Triethylamine and methanol were obtained 
from Aldrich Chemicals Ltd. and were HPLC grade. Supercritica1 fluid grade carbon 
dioxide (Air Products Ltd., Sunderland) of certified purity 99_ 995% was used for 
extraction. The chromatographic column used was a 15 cm x 4.6 mm id stainless-steel 
column packed with cyano bonded phase (5 fJ1l1, Phase Separations Ltd). 
The triethylamine \vas dissolved in the MeOH prior to mixing with the C02. The 
amount of modifier in the C02 was regulated by the flow rate of the master pump_ 
Stock solutions were prepared by dissoh mg appropriate amounts of the drugs into a 
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50 ml volumetric flask and diluting to volume ,vith MeOH Working standards 
. were 
prepared by serial dilution over the appropriate range. Samples were introduced onto 
the column via a Rbeodyne injector fitted with a 10-,....1 sample loop. The column 
eluent was monitored for UV absorption at a wavelength of 210 nm. Calibration 
curves of peak height verses concentration were generated for all the compounds. The 
percentage recovery was calculated by comparing the peak. heights of the extracted 
samples with those obtained by injections of the 100% standard solutions. 
Supercritical Fluid Extraction Methodology 
The animal feed was spiked with fluconazole and tioconazole individually whereas 
hexaconazole and UK.-47,265 were spiked jointly for the extraction and analysis of the 
drugs using the same spiking method described in the previous chapter. The extraction 
efficiency of SFE for the recovery of fluconazole from the rodent feed was determined 
at two levels, 109 of drug/kg of feed and 500 mg of drug/kg of feed. The extraction 
efficiency of SFE for the recovery oftioconazole from the rodent feed was determined 
at two levels: 2.5 g of druglkg of feed and 5 g of drug/kg of feed. The extraction 
efficiency for the recovery of hexaconazole and the UK-47,265 of fluconazole from 
the animal feed was also determined at two levels 1 g of UK-47,265/ kg of feed, 1.25 
g of hexaconazolelkg of feed and 2.5 g of UK.-47,265/kg of feed and 1.875 g of 
hexaconazolelkg of feed. The spiked feed samples of the known drug content were 
prepared in the same manner as described in the previous section. The spiked sample 
was quantitatively transferred to a cell prior to extractions being performed. The 
collection vial contained a few drops of MeOH and two cyano-propyl Bond Elute 
cartridges were placed in series at the exit to prevent any loss of the anal)te. 
Following extractions, all extracts were made up to volume in a 25 m1 volumetric 
flask. All SFE extracts were filtered through a 0.45 JlID membrane filter for the SFC 
assay. All experiments were repeated 5 times and triplicate injections of each 
extracted sample were carried out. 
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9.6 Results and Discussion 
9.6.1 Optimization of SFE 
It bas already been established in chapter 8 that the efficiency of SFE from animal 
feed is directly related to the extraction conditions and successful extraction can be 
achieved provided % methanol was kept high. 
The experimental conditions used for the extraction of fluconazole were: temperature 
80°C, carbon dioxide + 20% MeOH at 250 kg/cm2 pressure, flow rate of 2 mVrnin 
and extraction time 40 min. 
Experimental conditions for the extraction of tioconazole, hexaconazole and UK-
47,265 at both levels were: temperature 60°C, carbon dioxide + 20% MeOH at 250 
kg/cm2 pressure, flow rate of2 mlImin and extraction time 40 min. 
Blank extractions were carried out in duplicate at the optimized extraction conditions. 
This was necessary in order to ensure that no compounds extracted from the matrix 
itself would interfere with the pSFC analysis. 
9.6.2 Quantitative Analysis of Animal feed ~acts 
Optimization of the Operating Chromatographic Parameters for Analysis of the 
Antifungal Compounds 
Because of the more favourable mass transfer kinetics on SFC, owing to the high 
diffusivity and low viscosity, SFC has the potential of giying better separation 
perfonnance and shorter analysis time compared to HPLC. The objectives of this 
study were to evaluate the potential of pSFC "ith carbon dioxide and polar modifiers 
as the mobile phases for the analysis of the antifungal compounds. With pure carbon 
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dioxide, acceptable peak shape was obtained only for hexaconazole. Tioconazole was 
not eluted with pure carbon dioxide. This can be attributed to interactions between the 
solutes and active sites, such as residual silanol present on the stationary phase and 
also to the low polarity of carbon dioxide. Consequently, a mobile phase modifier had 
to be applied. 
9.6.3 Effect of Mobile Phase Composition 
As expectecL the concentration of the modifier in the mobile phase had the greatest 
impact on retention of all the compounds compared with any other instrumental 
parameters tested. Fluconazole was eluted as a broad peak. (figure 9.1) from the 
cyano column when pure carbon dioxide was used as the mobile phase at 60°C and an 
outlet pressure of 250 kg/cm2. The flow rate was set at 3 mllmin. A similar effect was 
observed with the UK-47,265. Tioconazole was not eluted with 100% C02. The 
addition of low concentrations of methanol to the mobile phase dramatically decreased 
retention time and improved peak shapes for both fluconazole and UK-47,265. To 
obtain reasonable elution times for fluconazole, a mobile phase containing 8% 
modifier was required. Similarly, to obtain a reasonable elution time for the UK-
47,265, a mobile phase composition containing 12% modifier was required. 
Hexaconazole was eluted with lower modifier concentration with good peak shapes 
but a modifier concentration of 12% was also chosen for hexaconazole as it was 
extracted together with the UK -47,265 from the feed. One area of difficulty uncovered 
during the analysis of tioconazole was adsorption of the drug by active silanol sites 
with the column. This was not unexpected as similar silanol interactions are 
commonly encountered in hpIc. A modifier concentration of 14% at 55°C and 272 
kg/cm2 outlet pressure eluted tioconazole from the polar cyano column. but the 
compound emerged as a severly broad peak (figure 9.2). A further increases in the 
modifier concentration from 14% to 20% did not improye the peak shape. 
Consequently the presence of a very polar .additive was found to be necessary to 
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reduce the retention time and to improve peak shape. Different concentrations of 
additive-methanol mixture were used as the chromatographic mobile phase with the 
cyano column. The addition of triethylamine in the MeOH (0.25 m1s of triethylamine 
per 50 mls of MeOH) decreased the retention time and improved the peak shape of 
tioconazole dramatically (see figure 9.6 later). Table 9.2 shows the effect of% MeOH 
modifier on retention for hexaconazole, fluconazole and UK -47,265. 
Signal 
o 
fluconazole 
5 Time (min)10 15 
Figure 9.1 Example pSFC chromatogram obtained for an animal feed 
extract of fluconazole. For chromatographic conditIons, see text 
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Signal 
o 
tioconazole 
7'5 15 
Time (min) 
Figure 9.2 Example pSFC chromatogram obtained for an animal feed 
extract oftioconazole. For chromatographic conditions, see text. 
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Table 9.2 showing the effect of %MeOH on retention for hexa I fl 
. conazo e, uconazole 
and UK-47,265. 
Compound Retention Capacity %MeOH Pressure Flow rate Temp 
time factor (k) (lQdcm2) (mllmin) (OC) 
Hexaconazole 1.11 0.59 12 250 3 
" 
1.39 0.99 8 250 3 
" 
1.75 1.33 5 250 3 
" 
3.45 2.13 0 250 3 
Fluconazole 1.45 1.01 12 292 2 
" 
3.40 2.47 8 292 2 
" 
4.98 3.48 5 292 2 
" 
~10.5 - 0 292 2 
UK-47,265 1.85 l.68 12 250 3 
" 
3.84 2.84 8 250 3 
" 
5.21 3.70 5 250 3 
" 
~11 - 0 250 3 
, 'l';. 
A typical effect of addition of a modifier on retention behaviour in SFC is 
demonstrated by plotting in capacity factor against % MeOH for hexaconazole 
(figure 9.3). The graph (r = 0.999) illustrates the fact that addition of a modifier 
shortens the retention of an analyte in SFC. 
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Figure 9.3 Example of re~nship between In capacity factor (k) and % 
modifier for hexaconazole 
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9.6.4 Effect of Pressure on Retention 
12 
• 
The effect of column outlet pressure on retention of all the compounds produced 
marginally small shifts on retention as compared with the modifier concentration. The 
operating pressure for the optimization of the compounds from the feed \\ as varied 
between 250-322 kg/cm2. Table 9.3 shows an example of the effect of pressure on 
retention for hexaconzole. 
Table 9.3 An example of the effect of pressure on retention for hexaconzole. 
Retention Capacity Pressure Temperature %MeOH Flow rate 
time factor (k) J)(g!cm2) (OC) (mUmin) 
1.49 1.13 322 65 8 2 
1.16 300 65 8 , 1.51 
-
1.54 1.20 272 65 8 2 
1.59 1.27 250 65 8 1 
9.6.5 Effect o!Temperature on Retention 
Temperature changes caused changes in retention for all of the compounds. The 
retention of all of the compounds increased when the temperature was increased. This 
effect is expected in SFC, as the retention and selectivity depend strongly depend on 
the density of the fluid and temperature changes are therefore an important factor in 
the optimization process. The range of temperature studied for the extraction of the 
compounds from the feed varied between 55°C and 70°C. Table 9.4 shows an 
example of the effect of temperature on retention for hexaconazole. 
Table 9.4 An example of the effect of temperature on retention for hexaconazole. 
Retention Capacity Pressure Temperature %MeOH Flow rate 
time factor (k) Ck2Icm2) (oC) (mJ/min) 
1.31 0.93 250 55 6 2 
l.50 1.17 250 60 6 2 
1.65 1.36 250 65 6 2 
1.84 1.84 250 70 6 2 
A typical effect of temperature on retention is demonstrated by plotting In capacity 
factor against I/temperature for hexaconazole (figure 9.4). The graph illustrates the 
fact that in SFC , the moblie phase strength increases as the density goes high. The 
lower the temperature, the higher the density is obtained. Therefore. the relationship 
between In k vs T-l becomes a negative slope in isobaric elution and the lower the 
temperature, the shorter the retention becomes. 
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9.7 Analysis of SFE Animal Feed Extracts of Fluconazole, Iioconazole, 
Hexaconazole and UK-47,265 
The optimum chromatographic conditions were first determined with the standards. 
The blank SFE extracts were then run at the optimum conditions to establish that the 
co-extracted material from the feed. did not interfere with the pSFC analysis at the 
chosen chromatographic conditions. The chromatogram for the blank feed was free of 
infering peaks at the retention time of all four compounds, allowing selective 
quantitation of all four compounds. 
The optimum chromatographic conditions established for the analysis of fluconazole 
at 10 gIkg of feed level from the animal feed were; temperature 55°C, carbon dioxide 
+ 80/0 MeOH at 292 kg/cm2 and a flow rate of 2 mVntin. Under these conditions. 
fluconazole was retained at 3.0 minutes. 
The optimum chromatographic conditions established for the analysis of fluconazole 
at 500 mg/kg of feed. level from the animal feed were: temperature 65°C, carbon 
dioxide + 8% MeOH at 292 kglcm2 and a flow rate of 2 mVmin Under these 
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conditions, fluconazole was retained at 3.4 minutes. Figure 9.5 shows an example 
chromatogram is of a blank animal feed eaxtract and a fluconazole animal feed 
extract. 
The optimum chromatographic conditions established for the analysis of tioconazole 
for both levels of feed level from the animal feed were; temperature 65°(, carbon 
dioxide + 20% MeOH containing triethylamine (0.25 mls of triethylamine per 50 ml 
of MeOH) at 250 kg!cm2 and a flow rate of 3 mllmin. Under these conditions, 
tioconazole was retained at 1.6 minutes. Figure 9.6 shows an example chromatogram 
of a blank animal feed extract and a tioconazole animal feed extract 
The optimum chromatographic conditions established for the analysis of hexaconazole 
and UK-47,265 for both levels of feed from the animal feed were; temperature 65°C. 
carbon dioxide + 12 % MeOH at 250 kg/cm2 and a flow rate of 3 mlImin. Under 
these conditions, hexaconazole was retained at 1.1 minutes and the internal standard 
of fluconazole was retained at l.85 minutes. Figure 9.7 shows an example 
chromatogram of a blank. animal feed extract and a hexaconazole and UK-47,265 
animal feed extract. 
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Signal 
o 2 4 
Time (min) 
F 19u re 9 5 a A typical S FE-pS FC trace of a 
blank animal feed extract 
Signal 
fluconazole 
o 2 
Time (min) 
Figure 9.5 bA typical SFE-pSFC trace of a 
fluconazole animal feed extract at a level of 
500 mgIKg of feed. 
Signal 
o 1 2 
Time (mm) 
Figure q 6 a A typical SFE-pSFC trace of a 
blank ammal feed extract 
Signal 
o 
hoconazole 
1 
Time (111m) 
2 
Figure 9.6 b A typical SFE-pSFC trace of a tioconazole 
anImal feed extract at a level of 2 5g1Kg of feed. 
Signal 
o 1 2 
Time (min) 
figure q 7 a A typical SFE-pSFC trace 
of a blank animal feed extract 
Signal 
o 
\IL''-<! L- L'lI:1 ZL,k' 
UK-47,265 
1 2 
Time (min) 
figure 9 7 b A tYPical SfE-pSfC trace of a 
hexaconazole and UK-47,2h'\ extract 
at a level of 125gIK of Hexaconazole and 
19lKg of UK-47,265. 
The results obtained for both levels of feed for all of the compounds are sho"n in 
tables 9.5-9.10. 
Table 9.5 Percentage recovery data for the pSFC analysis of fluconazole (500 mg/kg 
of feed) from animal feed. 
Extract 0/0 Recovery 0/0 RS.D 
(0 = 3 for each extract) Mean +S.D 
1 85.3 + 0.8 9.4 
2 85.6 ± 5.0 5.8 
3 84.6 ± 1.3 1.5 
4 88.5 ± 8.0 9.0 
5 82.6 ± 4.5 5.4 
The average recovery obtained for fluconazole at the 500 mglkg of feed level was 
85.32% with an RSD of 2.50/0. 
Table 9.6 Percentage recovery data for the pSFC analysis of fluconazole (10 g/kg of 
feed) from animal feed . 
Extract 0/0 Recovery 0/0 RS.D 
(0 - 3 for each extract) Mean + S.D 
1 96.7 + 4.1 
2 99.0 + 0.7 
3 95.8 + 4.8 
4 96.6 + 2.6 
5 87.1 + 3.5 
The average recovery obtained for fluconazole at the 10 g/kg of feed leyel was 
95.60/0 \\ith an RSD of 5.3%. 
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Table 9.7 Percentage recovery data for the pSFC analysis oftioconazole (2.5 gIkg of 
feed) from animal feed . 
Extract 0/0 Recovery 0/0 RS.D 
(0 = 3 for each extract) Mean +S.D 
1 96.6 ± 2.1 ') ') 
....... L 
2 98.8 ± 2.1 2.1 
3 95.4 ± 3.1 3.2 
4 94.1 ± 6.0 6.-l 
5 88.3 ± 2.8 3.2 
The average recovery obtained for tioconazole at the 2.5 glkg of feed level was 
94.6 % with an RSD of 4.2 %. 
Table 9.8 Percentage recovery data for the pSFC analysis of tioconazole (5 glkg of 
feed) from animal feed . 
Extract 0/0 Recovery 0/0 RS.D 
(0 - 3 for each extract) Mean + S.D 
1 96.8 + 6.1 6.3 
2 96.5 + 4.2 4.4 
3 84.7 + 3.7 4.4 
4 76.7 + 3.9 5.1 
5 90.2 + 5.5 6.1 
The average recovery obtained for tioconazole at the 5 glkg of feed level was 
91.0 % with an RSD of 6.4 %. 
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Table 9.9 Percentage recovery data for the pSFC analysis ofhexaconazole 0.25 g!kg 
of feed) and (1 gIkg of feed) from animal feed . 
Extract 0/0 Recovery 0/0 R.S.D 0/0 Recovery 0/0 R.S.D 
(0 = 3 for each for for UK-47,265 
extract) Hexacooazole 
Mean +S.D Mean + S.D 
1 90.3 ± 5.8 6.4 80.3 + 4.3 ~.4 
2 92.4 ± 2.9 3.1 81.0 + 5.5 6.8 
3 92.1 ± 6.5 7.1 76.9 + 6.3 8.2 
4 86.4 ± 5.1 5.9 77.4 ± 4.8 6.2 
5 92.0 ± 2.9 3.2 79.3 + 5.3 6.7 
The average recovery obtained for hexaconazole at 1.25 gIkg of feed and the UK-
47,265 at I g/ kg of feed level were 90.6 % and 78.9 % with a RSD of2.6 % and 2.4 
% respectively. 
Table 9.10 Percentage recovery data for the pSFC analysis of hexaconazole 
(1.875g/kg of feed) and theUk-47,265 (2.5 g/kg of feed) from animal feed . 
Extract 0/0 Recovery 010 R.S:D 0/0 Recovery 0/0 R.S.D 
(0 = 3 for each for for UK-47,265 
extract) Hexaconazole 
Mean + S.D Mean + S.D 
I 97.4 + 1.5 1.5 93.2 + 3.1 3.3 
2 101.0 + 3.5 3.5 91.1 + 4.6 5.0 
3 99.4 + 5.4 5.4 93.2 + 2.9 
3.1 
4 92.4 + 5.0 SA 91.8 + 2 2 
24 
5 92.1 +1.1 1.2 92.2 + 5.8 
6.3 
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The average recovery obtained for hexaconazole at 1.875 g/kg of feed and the UK-
47,265 at 2.5 g/ kg of feed level were 96.5 % and 92.3 % \\ith a RSD of 4.2 % and 
1.0 % respectively. 
9.8 Discussion 
The SFC method developed for the determination of antifungals from animal feed 
provides an alternative separation selectivity to the existing reverse phase HPLC 
technique with a shorter analysis time. Good chromatograms were achieved \\ith the 
cyano bonded column using MeOH-C02 based solvent modifiers. For elution of 
tioconazole, the addition of TEA in the mobile phase was necessary to obtain 
acceptable chromatography and it is suggested that the TEA acted as a competing 
base to mask free silanols on the surface of the stationary phase in order to reduce 
their interactions with tioconazole. 
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difficult and not very accurate, even when there are some experimental values. The 
solubility model proposed for testosterone (Chapter 6), based on the capacity factor 
measurements can be used as a resonable solubility predictor for testosterone at 
different temperatures using the biphenyl column. Changing the stationary phase to a 
cyanopropyl column however changes the interaction of the analyte to the stationary 
phase significantly and the model is not effective. 
The effect of temperature and pressure on the solubilities of steroids in supercritical 
carbon dioxide were demonstrated in chapter 7. Near the critical pressure of carbon 
dioxide, solubility increased dramatically as was expected because of a rapid increase 
in density with increasing pressure at constant temperature. 
The objective of the study with antifungals was to exarrune the extension of 
supercritical fluid extraction to the extraction of polar drugs. The ultimate aim was to 
determine antifungals from animal feed using supercritical fluid extraction and 
supercritical fluid chromatography and thereby demonstrate the versatility of 
SFE/SFC. 
Initial experiments with antifungals involved optimizing the conditions for the 
extraction of fluconazole, to determine the most significant variables influencing 
extraction. The infonnation obtained allowed the development of subsequent 
extractions of fluconazole, tioconazole, hexaconazole and UK -4 7 ,265 with 
supercritica1 carbon dioxide. The technique is shown to have many parameters that 
require careful consideration and understanding if it is to be successfully used. Carbon 
dioxide was ineffective in extracting all four antifungals from the animal feed. The 
introduction of methanol as a co-solvent into supercritical carbon dioxide modified the 
polarity and solvating power of the supercritical fluid and e~1ended the range of 
applications of SFE. A large percentage of the modifier was necessary for the 
extraction of these polar compounds. The matrix material, animal feed in this case. 
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associated with the antifungals had pronounced effects on the successful isolation of 
target analytes in the SFE experiments. An inert support material Celite, was used to 
study the solubility of fluconazole. The complexity of the extraction process was 
undoubtly increased by the introduction of the sample matrix. The results from the 
SFE experiments showed that increasing temperature, time, and % methanol all 
facilitate greater solubilization of all four antifungals, proving that the efficiency of 
SFE is directly related to the extraction conditions. 
The analysis of fluconazole from SFE proved difficult with HPLC. Although the SFE 
procedure was found to be simpler and less time consuming compared to the liquid 
extraction/SPE, however the SFE extracts contained vast amounts of co-ex1ractives 
which interfered with the HPLC analysis. This was one major disadvantage the SFE 
method had over the existed method of analysis, specially where the analysis of the 
drug was required at low levels. After extensive method development, the best 
RPHPLC separation achieved for fluconazole was at a level of 500 rng of druglkg of 
feed. The mobile phase required for separation of fluconazole from animal feed was 
15/85, waterlmethanol (v/v) and was indicative of the fact that NPHPLC is a better 
choice for the separation of fluconazole in presence of co-extractives and lead us to 
the use of pSFC as an alternative to NPHPLC. 
The GC analysis of fluconazole presented no problems even in the presence of the co-
extractives. Although possible derivitisation of fluconazole (a free OH- group in the 
fluconazole structure) was achievable, was not required for the GC analysis. GC-FID 
is a good choice of analysis at high levels of fluconazole concentration where the 
sensitivity of GC-MSD will enable to detect fluconazole concentration at lower levels. 
A SFC method was developed for the determination of 4 antifungals in animal feed 
matrix. The procedure provided an alternative separation selectivity to the existing 
RPHPLC techniques with much shorter analysis time. 
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The modification of the mobile phase with polar methanol was necessary to elute the 
antifungals. The retention in SFC is based on the selective interactions of the anahte 
with the mobile phase and the stationary phases. The retention characteristics of the 
antifungals were influenced by several parameters, of which, beside the nature of the 
mobile and stationary phases and the type of antifungal, the density of the mobile 
phase, the flow rate and the temperature were the most important. The method 
development time required was much shorter than the HPLC analysis and the peak 
shapes obtained for all four compounds were superior than RPHPLC analysis. The 
necessity to include triethylamine in the mobile phase to obtain acceptable 
chromatographic results for tioconazole suggests that it is necessary to use a 
competing base to mask free silanols on the surface of the stationary phase in order to 
reduce their interactions with the analyte. The levels of the antifungals analysed by 
pSFC with UV detection were at levels 500 mg to 10 g of the antifungalslkg of feed. 
The physico-chemical properties of supercritical fluids that provide important 
chromatographic advantages are important for the transport and gas phase 
introduction of analyte molecules into the ion source of a mass spectrometer, which 
could provide a highly sensitive and selective detection pSFC for analysis of very low 
levels of antifungals. 
10.1 Future Recommendations 
Future calculations ofC logP/solubility parameter should be carried \\$ other classes 
of pharmaceuticals than steroids to investigate if the relationship could be used as a 
solubility predictor for other compounds. 
In this thesis, the solubility data for a series of steroids is presented. Future work 
should involve ex1ractions of some of the soluble steroids such as testosterone. by 
using SFE from their formulation matrices, i.e. from tablets, capsules or ointment 
formulations. The solubility of pure compounds in supercntica1 fluids can be 
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enhanced by the addition of a cosolvent such as methanol and the SFE method may 
provide a faster solution to sample preparation especially in the analysis of steroids 
whose formulation require lengthy liquidlliquid extraction. 
Far more investigations are required is capacity factor measurements are to be used as 
an accurate solubility predictor for steroids, such as testosterone. Investigations 
should include finding an appropriate stationary phase where testosterone capacity 
factor can be measured accurately for both high densities and low densities. In order 
to extend the solubility model to more than one stationary phase, it will be necessary 
to run testosterone at different densities on different stationary phases to calculate the 
proportionality constant (i.e. interaction of the analyte with different stationary 
phases) which could then be used as the correction factor to correct between column. 
In the pharmaceutical industry, the assay of drug substances from the feed matrices is 
required at very low levels. Further work on determination of drugs from animal feed 
should involve quantitation of the drugs such as fluconazole, at lower levels, typically 
down to a concentration range of 4 mg/kg of feed. Since detector sensitivity was a 
limiting factor for the analysis of fluconazole by GC, the inherent sensitivity of GC-
MSD should be explored to see if fluconazole can be detected at the required low 
levels. The use of on column ECD should also be considered as a detection method for 
analysis of fluconazole as this detection method may prove to be sensitive enough to 
measure drug levels of fluconazole encountered in toxicological studies. Both clean up 
and pre-concentration step (SPE) will be required ifHPLC is chosen for the method of 
analysis following SFE. 
The use of pSFC was shown as the alternative approach to GC and HPLC in this 
thesis. This technique provides a promising new approach for determining 
fluconazole, 3ttd other antifungals, in animal feed. Howeyer. if pSFC is to compete 
\\ith HPLC. !tiTher work is needed in the deyelopment of a ngorous- anal~tica1 
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A~tract 
d The application of supercritical fluid extraction with carbon dioxide and modified carbon dio~ide for the 
etennination of fluconazole from an animal feed was studied. A fractional factorial design approach was ~ed to examine the significant experimental variables for quantitative extraction of fluconazole. Gas 
C rOtnatography with either flame ionisation or mass selective detection was used for quantitation of the ~xtracts. The results indicated that modifier (methanol) had the greatest effect on the recovery of fluconazole 
rom the animal feed. 
~words: Supercritical fluid extraction; Fluconazole; Animal feed; Fractional factorial design; Gas 
omatography 
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1. " Introduction 
In chronic toxicity studies, administration of ~rug substances to laboratory animals may 
lI1volve incorporating the drug into the ani-
Illals' feed [I]. The detennination of the drug 
SUbstance level in the feed matrices is necessary 
to. lllonitor dosage ,levels, verify dose unifor-illy throughout the feed mix and con finn the 
t rUg'S stability. Animal feeds are complex mix-
U!es of proteins, lipids, glucicide, cellulose and 
Illineral matter [2] and, if coextracted, the com-
f~ne~ts can interfere in the detennination of 
e analyte of interest. Various means of sam-
fie preparation have been investigated to ex-
~ct drug substances from feed prior to assay. 
[3 e~ I?ethods include liquid-solid extraction 
],: sohd-phase extraction [4], Soxhlet extrac-
----
• Corresponding author. 
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tion [5] and liquid-liquid extraction [6]. The 
use of supercritical fluid extract,ion to deter-
mine analytes from animal feed matrices has 
been investigated only briefly for several phar-
maceutical compounds [7-9]. The present 
method for the isolation of drugs from feed 
involves time consuming extraction/cleanup 
steps which also introduce analytical uncer-
tainty and a limited ability to automate such 
assays. Supercritical fluid extraction offers a 
simpler isolation procedure with the potential 
for in situ cleanup of analytes from complex 
matrices and the possibility of automation. 
This paper focuses on the use of supercritical 
fluid extraction for the extraction of flucona-
zole from animal feed matrix prior to chro-
matographic detennination. " 
Fluconazole (UK-49588; 2-(2,4-difluoro-
pheny-I,3-bis( IH-I,2,3-triazol-I-yl)-2-propan-
01; Fig. I) is a triazole compound with potent 
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also prepared. All extracts were analysed by 
HPLC with UV/vis detection using a seven-
point calibration plot with a correlation co-
efficient, r, of 0.9979. 
. h FID detCC-(particularly in the case of GC WIt " s'done 
tion) the spiking level of fluconazo.le ~~ediate 
at the 10 g kg- l (high) level. An Int~ , epared 
spiking level of 500 mg kg- l was al~~ ~ super-
and extracted using methanol-modI e lysed by 
2.4. Supercritical fluid extraction methodology critical CO2 , These extracts wer~ ana nt that 
, ,', GC with MSD detection. It is appare'll 'alloW The extraction. efficiency of SFE for the re- the inherent sensitivity of GC-MSD w~" 
covery of fluconazole from rodent feed was lower spiking levels to be analysed. 
determined at two levels, 10 g of drug kg- 1 of 
feed and 500 mg kg- l of feed. The spiked feed 
samples of known fluconazole content were 
prepared by adding aliquots of the fluconazole 
standard in dichloromethane to a 1 g weighed 
sample of animal feed in a glass jar. These jars 
were capped, shaken vigorously and the con-
tents left to dry overnight in an open jar. The 
spiked sample was quantitatively transferred to 
a cell and the extraction was carried out, using 
a fractional factorial design, to investigate SFE 
variable dependence. The flow-rate of extrac-
tion was maintained constant at 2 ml min- l 
throughout the experiment. The collection vial 
contained a few drops of methanol and two 
cyanopropyl Bond Elute cartridges were placed 
in series at the exit to prevent· any loss of 
fluconazole. Following extractions, all extracts 
were made up to volume in a 25 ml volumetric 
flask. The SFE extracts obtained at the 500 mg 
of drug kg-1 of feed level were analysed by 
GCjMS, while the extracts obtained at the 10 g 
of drug kg-I of feed were analysed by GC with 
flame ionisation detection. All experiments 
were done in duplicate. 
3. Results and discussion 
3.1. SPE-HPLC 
SPE were 
The extracts obtained from th~ d gave a 
visibly clean and the results' obta,I~~ .. 99.l% 
mean· fluconazole recovery o.,The 
{98.l%, 100.7%,97.9%, 100.2%, 98.7~o)·t waY of 
method described provides a conveo~enlY '!be 
'taUve . determining fluconazole quant.I bod was 
final solution obtained using thIS 1l1et Iso free 
both! sufficiently concentrated and, \le witb 
from coextractives to make it C01l1paU .. , :.,. 
HPLC analysis. . 
. '. 
. " . . . [feed" 
3.2. SFE o/fluconazole from amma . ,. . . 
• 11 ~, .1 
I · , ., h' fortn~tioa ava~~ '. n order to maXimIse t e III erime 
able from the minimum number. of e;~ design 
tal results, the use of an exp~n1l1~~esjgn was 
approach was pursued. A fractlOna f a si1l1ple 
selected (17]. This involved the use ~ . _ ,. 
model of the form . . - '(l) 
y';' bo + bl VI;:' b2V2 + b 3V3 + b~v~ .:. ' 't~~1); 
. extrac 
where Y is the response (percentag~ variables 
Vlt V2' V3 and V4 are the four 1l1aI~'!1le of ex~ 
selected, i.e. pressure, temperature, I pectiVelY: 
traction and percentage methanol? r:efticient~' 
Previously reported work [4] on the use of 
SPE followed by HPLC with UV detection for 
the isolation and determination of fluconazole 
from animal feed was done at the 40 mg kg-:-I 
level. The methodology was repeated' in this 
study to allow a direct comparison with SF£; 
The isolation and cleanup offered by SFE 
proved to be insufficient to eliminate extran-
eous material which co extracted with methanol-
modified supercritical CO2 , The nature of the 
coextracted material prevented quantitative 
analysis by HPLC with UV detection. It had 
been noted previously that fluconazole could 
be analysed using GC[14-16].Therefore, 
quantitative isolation by SFE followed by GC 
with either FlO or MSO has been evaluated. 
However. in order not to be sensitivity limited 
b1; b2 , b3 and b4 are the parametn~ , ,;; . 
bo is the intercept. . - tives fro~ 
Owing to the presence of coextra~ J1letba~ob 
the animal feed matrix, when HPLC WIt 
modifier was present, the u~e or extractS wa~ 
UV detection for the analYSIS of ,repOrte 
impractical. However, it had be~ oC [14-
that fluconazole could be analy~ed X detectioll 
16J. In order to facilitate analysIs ala els it was 
at high and intermediate spiking eV 'tb' eitbef 
. n WI • n 
necessary to use GC separaUo. detCCUO ~ 
flame ionization or mass selective howed a: 
The calibration plot for GC·FID s aoge (50 ) 
ceptable linearity over the c~osen o~fficieot (;e 
400 ~g ml- I ) with a correiatIo? c tbe sa1l1f e 
of 0.974. The peak height of eithe: o' saseltlls 
ftaUo . 01J 
or standard was used for quan I dogen 
resolution of fluconazole, from the en 
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Table 1 
Percentage 
fractional (reco~ery d~ta for the GC-FID analysis of fluconazole (to g kg- I of feed) from an animal feed using a 
___ actonal design. All experiments were done in duplicate 
Pr~u~~.-----------------------------------------------------------------
(kgCln-2) Temperature Time % MeOH % Recovery 
___ (0C) (min) 
250 -------------------------------
2~ 80 
250 ,. 80 
110 . ~ , 40 
II() , 80 
II!)' 40 
IJ() '. 40 
25() • :. 80 
17() . 40 
__ 65 
40 
5 
5 
5 
40 
20 
2 
20 
20 
20 
2 
2 
2 
-----------------------------------------------------
5 
40 
40 
20 10 
87.0 
76.6 
79.0 
90.9 
80.5 
16.9 
22.3 
27,3 
97.4 
'table 2 
Percenta 
fraction ~e( reco~ery d~ta for the GC-MSD analysis of fluconazole (500 mg kg- I of feed) from an animal feed using a ~actonal design. All experiments were done in duplicate 
Pressure ------------------------------------------------
(kgCln-2) Temperature Time % MeOH % Recovery 
~ _______ (-oC)------------(-m-in-)-----------------------------
2S!) , 
2S()', . 
II!) 
ll() 
110 -: .. <, 
II!) ;' : .. 
2~ ., ':; 
17!)")':' : . 
80 
80 
40 
80 
40 
40 
80 
40 
65 
4() 
5 
5 
5 
4() 
5 
40 
40 
20 
20 
o 
20 
20 
20 
o 
o 
o 
10 
99.6 
5.3 
82.7 
99.7 
72.5 
5.1 
16.8 
5.8 
100.3 ~. 
-----------~-------------------------, , -~ 
tnateriai . 
achie Co-extracted from the feed, was methanol was the only significant variable for reten~~d ~nder the conditions described at a the extraction of fluconazole from the animal 
. S. n hme of 19 min. feed matrix. The difference in the b coefficients ~~fl . 1 
aCcord' uconazole ammal feed was prepared (-0.3647 and -0.0419 for the to g kg- and 
tional ;ng t~ the above procedure and a frac- 500 mg kg- 1 spiking levels,' respectively) 
ent actonal design carried out at two differ- reflects the influence that the' percentage • of 
"'as Concentration levels. The extraction time methanol-time of extraction interaction has on 
40 rn~xt.ended, within the design, from 20 to extraction recovery. The consequence of the 
tiaJ r::alfi. order to compensate for any poten- addition of a small 'amount of methanol (2%) 
both} tflx effects. The results obtained for as opposed to CO2 only had a pronounced 
It sh evels of feed are shown in Tables 1 and 2. effect on extraction recovery (Tables 1 and 2). 
Illeth auld be noted that the percentage of The model for the 10 g kg- J extraction results 
and 2~01 ~as considered at three levels, 0, 10 is ". 
IVher X>, In the case of the 500 mg kg- 1 level, 
at 2 ~~s at the 10 g kg- 1 level it was considered 
lISed't 0 and 20010. Multilinear . regression was 
1'be 0 cal~ulate the coefficients in Eq. (1) [18J. Si&ni~efficle~ts are reported in Tables 3 and 4. 
~roba~~~ce IS determined by a '-test with a 
leVel .1hty (P) of 0.05 at the 95% confidence 
and tlth four degrees of freedom. In Tables 3 
0.05 ' a coefficient with a p-Ievel of less than 
cOnsi~r a,t-test of greater than 2.78'will be 
Qbtai ered significant. In both cases, the results 
ned indicate that the percentage of 
Percentage recovery of fluconazole 
= -4.751 +0.097(pressure) 
+ 0.509(temperature) , 
- O.365(time of extraction) 
+ 2.647(percentage ~ethanol) . 
r = 0.8535 (r2 = 0.7286)' at the 95% confidence 
interval. 
.' '. ' • 1- ., ' - .-; 
However, themodel for the ,500 mg kg-I, re-
sults is as fonows: 
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Table 3' " . : . 
Coefficients of regression and standard error of linear Eq. (I) for the GC-FID analysis of fluconazole from animal feed 
(10 g kg-I level) ~ 0' 
-
Variable Descriptor Beta Standard b Standard t(4) p-Ievel . . y: 
error error 
-
Pressure VI 0.212 0.261 0.097 0.120 0.812 0.462 <.'" 
Temperature V2 0.317 0.261 0.509 0.419 1.215 0.291 
Time V3 -0.198 0.261 -0.365 0.480 -0.760 0.489 
% MeOH V4 0.739 0.261 2.647 0.933 2.837 0.047 
-
Table 4 ' d 
Coefficients of regression and standard error of linear Eq. (I) for the GC-MSD analysis of fluconazole from animal ~ee 
(500 mg kg-I level) , 
-
Variable Descriptor Beta 
Pressure VI 0.020 
Temperature V2 0.182 
Time V3 -0.016 
% MeOH V4 0.907 
Percentage recovery of fluconazole 
= -11.813 + O.OlO(pressure) 
+ 0.405(temperature) 
- 0.042(time of extraction) 
+ 4.062(percentage methanol) 
Standard 
error 
0.246 
0.215 
0.214 
0.214 
r = 0.9199 (r2 = 0.8462) at the 95% confidence 
interval. 
A typical response surface was generated for 
fluconazole (Fig. 3) showing the effect of tem-
perature and percentage methanol, as modifier, 
on extraction recovery. The percentage extrac-
tion efficiency repeatability for the isolation 
and cleanup of fluconazole from animal. feed 
followed by GC·. with either FlO, or MSD 
detection ~as determined to be 87.0% (RSD 
8.4%) at the 10 g kg-I level and 91.0% 
(RSO = 1~.2%) at the 500 mg kg-~ level. In 
100 
SO 
t!- 60 
"{; 
~ AO 
~ 
Fig. 3. Response surface for fluconazole showing the effect 
of temperature and percentage modifier on extraction 
efficiency. 
b Standard t(4) p-leveI 
error 
---0.011 0.136 0.089 0.940 0 ' • .", 
0.405 0.479 0.847 0.445 
-0.042 0.546 -0.077 0.943· 
4.062 0.958 4.239 0.013 . 
---
each case the number of replicates was te~. °al 
The recovery of fluconazole from anull 
feed was determined, using a fractional fact~­
rial design approach, to be dependen~ upon \e 
addition of modifier in the extraction fluid. ride 
modifier's function is thought to be twO-fo f 
Firstly, the modifier increases the polarity ~ 
the extraction fluid and thus competes with \ e 
drug for the active site on the matrix. Second Yf' . 0 
the modifier acts to decrease the adsorptIOn. 
. by In-
solutes onto the surface of the matrix . 
creasing the swelling of the matrix, which. I~ 
turn increases the likelihood of solute diffuslO 
out of the matrix. 
.r", 
4. Conclusions 
.' . ~ 
A comparison of SPE with SFE for tbt 
isolation and cleanup of fluconazole froJ11 a~; 
mal feed has been made. The inter-depend~ of 
of the extraction procedure on the methO. Iy 
analysis and determination was effectJ~E 
demonstrated. The unselective nature of S a~ 
when methanol-modified supercritical C.0 2 ~ 
used, prevented analysis by HPLC Wlt~ tive 
detection owing to coextractives. Qua~tJta oC 
recovery of fluconazole was possible usJOg tbe 
with either flO or MSO detection' at Is 
'k leVe , 10000 mg kg-I and 500 mg kg-I Spl e . 'vity 
respectively. However, the inherent senslt~s to 
of GC-MSD should allow lower spike lev~ an 
be quantified. SPE-HPLC was shown to I :ing 
effective method of isolating and ana y 
S. Khundker et al./ J. Pharm. Biomed. Anal. 13 (1995) 1441-1447 1447 
fluconazole from animal feed at a low spike 
level (40 mg kg-I). In addition, the time taken 
py the SPE-HPLC method was shorter than 
~hat for the SFE-GC method (SPE-HPLC, 
~PE, ~20 min; HPLC, 10 min compared to 
rFE-GC; SFE. 40 min; GC. 25 min). 
r
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The solubility of ten steroids in supercritical carbon dioxide is 
reported over a range oftemperatures (3S-100°C) and 
pressures (84-231 kg cm-1). The solubility of testosterone, 
determined in this work, compares favourably with solubility 
data previously reported. The use of the solubility parameter 
and a hydrophobicity term (log P), has been shown to provide a 
qualitative estimate of steroid solubility. 
Keywords: Steroid solubility; supe;critii:al carbon dioxide; 
sOlubility prediction; solubility parameter; hydrophobicity, 
logP , ' c" 
Introduction 
The development of suitable methods for the extraction of 
analytes from matrices using supercritical fluids is greatly 
assisted if some indication of the analyte solubility IS available. 
Various methods for the prediction of analyte. ~olubility have 
been suggested and include the use of equations' of state,l 
Chromatographic retention data2 and solubility parameters.3 
This paper compares the results of a predictive method, based 
on solubility parameters and the hydrophobicity term (log P), 4 
with experimentally determined solubility data for ten ste-
roids. 
liydrophobicity in Terms oJOctanol-Water Pa'rtitioning 
Behaviour , 
A. commonly applied physico-chemical characteristic 
employed to determine drug activity in quantitative structure 
i activity relationships (QSAR) is the hydrophobic nature of a 
drug compound. Hydrophobicity is normally measured using 
the logarithm of the partition coefficient in octanol-water 
I systems (log P or kow). This group4 has previously shown, for a 
group of benzophenone compounds, that the hydrophobic 
nature of a molecule may be related to its solubility in the 
SUpercritical carbon dioxide phase. 
Several experimental methods are available to determine 
log P and include the shake-flask method,s-7 slow stirring,8 
Continuous partitioning method9,10 and isocraticl l-13 and 
gradientl4,IS HPLC. However, all are time consuming and are 
prone to excessive experimental error. Alternative 
approaches are available based on mathematical treatment of; .', 
the molecular structure. These molecular approaches can be 
divided into two classes; those which use molecular' frag-
lllentsl2,16 and those based on contributions from individual 
atoms,17,18 The former are to be preferred. The use~of 
Illolecular fragments has been approached f~om two diffe~et;lt 
perspectives. The first, 7 described as a constructionist 
approach, was developed by Hansch and Leol6 whereas the 
latter meth09, proposed b~ Rekker,12 uses a reductionist 
approach. In'each example, molecular fragments are used to 
derive a log P value. Molecular fragment contributions are 
available in tabular form for each approach. However, a 
computer-based approach was adopted in this work [C log P, 
Medchem (1989), Daylight Chemical Systems, Pomona Col-
lege Medical Chemistry Project, Pomona College, Claremont, 
CA, USA]. 
,', 
Determination oj the Solubility Parameter 
, ' 
The prediction of benzophenone 'solubility4' relied on the 
correlation between log P and the solubility parameter. There 
are several methods availabl~ for calculating the solubility 
parameter. These haye been ,evaluated by Kingl9 who 
concluded that a 10% variation between different methods is 
commonphice. Perhaps the simplest method of calculating the 
solubility parameter"is by the group contribution method 
proposed by Fedors.~, The !Dain advantage of this method is 
that it allows the estimation of the solubility parameter from 
only a knowledge of the molecular structure of the solute. 
Structurally complex solutes can thus be calculated without 
prior knowledge of their i thermodynamic properties. The 
Fedors method has been related to solubility in supercritical 
carbon dioxide, by_King and Friedrich3 via the reduced 
solubility parameter proposed by' Giddings eet al.21 King 
concluded that a large body of SFE data could be correlated in 
a quantitative manner to changes in the molecular structure. 
The solubility parameter, b, was described by Hildebrand in 
terms of thermodynamic properties on the mixing of dilute 
solutions.20 For low molecular mass compounds this was 
.found to be related to the energy of vaporization of a 
substanc,~, 6.Ey , at a given temperature, and the molar 
vohime'at that temperature, V. The solubility parameter (b2) 
is related ~to these two physical properties by eqn. (1): 
~ b2 = (6.Ey /V)°'S (1) 
By examining'tl;-e vast amount of molar volume and energy of 
vaporization data available for liquids, Fedors found that a 
general system for estimating both 6.Ey and V could be 
tabulated. The approach assumes that the group contributions 
of indi,vidual functional groups on a molecule can be summed 
to give an 9x,er-all estimate of the solubility parameter. 
In this paper, experimentally obtained solubility data, 
determined at different temperatures and over a range of 
pressures are reported for ten steroids. The experimental 
, res~~ts are comp~~ed with the Fedors solubility parameter ~nd 
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the hydrophobic term, log P, as a qualitative estimation of ',' pred~is~Ione; prednisone; and megestrol acetate (Fig. '.1)., 
steroid solubility in supercritical carbon dioxide. . SterOIds were provided in pure form by Glaxo Manufactu~~g 
Services,- (Barnard Castle; Co; Durham, UK). All solubility 
Experimenml 
The Jasco SFE-SFC system used in these experiments 
incorporates a Rheodyne switching valve and the Jasco 
back-pressure regulator (BPR). A sample of 10 mg of pure 
steroid mixed with Celite, an inert support, was placed in each 
sample cell. The sample cells were made of stainless steel (10 
em x 5.0 mm id) with a volume of approximately 2.0 ml. The 
steroids investigated were: testosterone; testosterone-17-pro-
pionate (given as testosterone propionate in Fig. 1); beclo-
methasone-17,21-dipropionate; betamethasone-17,21-dipro-
pionate; cortisone acetate; ~etamethasone; hydrocortisone; 
·<·h 
, ' T-.oao 
o 
.'j)1 
Prednioo"-
o 
o . II CH2 -O-C--CH2CH3 1- 0 c-o'li ., 
O-C-CH2CH3 
CH3 
Bec:1omeIb • ..-.17,21-Dipropioaote 
o 
o 
experiments were performed in duplicate. 
Extraction Conditions ' 
The SFE collection system used, required the supercriti~1 
solvent 'to' be' pumped through' the' sample cell in dynamiC 
, extraction mode. However, all steroid extractions utilized a 
, 2 min static extraction period prior to dynamic extraction tor 
. 10 min at a pump flow rate of 1 ml min-I. The static extractiOn 
, allowed the supercritical fluid to penetrate the sample, 
increasing the natural partitioning of the analytes into the 
solvent. The 10 min extraction time provided enough ma~s 
'.' 
i I J " ' 
M~I""te 
.. '" 
, " 
o 
;'J-' 
" 
. Cor1iaone_ 
o 
o 
• 1IeIometbuono-17,21-dipropioaate , ! ~ j 
~, , ' I A 
" , 
' .... 
HydlOCOl1isoDo 
Fig. 1 Structures of the investigated steroids. 
transfer to enable the analytes to be· collected in a· small 
amount of solvent at the outlet of the BPR, the. internal 
volume of the extraction cell was swept slightly more than six 
. full times with supercritical fIuid~'The mole fraction solubility 
is' dependent on the volume of carbon dioxide used in the 
extraction and is calculated as follows: 
mole fraction solubility. = 
moles of analyte extracted " 
moles of analyte extracted + moles of CO2 used ' 
For a 10 min extraction at 1 ml min- t a 10 ml volume of carbon 
dioxide is. used. Therefore the number of moles of carbon 
dioxide used is given by 
moles of CO2 = 
,volume of CO2 (ml) x densityofliquid CO2 (gml- I ) 
. relative molecular mass of CO2 (g mol -I) 
where the density of liquid CO2 is 0.93 g ml- t • Analysis of the 
extracts w~s peformed on a UVNIS spectrophotometer using 
Table 1 Comparison of literature and measured solubilities for 
testosterone at 35 and 55°C 
Literature Measured Literature Measured 
values at values at values at values at 
35°CJmole 35°CJmole 55°CJmole 55°CJmole 
Pressure! fraction fraction fraction fraction 
kgcm-2 x 10-7 X 10-7 X 10-7 X 10-7 
84 
101 
116 
132 
149 
164 
181 
200 
215 
231 
22.8 65.7 3.90 9.53 
. '73.1 82.2 9.50 28.6 
119 131 30.8 82.5 
201 246 84.4 104 
258 296 137 197 
316 312 .247 230 
343 329 423 279 
398 378 483 477 
450 411 619 690 
503 526 701 739 
1 X 10-3,---------------, 
~ 
e! ~ 1 X 10-' 
c 
~ 
~ 1x 10-6 I-
Q) 
(5 
'" IHerature values 
o This work 
'" ~ I I I 1 x 10 .... L-__ -L-__ --1___ ...L.-__ .....J 
50 100 150 200 250 
Pressurelkg cm-2 
Fig. 2 Solubility isotherm for testosterone at 35°C. 
1 x 10-3 ,----------------, 
'C 
'" Uterature values ~ 1 x 10-' I- D This work o g g e! 
'" x 0 D Q) ~ g 1 X 10-6 I- 9 ~ D 
~ D '" Q) 
~ 1 x 10 .... fo- D 
'" 
'" 
1 x 10-7 I 
50 100 150 200 250 
Pressurelkg cm-2 
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10 mm silica cells for all measurements. Quantification was 
achieved by diluting all extracted steroids to 10 mi' and 
measuring the absorbance against a four-point linear calibra-
tion graph. " 
Table 2 Measured steroid solubility data 
Pressure! 
kgcm-1 
Testosterone-
84 
101 
116 
132 
149 
164 
181 
200 
215 
Measured 
values at 
35°CJmole 
fraction· 
6.57 X 10-6 
8.22 X 10-6 
1.31 x 10-5 
. 2.46 x 10-5 
2.96 x 10-5 
3.12 x 10-5 
3.29 x 10-5 
3.78 x 10-5 ' 
4.11 x 10-5 
5.26 x 10-5 231 
Testosterone-17-propionate-
Measured 
values at 
55°CJmole 
fraction 
9.53 X 10-7 
2.86 X 10-6 
8.25 X 10-6 
1.04 x 10-5 
1.97 x 10-5 
2.30 x 10-5 
2.79 x 10-5 
4.77 x 10-5 
6.90 x 10-5 
7.39 x 10-5 
84 NO" 1.31 X 10-6 
101 (' NO 7.01 X 10-6 
116 NO 1.31 x 10-5 
132 NO 1.65 x 10-5 
149 NO 2.62 x 10-5 
164 NO 4.13 x 10-5 
181 NO 6.35 x 10-5 
200 NO 7.58 x 10-5 
215 NO 8.25 x 10-5 
231 ND 9.10 x 10-5 
Beclomethasone-17,21-dipropionate-
84 ' 1.46 X 10-6 • 1.87 X 10-7 
101 4.00 X 10-6 .' '5.03 X 10-7 
116 2.27 x 10-5 ' 2.30 X 10-6 
132 2.53 x 10-5 ; 4.68 X 10-6 
149 2.82 x 10-5 8.88 X 10-6 
164 4.32 x 10-5 1.09 x 10-5 
181 'NO' 2.62 x 10-5 
200 8.00 x 10-5 3.00 x 10-5 
215 8.64 x 10-5 3.39 x 10-5 
231 8.64 x 10-5 4.90 x 10-5 
Betameihasone-i 7,21-dipropionate- ..'. 
84 5.64 X 10-7 NO 
101 2.72 x 10-6 NO 
116 3.48 x 10-6 2.12 X 10-7 
132 6.39 x 10-6 ' 1.70 X 10-6 
149 2.19 x 10-5 4.62 X 10-6 
164 2.39 x 10-5 - 1.38 x 10-5 
181 4.66 x 10-5 1.88 x 10-5 
200 5.30 x 10-5 2.62 x 10-5 
215 6.06 x 10-5 ,5.84 x 10-5 . 
231 6.72 x 10-5 7.03 x 10-5 • 
Megestrol acetate-
84 NO 
101 NO 
116 NO 
132 NO 
149 NO 
164 NO 
181 NO 
200 NO 
215 NO 
231 NO 
Cortisone acetate-
84 4.83 x 10-7 
101 9.87 x 10-7 
116 1.93 x 10-6 
132 2.18 x 10-6 
6.40 X 10-7 
1.09 X 10-6 
- 2.32 X 10-6 
7.16 X 10-6 
1.36 x 10-5 
2.34 x 10-5 
3.82 x 10-5 
4.93 x 10-5 
5.17 x 10-5 
5.31 x 10-5 
1.49 X 10-7 
2.76 X 10-7 
4.49 X 10-7 
5.40 X 10-7 
Measured 
values at 
100°CJmole 
fraction 
4.60 X 10-7 
8.20 X 10-7 
1.56 X 10-6 
1.97 X 10-6 
1.64 x 10-5 
2.46 x 10-5 
3.94 x 10-5 
6.39 x 10-5 
8.53 x 10-5 
9.05 x 10-5 
5.64 X 10-7 
9.76 X 10-7 
1.31 X 10-6 
5.64 X 10-6 
1.22 x 10-5 
1.65 x 10-5 
5.36 x 10-5 
7.39 x 10-5 
8.53 x 10-5 
9.95 x 10-5 
NO 
1.20 X 10-7 
I 5.51 X 10-7 
8.01 x 10-5 
3.21 x 10-5 
6.01 X 10-6 
8.95 X 10-6 
1.01 x 10-5 
1.25 x 10-5 
3.09 x 10-5 
ND 
NO 
-NO 
'8.51 x 10-7 
3.11 X 10-6 
8.99 X 10-6 
1.19 x 10-5 
2.12 x 10-5 
. 5.55 x 10-5 
. 6.19 x 10-5 
1.09 X 10-6 
2.84 X 10-6 
8.06 X 10-6 -
1.37 x 10-5 
2.33 x 10-5 
2.95 x 10-5 
4.36 x 10-5 .. ; 
5.07 x 10-5 
5.54 x 10-5 
.: 6.61 x 10-5 
1.11 X 10-7 . 
2.25 X 10-7 
·3.51 X 10-7 " 
4.90 X 10-7 '!. 
continued-
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149 2.65"(10-6 ' '1.23 X 10-6 1.11 X 10-6 
164 3.10x 10-6 1.42 x 10-6 1.25 X 10-6 
181 3.09 x 10-6 1.52 X 10-6 1.32 X 10-6 
200 3.24 X 10-6 1.61 X 10-6 1.45 X 10-6 
215 3.78 x 10-6 2.08 X 10-6 1.91 X 10-6 
231 ' '4.14 X 10-6 2.55 X 10-6 2.31 X 10-6 
Betamethasone-
84 1.33 x 10-8 1.21 X 10-9 ND 
101 . . '3.71 X 10-8 3.62 X 10-9 ND 
116 7.73 x 10-8 2.54 X 10-8 ND 
132 1.21 x 10-7 3.63 X 10-8 ND 
149 1.49 x 10-7 4.71 X 10-8 ND 
164 2.28 x 10-7 7.73 X 10-8 ND 
181 2.67 x 10-7, .- 8.33 X 10-8 ND 
200 3.31 x 10-7 1.12 X 10-7 ND 
215 3.45 x 10-7 , 1.21 X 10-7 ND 
231 3.63 x 10-7 1.28 X 10-7 ND 
Hydrocortisone-
84 ND ND ND 
101 4.58 x 10-8 4.25 X 10-9 2.51 X 10-9 
116 9.81 x 10-8 9.79 X 10-8. 6.31 X 10-8 
132 1.24 x 10-7, < 1.63 X 10-7 1.39 X 10-7 
149 1.48 x 10-7 2.32 X 10-7 1.64 X 10-7 
164 2.54 x 10-7 3.93 X 10-7 " 4.57 X 10-7 . 
181 05.16 x 10-7 5.68 X 10-7 5.02 X 10-7 
200 5.75 X 10-7 6.93 X 10-7 6.44 X 10-7 
215 8.73 X 10-7 8.65 X 10-7 ND 
231 9.01 X 10-7 8.78 X 10-7 7.34 X 10-7 
Prednisolone-
84 3.94 X 10-9 1.22 X 10-9 ND 
101 2.76 X 10-8 3.75 X 10-9 .ND 
116 6.67 x 10-;-8 1.15 X 10-8 9.05 X 10-9 
132 9.34 X 10-8 2.68 X 10-8 1.13 X 10-8 
149 1.17 x 10-7 3.92 X 10-8 1.46 X 10-8 
164 1.70 x 10-7 4.66 X 10-8 , 3.29 X 10-8 
181 2.55 x 10-7 6.56 X 10-8 5.40 X 10-8 
200 3.50 X 10-7 9.79 X 10-8 7.01 X 10-8 
215 4.13 x 10-7 1.22 X 10-7 8.58 X 10-8 
231 7.28 x, 10;-7 1.31 X 10-7 9.86 X 10-8 
Predniso~~ 
84 6.57 X 10-9 1.22 X 10-9 ND 
101 2.63 x 10-8 1.35 X 10-9 ND 
116 5.13 x 10-8 I, 6.28 X 10-9 5.01 X 10-9 
132 7.89 x 10-8 1.60 x 10-8 1.40 x 10-8 
149 1.18 x 10-7 . 3.87 X 10-8 3.41 X 10-8 
164 1.54 x 10-7 8.00 X 10-8 ·7.88 X 10-8 
181 ',~ 2.88 X 10-7 1.26 X 10-7 1.12 X 10-7 
200 4.85 X 10-7 2.66 X 10-7 1.91 X 10-7 
215 ,6.59 x 10-7 4.27 X 10-7 3.13 X 10-7 
231 
" 
8.93 x 10-7 6.37 x 10-7 5.88 X 10-7 
• ND = Not determined. 
Table 3 Example calculation of solubility parameter by the Fedors 
method for te~tosterone 6z = (AEv/V)°.s = 11.16, 
Contri- AEvper Vper 
Total Al!v ' Total V 
for for 
bution . fragment " fragment Testosterone Testosterone 
CH3- 1125 33.5 2250 67 
CH2- 1180 16.1 9440 128.8 
CH- 820 -1.0 3280 -4 
HC= 1030 . 13.5 1030 13.5 
C- 350 -19.2 700 -38.4 
C= 1030 -5.5 1030 -5.5 
C=O 4150 10.8 4150 10.8 
OH 7120 10 7120 10 
Ring closure' 250 16 '1000' 64 
~atoms 
Conjugated 400 -2.2 400 -2.2 
double bonds 
Total 30400 244 
Results and Discussion Ii ,I , .' ,I",. Y .'1·" 
Steroid Solubility Studies 
, , - ~ / j 
Initial work focused on a direct comparison be'tween solubility 
data reported for testosterone22 , 'and, experimental data 
acquired during the course of, this work, thus allowing the 
robustness of the experimental method to be evaluated. The 
experiments were designed to provide increased knowledge 
on the solubility of steroid hormones in supercritical carbon 
dioxide, which at the same time, allowed realistic selection of 
conditions for the extraction of steroid hormones from tablets, 
ointment or creams. I " • 
Testosterone has a greater solubility in' supercritical C02 
than most of the nine other steroids studied in this work. 
Testosterone's solubility in supercritical CO2 has been deter-
mined22 using apparatus capable of dealing with much greater 
amounts of solubilized solid than the analytical SFE 
instrumentation used in this work. However, a comparison 
was undertaken and the solubility determined at two different 
temperatures (35 and 55°C) and over, a range of pressures. 
Table 1 shows that the measured mole fraction solubilities for 
testosterone are similar to the literature yalues. This is shown 
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Tabl~ 4 Prediction of steroid solubility in supercritical CO2 using solubility parameter and Clog P 
Identifier for Solubility Predicted solubility 
Steroid Fig. 4 parameter, b2 ClogP* in supercritical CO2 
Betamethasone-17,21-
dipropionate 
Betamethasone 
Testosterone 
Testosterone-17-
propionate 
Hydrocortisone 
Megestrol acetate 
Prednisolone 
Prednisone 
Cortisone acetate 
BecIomethasone-17,21-
dipropionate 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11.42 
13.83 
11.16 
9.95 
13.87 
10.44 
14.09 
13.48 
12.08 
11.53 
2.872 
0.806 
3.349 
4.784 
0.658 
3.904 
0.444 
-0.Q18 
0.700 
3.212 
Soluble 
Insoluble 
Soluble 
Soluble 
Insoluble 
Soluble 
Insoluble 
Insoluble 
Intermediate 
Soluble 
• Taken from Clog P, Medchem (1989), Daylight Chemical Systems, Pomona College Medical Chemistry Project, Pomona College, 
Claremont, CA, USA. 
by the isotherms of both experimental and literature values in 
Figs. 2 and .3. All experimental values were determined at . 
least in duplicate. The experimental variation in the solubility 
determination was estimated to be < 3% Sr. 
The fact that the extraction method and the chosen method 
of analysis provided very similar results to the literature 
values, led to the conclusion that this was a suitable method of' 
solubility determination. The greatest variation from the 
literature values was observed at the lower pressures studied. 
Errors in this region are thought more likely because of the 
very small solubility shown by testosterone and the other 
steroids at the resulting density conditions and also the smaller 
experimental scale of this work. The results for testosterone 
and the other nine steroids are shown in Table 2. 
Steroid Solubility Prediction Using C log P and Solubility 
Parameter 
The solubility parameter for each steroid was ~alculated 
according to the scheme shown in Table 3. Table 4 summarizes 
aU the calculated solubility parameter data with the computer 
database values for Clog P. A plot of solubility parameter 
versus Clog P is shown in Fig. 4. From this it can be deduced 
that the probable solubility of the selected steroids is likely to 
be as indicated in Table 4 .. Obviously, this scheme does not 
estimate supercritical conditions, such as, temperature and 
pressure but the trends shown in Fig. 5, a plot of steroid 
solubility isotherms at 55°C, indicates a reasonable approxi-
mation to solubility in supercritical carbon dioxide. 
Conclusions 
A prediction of steroid solubility in supercritical carbon 
dioxide is described, based on the solubility parameter and the 
hydrophobic term, Clog P. The qualitative data identifies 
trends in steroid solubility which compare favourably with the 
experimentally determined values for ten steroids in super-
Critical carbon dioxide over a range of temperatures and 
pressures. 
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Research Centre; Glaxo Manufacturing Services, Barnard 
Castle; and, Pfizer Central Research, Sandwich. The assis-
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(al> a2) define the contribution of each variable Xi to a given 
principal component, PCx : 
PCx = al*XI + a2*X2 . . . (1) 
( A factor score represents the value of an individual sample with 
, respect to a given principal component. The score for sample 
number n on principal component PCx is: 
score = au * X ln + a2x * X2n • • • (2) 
where the aix are the loadings for PCx and Xin are the values of 
the variables describing sample number n. 
When the scores for factors 1 and 2 were plotted against one 
another three distinct groups were indicated. Investigation of 
the associated loadings showed that the most important factors 
in determining group membership of the samples were (for 
, powder): aluminium, copper, manganese, molybdenum and 
silicon; and (for wire): aluminium, manganese, molybdenum 
and silicon. 
However, the molybdenum content showed the largest 
percentage difference between the three groups with group 1 
containing 51.5% and 48.6%, group 2 containing 36.1% and 
39.3% and group 3 containing 12.4% and 12.1% for powder 
and wire, respectively. Similar findings have suggested that 
ores (ferberite and reinite) from the two tungsten-producing 
ANALYTICAL PROCEEDINGS, DECEMBER 1993, VOL 30 
areas of the Uganda Protectorate could be characterized 
according to their manganese4 and molybdenums content. 
Conclusions 
The use of a chemometric approach to data interpretation has 
shown that a significantly smaller number of element assays are 
required to elucidate the quality of tungsten for electric light 
filament application. The continued use of chemometrics may 
alleviate the necessity for high-cost instrumentation for routine 
analysis. 
The authors are grateful to Dr. R. Snee, Lamp Metals Ltd., 
Gateshead, for the tungsten data. 
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Extraction of Ibuprofen by Supercritical Carbon Dioxide 
S. Khundker, J. R. Dean* and S. M. Hitchen 
Department of Chemical and Life Sciences, University of Northumbria at Newcastle, Ellison Building, 
Newcastle upon Tyne NE1 8ST 
Supercritical fluids have unique properties which are particu-
larly effective in extraction processes. I They exhibit solvation 
properties similar to those of liquids and have lower viscosities 
and higher diffusivities which leads to rapid and efficient 
extraction of analltes. Moreover, the solvent strength of a 
supercritical fluid increases with increasing density, thus 
allowing alteration of the extraction selectivity simply by 
Changing the pressure or the temperature. Carbon dioxide is 
the most common supercritical fluid in use due to its low critical 
temperature, moderate critical pressure, relative inertness, 
non-toxicity and ready availability in high purity at low cost. 
In the pharmaceutical industry, the use of supercritical fluid 
extraction for sample preparation is becoming more wide-
spread, owing to its safety and environmental advantages 
relative to other extraction methods. This paper reports the 
, extraction of the non-steroidal anti-inflammatory drug ibupro-
, fen3 [racemic 2-(4-isobutylphenyl)propionic acid; Fig. 1] using 
supercritical carbon dioxide. 
Experimental 
, Instrumentation 
• An Isco Model 260D pump module and controller (SFX 2-10) 
I Was used for extraction. Supercritical fluid chromatography 
(SFC) grade carbon dioxide (Air Products, Sunderland) was 
used with a certified purity of 99.995%. A schematic diagram 
of the apparatus is shown in Fig. 2. 
Me Me 
H-f-CH2Q6H-COOH 
Me 
Fig. 1 Structural formula of ibuprofen 
* To whom correspondence should be addressed. 
Carbon 
dioxide 
Restrictor 
Rubber 
septum 
High-pressure 
syringe pump 
Restrictor 
heater 
Fig. 2 Schematic diagram of supercritical fluid extractor 
Liquid carbon dioxide was pumped usinr a syringe pump capable of delivering a flow rate of 1 III min-to 90 ml min -I at 
pressures up to 7500 psi. t The extraction vessels consisted of a 
metal body with upper and lower endcaps fitted with filters. 
These filters were inserted into the endcaps which then were 
screwed onto the metal body containing the sample. The 
extraction chamber was tightly fitted into an aluminium heater 
block consisting of a stainless steel body capable of withstand-
ing the high pressures (10000 psi) and temperatures (150°C) 
used in the extraction processes. The aluminium block acts as a 
very effective heat-transfer medium between the extraction 
vessel and chamber for stable temperature control. Depressur-
ization was achieved using a silica fused capillary restrictor (50 
Ilm) into an appropriate collection solvent. The collection 
solvent was placed in a screw-capped amber vial fitted. with a 
rubber septum. A hypodermic needle pierced the septum to 
I 
t 1 psi = 6.89476 x 1()-1 Pa. 
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t 
al g 
e g 
~ 
'2.98"6.44 t-
Time/min 
~ig. 3 Typical high-performance liquid chromatography trace for 
Ibuprofen. Column: CIS; acetonitrile-phosphate buffer (6 + 4); pH 
3.0; flow rate 1 ml min-I; detection at 254 nm 
alI ow carbon dioxide to vent. Blockages were minimized by 
heating the entire length of the fused silica restrictor to 100 0c. 
HPLC Analysis of Ibuprofen 
The high-performance liquid chromatography (HPLC) was 
carried out using an LDC Spectromonitor III with ultraviolet 
detection (254 nm). Chromatographic peaks were recorded 
~sing an LDaMilton Roy CI-tO integrator. A 20 III sample of 
Ibuprofen was injected onto an octadecyl column with aceto-
nitrile-phosphate buffer (6 + 4) at pH3.0andat a flow rate of 1 
1111 min-I. The retention time of ibuprofen was 7 min. Each 
extract was injected three times and the average peak area was 
used for calculating the percentage amount extracted. Fig. 3 
shows a typical HPLC trace of ibuprofen. 
Supercritical Fluid Extraction Procedure 
The extraction of ibuprofen involved spiking Celite with 100 III 
(50000 ppm) of ibuprofen standard in methanol. The spiked 
sample was then quantitatively transferred into the 2.5 ml 
extraction vessel and dynamic extraction carried out for to min 
with supercritical carbon dioxide, at different temperatures 
a?d pressures. After extraction, the collection vessel was 
I1nsed several times with HPLC mobile phase and the final 
Volume adjusted to 10 ml. The experiment was performed in 
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Fig. 4 Solubility isotherm for ibuprofen in supcrcritical carbon 
dioxide. A. 50; B. 60; C. 70°C 
triplicate at each set of extraction conditions. The extracted 
sample was analysed by HPLC. 
Results and Discussion 
The primary factors that influence extraction, i.e., density and 
temperature, were investigated. From the results obtained, a 
series of isotherms were constructed (Fig. 4) at three tempera-
tures (50, 60 and 70°C). It is apparent that ibuprofen, although 
being slightly polar, is soluble in supercritical carbon dioxide at 
moderately high density and temperature. As Fig. 4 shows, 
small changes in pressure had dramatic effects on percentage 
extracted across the whole of the isotherm. The optimum 
conditions found for the extraction of ibuprofen were a 
temperature of 70°C and a density of 0.7 g ml- I. 
Conclusion 
It is clear that SFE can be used as a sample preparation 
technique in the pharmaceutical industry. However, it must be 
noted that the extraction of an analyte in different pharma-
ceutical matrices does present recovery problems. Future work 
will involve extraction of ibuprofen from different tablet 
matrices. 
The authors are grateful to Jones Chromatography Ltd., 
Clwyd, for the loan of the Isco SFE system. 
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l{ecent developments in computer technology are leading to 
dramatic increases in the use of computational chemistry for 
1l10dellinr., optimization and artificial intelligence. All these 
ll1ethods .2 have been adapted and applied to supercritical fluid 
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extraction. This paper, however focuses on two particular 
types of computational chemistry: one in which a neural 
network is used to predict analyte solubility in supercritical 
carbon dioxide and another where a molecular modelling 
program is used to investigate the solute-solvent interactions 
which occur during supercritical fluid extraction. The software 
